EurekaMag PDF full texts Chapter 72,033

Tong, W.-H.; Mu, J.-F.; Zhang, S.-P. 2021: LINC00346 accelerates the malignant progression of colorectal cancer via competitively binding to miRNA-101-5p/MMP9. European Review for Medical and Pharmacological Sciences 25(9): 3398

Peng, W-Xin.; He, R-Zhang.; Zhang, Z.; Yang, L.; Mo, Y-Yuan. 2019: LINC00346 promotes pancreatic cancer progression through the CTCF-mediated Myc transcription. Oncogene 38(41): 6770-6780

Li, Y.; Li, H.; Wang, W.; Yu, X.; Xu, Q. 2020: LINC00346 regulates glycolysis by modulation of glucose transporter 1 in breast cancer cells. Molecular and Cellular Probes 54: 101667

Zhao, W.; Jin, Y.; Wu, P.; Yang, J.; Chen, Y.; Yang, Q.; Huo, X.; Li, J.; De, W.; Chen, J.; Yang, F. 2020: LINC00355 induces gastric cancer proliferation and invasion through promoting ubiquitination of P53. Cell Death Discovery 6: 99

Zhao, W.; Jin, Y.; Wu, P.; Yang, J.; Chen, Y.; Yang, Q.; Huo, X.; Li, J.; De, W.; Chen, J.; Yang, F. 2020: LINC00355 induces gastric cancer proliferation and invasion through promoting ubiquitination of P53. Cell Death Discovery 6(1): 99

Luan, P.-B.; Sun, X.-M.; Yao, J. 2020: LINC00355 inhibits apoptosis and promotes proliferation of gastric cancer cells by regulating Wnt/β-catenin signaling pathway. European Review for Medical and Pharmacological Sciences 24(16): 8377-8383

Sun, X.; Wang, G.; Ding, P.; Li, S. 2020: LINC00355 promoted the progression of lung squamous cell carcinoma through regulating the miR-466/LYAR axis. Brazilian Journal of Medical and Biological Research 53(12): E9317

Zhou, F.; Lei, Y.; Xu, X.; Zhou, H.; Liu, H.; Jiang, J.; Yang, Y.; Wu, B. 2020: LINC00355:8 promotes cell proliferation and migration with invasion via the MiR-6777-3p/Wnt10b axis in Hepatocellular Carcinoma. Journal of Cancer 11(19): 5641-5655

Li, L.; Zheng, B.; Zhang, F.; Luo, X.; Li, F.; Xu, T.; Zhao, H.; Shi, G.; Guo, Y.; Shi, J.; Sun, J. 2021: LINC00370 modulates miR-222-3p-RGS4 axis to protect against osteoporosis progression. Archives of Gerontology and Geriatrics 97: 104505

Han, H.; Shao, Q.; Liu, X. 2020: LINC00441 promotes cervical cancer progression by modulating miR-450b-5p/RAB10 axis. Cancer Cell International 20: 368

Yang, J.; Wang, W.-G.; Zhang, K.-Q. 2020: LINC00452 promotes ovarian carcinogenesis through increasing ROCK1 by sponging miR-501-3p and suppressing ubiquitin-mediated degradation. Aging 12(21): 21129-21146

Yang, Y.; Xu, W.; Zheng, Z.; Cao, Z. 2019: LINC00459 sponging miR-218 to elevate DKK3 inhibits proliferation and invasion in melanoma. Scientific Reports 9(1): 19139

Cisneros-Villanueva, M.; Hidalgo-Pérez, L.; Cedro-Tanda, A.; Peña-Luna, M.ón.; Mancera-Rodríguez, M.A.; Hurtado-Cordova, E.; Rivera-Salgado, I.; Martínez-Aguirre, A.; Jiménez-Morales, S.; Alfaro-Ruiz, L.A.; Arellano-Llamas, R.ío.; Tenorio-Torres, A.; Domínguez-Reyes, C.; Villegas-Carlos, F.; Ríos-Romero, M.; Hidalgo-Miranda, A. 2021: LINC00460 Is a Dual Biomarker that Acts as a Predictor for Increased Prognosis in Basal-Like Breast Cancer and Potentially Regulates Immunogenic and Differentiation-Related Genes. Frontiers in Oncology 11: 628027

Yang, Y.; Wang, R.; Feng, L.; Ma, H.; Fang, J. 2021: LINC00460 Promotes Cell Proliferation, Migration, Invasion, and Epithelial-Mesenchymal Transition of Head and Neck Squamous Cell Carcinoma via miR-320a/BGN Axis. Oncotargets and Therapy 14: 2279-2291

Wu, J.; Sun, S.; Liao, W.; Chen, E.; Wang, X.; Song, Y.; Duan, F.; Deng, W.; Li, S. 2021: LINC00460 promotes pancreatic cancer progression by sponging miR-491-5p. Journal of Gene Medicine 23(6): E3333

Wang, H.-X.; Kang, L.-J.; Qin, X.; Xu, J.; Fei, J.-W. 2020: LINC00460 promotes proliferation and inhibits apoptosis of non-small cell lung cancer cells through targeted regulation of miR-539. European Review for Medical and Pharmacological Sciences 24(12): 6752-6758

Hou, P.; Meng, S.; Li, M.; Lin, T.; Chu, S.; Li, Z.; Zheng, J.; Gu, Y.; Bai, J. 2021: LINC00460/DHX9/IGF2BP2 complex promotes colorectal cancer proliferation and metastasis by mediating HMGA1 mRNA stability depending on m6A modification. Journal of Experimental and Clinical Cancer Research: Cr 40(1): 52

Guan, Y.; Guan, A.; Chen, L.; Gong, A. 2021: LINC00461 facilitates HNSCC development and reduces chemosensitivity by impairing miR-195-mediated inhibition of HOXA10. Molecular Therapy Oncolytics 21: 74-86

Jiang, H.; Deng, W.; Zhu, K.; Zeng, Z.; Hu, B.; Zhou, Z.; Xie, A.; Zhang, C.; Fu, B.; Zhou, X.; Wang, G. 2021: LINC00467 Promotes Prostate Cancer Progression via M2 Macrophage Polarization and the miR-494-3p/STAT3 Axis. Frontiers in Oncology 11: 661431

Xiao, J.; Gong, L.; Xiao, M.; He, D.; Xiang, L.; Wang, Z.; Cheng, Y.; Deng, L.; Cao, K. 2021: LINC00467 Promotes Tumor Progression via Regulation of the NF-kb Signal Axis in Bladder Cancer. Frontiers in Oncology 11: 652206

Zhu, Y.; Li, J.; Bo, H.; He, D.; Xiao, M.; Xiang, L.; Gong, L.; Hu, Y.; Zhang, Y.; Cheng, Y.; Deng, L.; Zhu, R.; Ma, Y.; Cao, K. 2020: LINC00467 is up-regulated by TDG-mediated acetylation in non-small cell lung cancer and promotes tumor progression. Oncogene 39(38): 6071-6084

Huang, T.; Wang, Y-Jie.; Huang, M-Tao.; Guo, Y.; Yang, L-Chang.; Liu, X-Jin.; Tan, W-Yuan.; Long, J-Hong. 2021: LINC00470 accelerates the proliferation and metastasis of melanoma through promoting APEX1 expression. Cell Death and Disease 12(5): 410

Wu, C.; Su, J.; Long, W.; Qin, C.; Wang, X.; Xiao, K.; Li, Y.; Xiao, Q.; Wang, J.; Pan, Y.; Liu, Q. 2020: LINC00470 promotes tumour proliferation and invasion, and attenuates chemosensitivity through the LINC00470/miR-134/Myc/ABCC1 axis in glioma. Journal of Cellular and Molecular Medicine 24(20): 12094-12106

Guo, H.-L.; Wang, X.; Yang, G.-Y.; Wu, Y.-Y.; Chen, Y.-C.; Zhan, H.-S.; Zhao, Y.-F. 2020: LINC00472 promotes osteogenic differentiation and alleviates osteoporosis by sponging miR-300 to upregulate the expression of FGFR2. European Review for Medical and Pharmacological Sciences 24(9): 4652-4664

Fan, G.; Liu, J.; Zhang, Y.; Guan, X. 2021: LINC00473 exacerbates osteoarthritis development by promoting chondrocyte apoptosis and proinflammatory cytokine production through the miR-424-5p/LY6E axis. Experimental and Therapeutic Medicine 22(5): 1247

Hao, X.-F.; Zhang, Y.-X.; Wang, X.-X.; Sun, W.; Zhao, J.; Chen, G.-R. 2020: LINC00473 functions as an oncogene and predicts poor prognosis in pancreatic cancer via the cAMP/β-catenin axis. European Review for Medical and Pharmacological Sciences 24(10): 5345-5352

Xu, Y.; Jiang, Y.; Wang, Y.; Ren, Y.; Zhao, Z.; Wang, T.; Li, T. 2020: LINC00473 regulated apoptosis, proliferation and migration but could not reverse cell cycle arrest of human bone marrow mesenchymal stem cells induced by a high-dosage of dexamethasone. Stem Cell Research 48: 101954

Brex, D.; Barbagallo, C.; Mirabella, F.; Caponnetto, A.; Battaglia, R.; Barbagallo, D.; Caltabiano, R.; Broggi, G.; Memeo, L.; Di Pietro, C.; Purrello, M.; Ragusa, M. 2020: LINC00483 Has a Potential Tumor-Suppressor Role in Colorectal Cancer Through Multiple Molecular Axes. Frontiers in Oncology 10: 614455

Qiao, Y.-S.; Zhou, J.-H.; Jin, B.-H.; Wu, Y.-Q.; Zhao, B. 2021: LINC00483 is regulated by IGF2BP1 and participates in the progression of breast cancer. European Review for Medical and Pharmacological Sciences 25(3): 1379-1386

Xu, H.; Ye, Y. 2021: LINC00488 stimulates the progression of esophageal cancer by targeting microRNA-485-5p. Oncology Letters 21(2): 86

Xu, J.; Chen, G.; Zhang, Y.; Huang, Z.; Cheng, X.; Gu, H.; Xia, J.; Yin, X. 2020: LINC00511 Promotes Osteosarcoma Tumorigenesis and Invasiveness through the miR-185-3p/E2F1 Axis. Biomed Research International 2020: 1974506

Agbana, Y.L.; Abi, M.-E.; Ni, Y.; Xiong, G.; Chen, J.; Yun, F.; Yi, Z.; Zhang, Q.; Yang, Z.; Kuang, Y.; Zhu, Y. 2020: LINC00511 as a prognostic biomarker for human cancers: a systematic review and meta-analysis. Bmc Cancer 20(1): 682

Peng, X.; Li, X.; Yang, S.; Huang, M.; Wei, S.; Ma, Y.; Li, Y.; Wu, B.; Jin, H.; Li, B.; Tang, S.; Fan, Q.; Liu, J.; Yang, L.; Li, H. 2021: LINC00511 drives invasive behavior in hepatocellular carcinoma by regulating exosome secretion and invadopodia formation. Journal of Experimental and Clinical Cancer Research: Cr 40(1): 183

Lu, Y.; Tian, M.; Liu, J.; Wang, K. 2021: LINC00511 facilitates Temozolomide resistance of glioblastoma cells via sponging miR-126-5p and activating Wnt/β-catenin signaling. Journal of Biochemical and Molecular Toxicology 35(9): E22848

Wu, Y.; Li, L.; Wang, Q.; Zhang, L.; He, C.; Wang, X.; Liu, H. 2020: LINC00511 promotes lung squamous cell carcinoma proliferation and migration via inhibiting miR-150-5p and activating TADA1. Translational Lung Cancer Research 9(4): 1138-1148

Zhu, F-Y.; Zhang, S-R.; Wang, L-H.; Wu, W-D.; Zhao, H. 2019: LINC00511 promotes the progression of non-small cell lung cancer through downregulating LATS2 and KLF2 by binding to EZH2 and LSD1. European Review for Medical and Pharmacological Sciences 23(19): 8377-8390

Dong, L.-M.; Zhang, X.-L.; Mao, M.-H.; Li, Y.-P.; Zhang, X.-Y.; Xue, D.-W.; Liu, Y.-L. 2021: LINC00511/miRNA-143-3p Modulates Apoptosis and Malignant Phenotype of Bladder Carcinoma Cells via PCMT1. Frontiers in Cell and Developmental Biology 9: 650999

Luo, X.; Wang, H. 2021: LINC00514 upregulates CCDC71L to promote cell proliferation, migration and invasion in triple-negative breast cancer by sponging miR-6504-5p and miR-3139. Cancer Cell International 21(1): 180

Tang, H.; Dou, Y.; Meng, Y.; Lu, Q.; Liang, L.; Luo, Y. 2020: LINC00538 promotes the progression of colon cancer through inhibiting NKD2 expression. Journal of Buon: Official Journal of the Balkan Union of Oncology 25(6): 2657-2664

Shao, X.; Zhao, T.; Xi, L.; Zhang, Y.; He, J.; Zeng, J.; Deng, L. 2021: LINC00565 promotes the progression of colorectal cancer by upregulating EZH2. Oncology Letters 21(1): 53

Luo, T.; Yan, L.; Liu, H. 2020: LINC00632 inhibits the malignant development of non-small cell lung cancer by downregulating miR-1203. Journal of Buon: Official Journal of the Balkan Union of Oncology 25(3): 1517-1524

Liu, W.-H.; Lu, J.-J.; Yu, R.-K.; Zhou, L.; Yu, Q.; Li, D.-F.; Zhu, Q.-H. 2021: LINC00641 regulates prostate cancer cell growth and apoptosis via the miR-365a-3p/VGLL4 axis. European Review for Medical and Pharmacological Sciences 25(1): 108-115

Yang, J.; Yu, D.; Liu, X.; Changyong, E.; Yu, S. 2020: LINC00641/miR-4262/NRGN axis confines cell proliferation in glioma. Cancer Biology and Therapy 21(8): 758-766

Hu, Y.; Su, Y.; Lei, X.; Zhao, H.; Wang, L.; Xu, T.; Guo, J.; Yang, W.; Zhang, X. 2020: LINC00641/miR-582-5p mediate oxaliplatin resistance by activating autophagy in gastric adenocarcinoma. Scientific Reports 10(1): 14981

Liu, Y.; Huang, X.; Guo, L.; Luo, N. 2022: LINC00649 Facilitates the Cellular Process of Bladder Cancer Cells via Signaling Axis miR-16-5p/JARID2. Urologia Internationalis 106(3): 304-312

Guo, C.; Gao, Y.-Y.; Ju, Q.-Q.; Zhang, C.-X.; Gong, M.; Li, Z.-L. 2020: LINC00649 underexpression is an adverse prognostic marker in acute myeloid leukemia. Bmc Cancer 20(1): 841

Cao, X.; Zhang, G.; Li, T.; Zhou, C.; Bai, L.; Zhao, J.; Tursun, T. 2020: LINC00657 knockdown suppresses hepatocellular carcinoma progression by sponging miR-424 to regulate PD-L1 expression. Genes and Genomics 42(11): 1361-1368

Zhao, L.; Liu, C.; Yan, S.; Hu, G.; Xiang, K.; Xiang, H.; Yu, H. 2020: LINC00657 promotes colorectal cancer stem-like cell invasion by functioning as a miR-203a sponge. Biochemical and Biophysical Research Communications 529(2): 500-506

Lei, Y.; Wang, Y.-H.; Wang, X.-F.; Bai, J. 2021: LINC00657 promotes the development of colon cancer by activating PI3K/AKT pathway. European Review for Medical and Pharmacological Sciences 25(6): 2460

Yao, Y.; Liu, Y.; Jin, F.; Meng, Z. 2021: LINC00662 Promotes Oral Squamous Cell Carcinoma Cell Growth and Metastasis through miR-144-3p/EZH2 Axis. Yonsei Medical Journal 62(7): 640-649

Xia, X.-Q.; Lu, W.-L.; Ye, Y.-Y.; Chen, J. 2020: LINC00662 promotes cell proliferation, migration and invasion of melanoma by sponging miR-890 to upregulate ELK3. European Review for Medical and Pharmacological Sciences 24(16): 8429-8438

Zhang, Z.; Liang, X.; Ren, L.; Zhang, S.; Li, S.; Wan, T.; Xu, D.; Lv, S. 2020: LINC00662 promotes cell viability and metastasis in esophageal squamous cell carcinoma by sponging miR-340-5p and upregulating HOXB2. Thoracic cancer 11(8): 2306-2315

Tao, L.M.; Gong, Y.F.; Yang, H.M.; Pei, J.H.; Zhao, X.J.; Liu, S.S. 2020: LINC00662 promotes glycolysis and cell survival by regulating miR- 375/HIF-1α axis in ovarian cancer. Journal of Biological Regulators and Homeostatic Agents 34(3): 467-477

Guo, T.; Gong, C.; Wu, P.; Battaglia-Hsu, S-Fang.; Feng, J.; Liu, P.; Wang, H.; Guo, D.; Yao, Y.; Chen, B.; Xiao, Y.; Liu, Z.; Li, Z. 2020: LINC00662 promotes hepatocellular carcinoma progression via altering genomic methylation profiles. Cell Death and Differentiation 27(7): 2191-2205

Wu, J.; Guo, X.; Xu, D.; Zhang, H. 2020: LINC00662 sponges miR-107 accelerating the invasiveness and proliferation of glioma cells. Journal of Cancer 11(19): 5700-5712

Qi, L.; Sun, B.; Yang, B.; Lu, S. 2021: LINC00665 Stimulates Breast Cancer Progression via Regulating miR-551b-5p. Cancer Management and Research 13: 1113-1121

Han, T.; Gao, M.; Wang, X.; Li, W.; Zhuo, J.; Qu, Z.; Chen, Y. 2021: LINC00665 activates Wnt/β-catenin signaling pathway to facilitate tumor progression of colorectal cancer via upregulating CTNNB1. Experimental and Molecular Pathology 120: 104639

Cai, Y.; Hao, M.; Chang, Y.; Liu, Y. 2021: LINC00665 enhances tumorigenicity of endometrial carcinoma by interacting with high mobility group AT-hook 1. Cancer Cell International 21(1): 8

Zhang, D.-W.; Gu, G.-Q.; Chen, X.-Y.; Zha, G.-C.; Yuan, Z.; Wu, Y. 2020: LINC00665 facilitates the progression of osteosarcoma via sponging miR-3619-5p. European Review for Medical and Pharmacological Sciences 24(19): 9852-9859

Xia, L.; Chen, Y.-X.; Lian, J.-B. 2021: LINC00665 promotes Hela cell proliferation, migration, invasion and epithelial-mesenchymal transition by activating the WNT-CTNNB1/β‑catenin signaling pathway. Sheng Li Xue Bao: 73(2): 233-243

Xu, D.; Song, Q.; Liu, Y.; Chen, W.; Lu, L.; Xu, M.; Fang, X.; Zhao, W.; Zhou, H. 2021: LINC00665 promotes Ovarian Cancer progression through regulating the miRNA-34a-5p/E2F3 axis. Journal of Cancer 12(6): 1755-1763

Ji, W.; Diao, Y-Ling.; Qiu, Y-Ran.; Ge, J.; Cao, X-Chen.; Yu, Y. 2020: LINC00665 promotes breast cancer progression through regulation of the miR-379-5p/LIN28B axis. Cell Death and Disease 11(1): 16

Zhang, X.; Wu, J. 2021: LINC00665 promotes cell proliferation, invasion, and metastasis by activating the TGF-β pathway in gastric cancer. Pathology Research and Practice 224: 153492

Yang, X.; Wang, Y.; Pang, S.; Li, X.; Wang, P.; Ma, R.; Ma, Y.; Song, C. 2021: LINC00665 promotes the progression of acute myeloid leukemia by regulating the miR-4458/DOCK1 pathway. Scientific Reports 11(1): 5009

Abuduer, M.; A, E.Z.G. 2021: LINC00665 promotes the viability, migration and invasion of T cell acute lymphoblastic leukemia cells by targeting miR-101 via modulating PI3K/Akt pathway. Tissue and Cell 71: 101579

Yue, C.; Yu, C.; Peng, R.; Wang, J.; Li, G.; Xu, L. 2021: LINC00665/miR-379-5p/GRP78 regulates cisplatin sensitivity in gastric cancer by modulating endoplasmic reticulum stress. Cytotechnology 73(3): 413-422

Zhao, X.; Weng, W.; Long, Y.; Pan, W.; Li, Z.; Sun, F. 2020: LINC00665/miR-9-5p/ATF1 is a novel axis involved in the progression of colorectal cancer. Human Cell 33(4): 1142-1154

Yu, J.; Wang, F.; Zhang, J.; Li, J.; Chen, X.; Han, G. 2020: LINC00667/miR-449b-5p/YY1 axis promotes cell proliferation and migration in colorectal cancer. Cancer Cell International 20: 322

Li, J.; Dong, W.; Jiang, Q.; Zhang, F.; Dong, H. 2021: LINC00668 cooperated with HuR dependent upregulation of PKN2 to facilitate gastric cancer metastasis. Cancer Biology and Therapy 2021: 1-13

Qing, X.; Tan, G.-L.; Liu, H.-W.; Li, W.; Ai, J.-G.; Xiong, S.-S.; Yang, M.-Q.; Wang, T.-S. 2020: LINC00669 insulates the JAK/STAT suppressor SOCS1 to promote nasopharyngeal cancer cell proliferation and invasion. Journal of Experimental and Clinical Cancer Research: Cr 39(1): 166

Jin, G.; Mi, H.; Ye, Y.; Yao, Q.; Yuan, L.; Wu, X. 2021: LINC00671 inhibits renal cell cancer progression via regulating miR-221-5p/SOCS1 axis. American Journal of Translational Research 13(7): 7524-7537

Zhou, M.; Mao, Y.; Yu, S.; Li, Y.; Yin, R.; Zhang, Q.; Lu, T.; Sun, R.; Lin, S.; Qian, Y.; Xu, Y.; Fan, H. 2020: LINC00673 Represses CDKN2C and Promotes the Proliferation of Esophageal Squamous Cell Carcinoma Cells by EZH2-Mediated H3K27 Trimethylation. Frontiers in Oncology 10: 1546

Shi, W.-J.; Liu, H.; Ge, Y.-F.; Wu, D.; Tan, Y.-J.; Shen, Y.-C.; Wang, H.; Xu, H. 2020: LINC00673 exerts oncogenic function in cervical cancer by negatively regulating miR-126-5p expression and activates PTEN/PI3K/AKT signaling pathway. Cytokine 136: 155286

Pan, Y.; Fang, Y.; Xie, M.; Liu, Y.; Yu, T.; Wu, X.; Xu, T.; Ma, P.; Shu, Y. 2020: LINC00675 Suppresses Cell Proliferation and Migration via Downregulating the H3K4me2 Level at the SPRY4 Promoter in Gastric Cancer. Molecular Therapy. Nucleic Acids 22: 766-778

Yao, M.; Shi, X.; Li, Y.; Xiao, Y.; Butler, W.; Huang, Y.; Du, L.; Wu, T.; Bian, X.; Shi, G.; Ye, D.; Fu, G.; Wang, J.; Ren, S. 2020: LINC00675 activates androgen receptor axis signaling pathway to promote castration-resistant prostate cancer progression. Cell Death and Disease 11(8): 638

Wang, H.; Feng, L.; Zheng, Y.; Li, W.; Liu, L.; Xie, S.; Zhou, Y.; Chen, C.; Cheng, D. 2020: LINC00680 Promotes the Progression of Non-Small Cell Lung Cancer and Functions as a Sponge of miR-410-3p to Enhance HMGB1 Expression. Oncotargets and Therapy 13: 8183-8196

Shu, G.; Su, H.; Wang, Z.; Lai, S.; Wang, Y.; Liu, X.; Dai, L.; Bi, Y.; Chen, W.; Huang, W.; Zhou, Z.; He, S.; Dai, H.; Tang, B. 2021: LINC00680 enhances hepatocellular carcinoma stemness behavior and chemoresistance by sponging miR-568 to upregulate AKT3. Journal of Experimental and Clinical Cancer Research: Cr 40(1): 45

Lu, H.; Zhang, Q.; Sun, Y.; Wu, D.; Liu, L. 2020: LINC00689 induces gastric cancer progression via modulating the miR-338-3p/HOXA3 axis. Journal of Gene Medicine 22(12): E3275

Du, Y.-L.; Liang, Y.; Shi, G.-Q.; Cao, Y.; Qiu, J.; Yuan, L.; Yong, Z.; Liu, L.; Li, J. 2020: LINC00689 participates in proliferation, chemoresistance and metastasis via miR-31-5p/YAP/β-catenin axis in colorectal cancer. Experimental Cell Research 395(1): 112176

Meng, L.; Li, Z.; Chen, Y.; Liu, D.; Liu, Z. 2020: LINC00689 promotes prostate cancer progression via regulating miR-496/CTNNB1 to activate Wnt pathway. Cancer Cell International 20: 215

Guo, H.; Li, J.; Fan, F.; Zhou, P. 2021: LINC00707 Regulates miR-382-5p/VEGFA Pathway to Enhance Cervical Cancer Progression. Journal of Immunology Research 2021: 5524632

Pang, L.-R.; Huang, M.-X.; Li, H.; Chen, G.; Zhong, G.-P.; Yao, B.; Chen, J. 2020: LINC00707 accelerates the proliferation, migration and invasion of clear cell renal cell carcinoma. European Review for Medical and Pharmacological Sciences 24(12): 6616-6622

Yang, L.; Pei, L.; Yi, J. 2021: LINC00839 Regulates Proliferation, Migration, Invasion, Apoptosis and Glycolysis in Neuroblastoma Cells Through miR-338-3p/GLUT1 Axis. Neuropsychiatric Disease and Treatment 17: 2027-2040

Huang, X.; Pan, L.; Zuo, Z.; Li, M.; Zeng, L.; Li, R.; Ye, Y.; Zhang, J.; Wu, G.; Bai, R.; Zhuang, L.; Wei, L.; Zheng, Y.; Su, J.; Deng, J.; Deng, S.; Zhang, S.; Zhu, S.; Che, X.; Wang, C.; Wu, C.; Chen, R.; Lin, D.; Zheng, J. 2021: LINC00842 inactivates transcription co-regulator PGC-1α to promote pancreatic cancer malignancy through metabolic remodelling. Nature Communications 12(1): 3830

Tuo, Z.; Liang, L.; Zhou, R. 2021: LINC00852 is associated with poor prognosis in non-small cell lung cancer patients and its inhibition suppresses cancer cell proliferation and chemoresistance via the hsa-miR-145-5p/KLF4 axis. Journal of Gene Medicine 23(12): E3384

Qiao, Z.-W.; Jiang, Y.; Wang, L.; Wang, L.; Jiang, J.; Zhang, J.-R.; Mu, P. 2021: LINC00852 promotes the proliferation and invasion of ovarian cancer cells by competitively binding with miR-140-3p to regulate AGTR1 expression. Bmc Cancer 21(1): 1004

Su, W.; Wang, L.; Zhao, H.; Hu, S.; Zhou, Y.; Guo, C.; Wu, B.; Li, L.; Yang, Z.; Beer, D.G.; Chen, G. 2020: LINC00857 Interacting with YBX1 to Regulate Apoptosis and Autophagy via MET and Phosphor-AMPKa Signaling. Molecular Therapy. Nucleic Acids 22: 1164-1175

Tang, S.; Liu, Q.; Xu, M. 2021: LINC00857 promotes cell proliferation and migration in colorectal cancer by interacting with YTHDC1 and stabilizing SLC7A5. Oncology Letters 22(2): 578

Du, J.; Liang, Y.; Li, J.; Zhao, J.-M.; Lin, X.-Y. 2020: LINC00858 knockdown inhibits gastric cancer cell growth and induces apoptosis through reducing WNK2 promoter methylation. Cellular Oncology 43(4): 709-723

Jianfang, W.; Hui, W.; Le, K. 2022: LINC00870 regulates Th1/Th2 via the JAK/STAT pathway in peripheral blood mononuclear cells infected with Mycobacterium tuberculosis. International Immunopharmacology 102: 107188

Shen, X.-M.; Han, S.; Liu, N.; Xu, H.-Q.; Yan, C.-X.; Yu, C.-J. 2021: LINC00887 aggravates the malignant progression of glioma via upregulating CCND1. European Review for Medical and Pharmacological Sciences 25(4): 1928-1935

Yue, W.-J.; Wang, Y.; Li, W.-Y.; Wang, Z.-D. 2020: LINC00887 regulates the proliferation of nasopharyngeal carcinoma via targeting miRNA-203b-3p to upregulate NUP205. European Review for Medical and Pharmacological Sciences 24(17): 8863-8870

Li, S.; Zhang, Y.; Dong, J.; Li, R.; Yu, B.; Zhao, W.; Liu, J. 2021: LINC00893 inhibits papillary thyroid cancer by suppressing AKT pathway via stabilizing PTEN. Cancer Biomarkers: Section a of Disease Markers 30(3): 277-286

Gao, X.; Xue, Y.; Yang, K. 2021: LINC00899 promotes osteogenic differentiation by targeting miR-374a and RUNX2 expression. Experimental and Therapeutic Medicine 22(4): 1071

Zeng, H.; Wei, Y.; Wei, X.; Feng, R. 2021: LINC00908 Promotes Diffuse Large B-Cell Lymphoma Development by Down-Regulating miR-671-5p. Cancer Management and Research 13: 3589-3599

Wang, Y.; Dong, T.; Wang, P.; Li, S.; Wu, G.; Zhou, J.; Wang, Z. 2021: LINC00922 regulates epithelial-mesenchymal transition, invasive and migratory capacities in breast cancer through promoting NKD2 methylation. Cellular Signalling 77: 109808

Wan, J.; He, X.-L.; Jian, Q.-C.; Fan, Z.-F.; Shi, Y.; Luo, L.-F. 2021: LINC00937 suppresses keloid fibroblast proliferation and extracellular matrix deposition by targeting the miR-28-5p/MC1R axis. Histology and Histopathology 36(9): 995-1005

Xu, M.; Cui, R.; Ye, L.; Wang, Y.; Wang, X.; Zhang, Q.; Wang, K.; Dong, C.; Le, W.; Chen, B. 2021: LINC00941 promotes glycolysis in pancreatic cancer by modulating the Hippo pathway. Molecular Therapy. Nucleic Acids 26: 280-294

Ai, Y.; Wu, S.; Zou, C.; Wei, H. 2020: LINC00941 promotes oral squamous cell carcinoma progression via activating CAPRIN2 and canonical WNT/β-catenin signaling pathway. Journal of cellular and molecular medicine 24(18): 10512-10524

Fang, L.; Wang, S.-H.; Cui, Y.-G.; Huang, L. 2021: LINC00941 promotes proliferation and metastasis of pancreatic adenocarcinoma by competitively binding miR-873-3p and thus upregulates ATXN2. European Review for Medical and Pharmacological Sciences 25(4): 1861-1868

Wang, R.; Wang, X.; Zhang, J.; Liu, Y. 2021: LINC00942 Promotes Tumor Proliferation and Metastasis in Lung Adenocarcinoma via FZD1 Upregulation. Technology in Cancer Research and Treatment 20: 1533033820977526

Meng, C.; Gao, J.; Ma, Q.; Sun, Q.; Qiao, T. 2020: LINC00943 knockdown attenuates MPP + -induced neuronal damage via miR-15b-5p/RAB3IP axis in SK-N-SH cells. Neurological Research 2020: 1-10

Zhen, H.; Du, P.; Yi, Q.; Tang, X.; Wang, T. 2021: LINC00958 promotes bladder cancer carcinogenesis by targeting miR-490-3p and AURKA. Bmc Cancer 21(1): 1145

Jiang, Y.; Qiao, Z.; Jiang, J.; Zhang, J. 2021: LINC00958 promotes endometrial cancer cell proliferation and metastasis by regulating the miR-145-3p/TCF4 axis. Journal of Gene Medicine 23(7): E3345

Wang, B.; Tang, D.; Liu, Z.; Wang, Q.; Xue, S.; Zhao, Z.; Feng, D.; Sheng, C.; Li, J.; Zhou, Z. 2021: LINC00958 promotes proliferation, migration, invasion, and epithelial-mesenchymal transition of oesophageal squamous cell carcinoma cells. Plos one 16(5): E0251797

Jia, B.; Dao, J.; Han, J.; Huang, Z.; Sun, X.; Zheng, X.; Xiang, S.; Zhou, H.; Liu, S. 2021: LINC00958 promotes the proliferation of TSCC via miR-211-5p/CENPK axis and activating the JAK/STAT3 signaling pathway. Cancer Cell International 21(1): 147

Ye, J.; Liu, J.; Tang, T.; Xin, L.; Bao, X.; Yan, Y. 2021: LINC00963 affects the development of colorectal cancer via MiR-532-3p/HMGA2 axis. Cancer Cell International 21(1): 87

Zuo, W.; Zhou, K.; Deng, M.; Lin, Q.; Yin, Q.; Zhang, C.; Zhou, J.; Song, Y. 2020: LINC00963 facilitates acute myeloid leukemia development by modulating miR-608/MMP-15. Aging 12(19): 18970-18981

Zhang, R.; Niu, C.; Guan, Y.; Wu, J.; Hu, L. 2021: LINC00963 silencing inhibits the proliferation and migration of high glucose-induced retinal endothelial cells via targeting miR-27b. Experimental and Therapeutic Medicine 22(5): 1274

Hou, M.; Li, C.; Dong, S. 2021: LINC00963/miR-4458 regulates the effect of oxaliplatin in gastric cancer by mediating autophagic flux through targeting of ATG16L1. Scientific Reports 11(1): 20951

Zhu, Y.; Bo, H.; Chen, Z.; Li, J.; He, D.; Xiao, M.; Xiang, L.; Jin, L.; Zhou, J.; Gong, L.; Zhou, Y.; Zhou, M.; Xiong, W.; Xing, X.; Li, R.; Cao, K. 2020: LINC00968 can inhibit the progression of lung adenocarcinoma through the miR-21-5p/SMAD7 signal axis. Aging 12(21): 21904-21922

Liao, C.; Zhou, Y.; Li, M.; Xia, Y.; Peng, W. 2020: LINC00968 promotes osteogenic differentiation in vitro and bone formation in vivo via regulation of miR-3658/RUNX2. Differentiation; Research in Biological Diversity 116: 1-8

Liu, Y.; Li, X.; Zhang, C.; Zhang, H.; Huang, Y. 2020: LINC00973 is involved in cancer immune suppression through positive regulation of Siglec-15 in clear-cell renal cell carcinoma. Cancer science 111(10): 3693-3704

Deng, L-Lin.; Chi, Y-Yun.; Liu, L.; Huang, N-Si.; Wang, L.; Wu, J. 2016: LINC00978 predicts poor prognosis in breast cancer patients. Scientific Reports 6: 37936

Xu, X.; Gu, J.; Ding, X.; Ge, G.; Zang, X.; Ji, R.; Shao, M.; Mao, Z.; Zhang, Y.; Zhang, J.; Mao, F.; Qian, H.; Xu, W.; Cai, H.; Wang, F.; Zhang, X. 2019: LINC00978 promotes the progression of hepatocellular carcinoma by regulating EZH2-mediated silencing of p21 and E-cadherin expression. Cell Death and Disease 10(10): 752

Fu, C.; Xin, J.; Zhang, W.; Lai, J.; Huang, Z. 2021: LINC00992 exerts oncogenic activities in prostate cancer via regulation of SOX4. Experimental Cell Research 408(1): 112855

Ma, E.; Wang, Q.; Li, J.; Zhang, X.; Guo, Z.; Yang, X. 2020: LINC01006 facilitates cell proliferation, migration and invasion in prostate cancer through targeting miR-34a-5p to up-regulate DAAM1. Cancer Cell International 20: 515

Song, Y.; Wang, S.; Cheng, X. 2021: LINC01006 regulates the proliferation, migration and invasion of hepatocellular carcinoma cells through regulating miR-433-3p/CBX3 axis. Annals of Hepatology 25: 100343

Pan, X.; Li, D.; Huo, J.; Kong, F.; Yang, H.; Ma, X. 2018: LINC01016 promotes the malignant phenotype of endometrial cancer cells by regulating the miR-302a-3p/miR-3130-3p/NFYA/SATB1 axis. Cell Death and Disease 9(3): 303

Jiang, L.; Zhang, M.; Wang, S.; Xiao, Y.; Wu, J.; Zhou, Y.; Fang, X. 2020: LINC01018 and SMIM25 sponged miR-182-5p in endometriosis revealed by the ceRNA network construction. International Journal of Immunopathology and Pharmacology 34: 2058738420976309

She, J.-K.; Fu, D.-N.; Zhen, D.; Gong, G.-H.; Zhang, B. 2020: LINC01087 is Highly Expressed in Breast Cancer and Regulates the Malignant Behavior of Cancer Cells Through miR-335-5p/Rock1. Oncotargets and Therapy 13: 9771-9783

Zhang, W.; Fei, J.; Yu, S.; Shen, J.; Zhu, X.; Sadhukhan, A.; Lu, W.; Zhou, J. 2018: LINC01088 inhibits tumorigenesis of ovarian epithelial cells by targeting miR-24-1-5p. Scientific Reports 8(1): 2876

Li, M.; Guo, X. 2020: LINC01089 Blocks the Proliferation and Metastasis of Colorectal Cancer Cells via Regulating miR-27b-3p/HOXA10 Axis. Oncotargets and Therapy 13: 8251-8260

Li, X.; Lv, F.; Li, F.; Du, M.; Liang, Y.; Ju, S.; Liu, Z.; Zhou, B.; Wang, B.; Gao, Y. 2020: LINC01089 Inhibits Tumorigenesis and Epithelial-Mesenchymal Transition of Non-small Cell Lung Cancer via the miR-27a/SFRP1/Wnt/β-catenin Axis. Frontiers in Oncology 10: 532581

Zhang, H.; Zhang, H.; Li, X.; Huang, S.; Guo, Q.; Geng, D. 2021: LINC01089 functions as a ceRNA for miR-152-3p to inhibit non-small lung cancer progression through regulating PTEN. Cancer Cell International 21(1): 143

Li, S.; Han, Y.; Liang, X.; Zhao, M. 2021: LINC01089 inhibits the progression of cervical cancer via inhibiting miR-27a-3p and increasing BTG2. Journal of Gene Medicine 23(1): E3280

Guo, X.; Li, M. 2020: LINC01089 is a tumor-suppressive lncRNA in gastric cancer and it regulates miR-27a-3p/TET1 axis. Cancer Cell International 20: 507

Qian, Y.; Zhang, Y.; Ji, H.; Shen, Y.; Zheng, L.; Cheng, S.; Lu, X. 2021: LINC01089 suppresses lung adenocarcinoma cell proliferation and migration via miR-301b-3p/STARD13 axis. Bmc Pulmonary Medicine 21(1): 242

Wang, Z.-X.; Xu, Z.-N.; Sun, H.-B.; Wang, Y.; Han, Z.-F.; Yu, Y.; Han, X.-L.; Yin, Y.-Y.; Xu, L. 2021: LINC01093 promotes proliferation and invasion of non-small cell lung cancer cells via targeting akt signaling pathway. European Review for Medical and Pharmacological Sciences 25(7): 2828

Zhu, B.; Liu, W.; Liu, H.; Xu, Q.; Xu, W. 2020: LINC01094 Down-Regulates miR-330-3p and Enhances the Expression of MSI1 to Promote the Progression of Glioma. Cancer Management and Research 12: 6511-6521

Luo, C.; Lin, K.; Hu, C.; Zhu, X.; Zhu, J.; Zhu, Z. 2021: LINC01094 promotes pancreatic cancer progression by sponging miR-577 to regulate LIN28B expression and the PI3K/AKT pathway. Molecular Therapy. Nucleic Acids 26: 523-535

Chen, H.; Liu, Y.; Liu, P.; Dai, Q.; Wang, P. 2021: LINC01094 promotes the invasion of ovarian cancer cells and regulates the Wnt/β-catenin signaling pathway by targeting miR-532-3p. Experimental and Therapeutic Medicine 22(5): 1228

Jiang, Y.; Li, W.; Yan, Y.; Yao, X.; Gu, W.; Zhang, H. 2020: LINC01094 triggers radio-resistance in clear cell renal cell carcinoma via miR-577/CHEK2/FOXM1 axis. Cancer Cell International 20: 274

Xu, J.; Zhang, P.; Sun, H.; Liu, Y. 2020: LINC01094/miR-577 axis regulates the progression of ovarian cancer. Journal of Ovarian Research 13(1): 122

Meng, L.; Xing, Z.; Guo, Z.; Liu, Z. 2020: LINC01106 post-transcriptionally regulates ELK3 and HOXD8 to promote bladder cancer progression. Cell Death and Disease 11(12): 1063

Huang, T.; Cai, M.; Chen, C.; Ling, C.; Zhang, B.; Zheng, W.; Luo, L. 2021: LINC01116 boosts the progression of pituitary adenoma via regulating miR-744-5p/HOXB8 pathway. Molecular and Cellular Endocrinology 536: 111350

Liang, W.; Wu, J.; Qiu, X. 2021: LINC01116 facilitates colorectal cancer cell proliferation and angiogenesis through targeting EZH2-regulated TPM1. Journal of Translational Medicine 19(1): 45

Wang, T.; Cao, L.; Dong, X.; Wu, F.; De, W.; Huang, L.; Wan, Q. 2020: LINC01116 promotes tumor proliferation and neutrophil recruitment via DDX5-mediated regulation of IL-1β in glioma cell. Cell Death and Disease 11(5): 302

Wu, D.; Zhou, J.; Tan, M.; Zhou, Y. 2021: LINC01116 regulates proliferation, migration, and apoptosis of keloid fibroblasts by the TGF-β1/SMAD3 signaling via targeting miR-3141. Analytical Biochemistry 627: 114249

Chen, X.; Li, Z.; Xu, D.; Li, S. 2020: LINC01121 induced intervertebral disc degeneration via modulating miR-150-5p/MMP16 axis. Journal of Gene Medicine 22(10): E3231

Zhao, X.; Liu, F.; Zhang, J.; Zhang, J.; Zhang, L.; Chen, L. 2021: LINC01128 - miR-16 interaction regulates the migration and invasion of human chorionic trophoblast cells. Hypertension in Pregnancy 2021: 1-10

Yin, D.; Hu, Z.-Q.; Luo, C.-B.; Wang, X.-Y.; Xin, H.-Y.; Sun, R.-Q.; Wang, P.-C.; Li, J.; Fan, J.; Zhou, Z.-J.; Zhou, J.; Zhou, S.-L. 2021: LINC01133 promotes hepatocellular carcinoma progression by sponging miR-199a-5p and activating annexin A2. Clinical and Translational Medicine 11(5): E409

Li, Z.; Xu, D.; Chen, X.; Li, S.; Chan, M.T.V.; Wu, W.K.K. 2020: LINC01133: an emerging tumor-associated long non-coding RNA in tumor and osteosarcoma. Environmental Science and Pollution Research International 27(26): 32467-32473

Wu, J.; Wang, N.; Yang, Y.; Jiang, G.; Mu, Q.; Zhan, H.; Li, F. 2021: LINC01152 upregulates MAML2 expression to modulate the progression of glioblastoma multiforme via Notch signaling pathway. Cell Death and Disease 12(1): 115

Sun, Z.; Wei, N.; Yao, S.; Wang, G.; Sun, Y.; Wang, Z.; Yuan, D. 2021: LINC01158 works as an oncogene in glioma via sponging miR-6734-3p to boost CENPK expression. Cancer Cell International 21(1): 280

Chen, S.; Yuan, H.; Chen, B.-C.; Wan, Z.-A.; Tu, S.-L.; Hu, X.-Y. 2020: LINC01198 promotes colorectal cancer cell proliferation and inhibits apoptosis via Notch signaling pathway. European Review for Medical and Pharmacological Sciences 24(16): 8439-8446

Chi, D.; Zhang, W.; Jia, Y.; Cong, D.; Yu, K.; Hu, S. 2020: LINC01207 Predicts Poor Prognosis and Suppresses Cell Growth and Metastasis via Regulating GSK-3β/β-Catenin Signaling Pathway in Malignant Glioma. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research 26: E923189

Zhang, B.; Jin, Z.; Zhang, H. 2022: LINC01207 promotes the progression of non-small cell lung cancer via regulating ARHGAP11A by sponging miR-525-5p. Cancer Biomarkers: Section a of Disease Markers 33(3): 401-414

Xing, S.; Zhang, Y.; Zhang, J. 2020: LINC01224 Exhibits Cancer-Promoting Activity in Epithelial Ovarian Cancer Through microRNA-485-5p-Mediated PAK4 Upregulation. Oncotargets and Therapy 13: 5643-5655

Sun, H.; Yan, J.; Tian, G.; Chen, X.; Song, W. 2021: LINC01224 accelerates malignant transformation via MiR-193a-5p/CDK8 axis in gastric cancer. Cancer medicine 10(4): 1377-1393

Gu, J.; Dong, L.; Wang, Y.; Nie, W.; Liu, W.; Zhao, J.-A. 2021: LINC01224 promotes colorectal cancer progression through targeting miR-485-5p/MYO6 axis. World Journal of Surgical Oncology 19(1): 281

Fu, W.; Zhao, J.; Hu, W.; Dai, L.; Jiang, Z.; Zhong, S.; Deng, B.; Huang, Y.; Wu, W.; Yin, J. 2021: LINC01224/ZNF91 Promote Stem Cell-Like Properties and Drive Radioresistance in Non-Small Cell Lung Cancer. Cancer Management and Research 13: 5671-5681

Wang, X.; Zhang, W.; Tang, J.; Huang, R.; Li, J.; Xu, D.; Xie, Y.; Jiang, R.; Deng, L.; Zhang, X.; Chai, Y.; Qin, X.; Sun, B. 2016: LINC01225 promotes occurrence and metastasis of hepatocellular carcinoma in an epidermal growth factor receptor-dependent pathway. Cell Death and Disease 7: E2130

Du, W.; Lei, C.; Wang, Y.; Ding, Y.; Tian, P. 2021: LINC01232 Sponges Multiple mi RNAs and its Clinical Significance in Pancreatic Adenocarcinoma Diagnosis and Prognosis. Technology in Cancer Research and Treatment 20: 1533033820988525

Li, Q.; Lei, C.; Lu, C.; Wang, J.; Gao, M.; Gao, W. 2019: LINC01232 exerts oncogenic activities in pancreatic adenocarcinoma via regulation of TM9SF2. Cell Death and Disease 10(10): 698

Liu, Q.; Dong, J.; Li, J.; Duan, Y.; Wang, K.; Kong, Q.; Zhang, H. 2021: LINC01255 combined with BMI1 to regulate human mesenchymal stromal senescence and acute myeloid leukemia cell proliferation through repressing transcription of MCP-1. Clinical and Translational Oncology: Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 23(6): 1105-1116

Sun, Z.; Dang, Q.; Liu, Z.; Shao, B.; Chen, C.; Guo, Y.; Chen, Z.; Zhou, Q.; Hu, S.; Liu, J.; Yuan, W. 2021: LINC01272/miR-876/ITGB2 axis facilitates the metastasis of colorectal cancer via epithelial-mesenchymal transition. Journal of Cancer 12(13): 3909-3919

Fu, D.; Ren, Y.; Wang, C.; Yu, L.; Yu, R. 2021: LINC01287 facilitates proliferation, migration, invasion and EMT of colon cancer cells via miR-4500/MAP3K13 pathway. Bmc Cancer 21(1): 782

Chu, J.; Geng, G.; Ai, X.; Jia, W.; Wang, J.; Xu, B.; Kong, X.; Kong, L. 2022: LINC01291 promotes hepatocellular carcinoma development by targeting the miR-186-5p/OXSR1 axis. Journal of Gene Medicine 24(2): E3394

Sun, Z.; Shao, B.; Liu, Z.; Dang, Q.; Guo, Y.; Chen, C.; Guo, Y.; Chen, Z.; Liu, J.; Hu, S.; Yuan, W.; Zhou, Q. 2021: LINC01296/miR-141-3p/ZEB1-ZEB2 axis promotes tumor metastasis via enhancing epithelial-mesenchymal transition process. Journal of Cancer 12(9): 2723-2734

Xiao, D.; Cui, X.; Fang, N.; Yu, S.; Wang, X. 2021: LINC01303 promotes the proliferation and migration of laryngeal carcinoma by regulating miR-200c/TIMP2 axis. American Journal of Translational Research 13(3): 1643-1656

Xu, Y.; Zhu, H.; Ma, H.; Yuan, L.; Hu, Q.; Yang, L. 2020: LINC01305 inhibits malignant progression of cervical cancer via miR-129-5p/Sox4 axis. American Journal of Translational Research 12(11): 7581-7592

Chen, F.-B.; Wu, P.; Zhou, R.; Yang, Q.-X.; Zhang, X.; Wang, R.-R.; Qi, S.-C.; Yang, X. 2020: LINC01315 Impairs microRNA-211-Dependent DLG3 Downregulation to Inhibit the Development of Oral Squamous Cell Carcinoma. Frontiers in Oncology 10: 556084

Shen, Q.; Xu, Z.; Sun, G.; Wang, H.; Zhang, L. 2021: LINC01342 silencing upregulates microRNA-508-5p to inhibit progression of lung cancer by reducing cysteine-rich secretory protein 3. Cell Death Discovery 7(1): 238

Ai, B.; Kong, X.; Wang, X.; Zhang, K.; Yang, X.; Zhai, J.; Gao, R.; Qi, Y.; Wang, J.; Wang, Z.; Fang, Y. 2019: LINC01355 suppresses breast cancer growth through FOXO3-mediated transcriptional repression of CCND1. Cell Death and Disease 10(7): 502

Xu, Q.; He, L.; Ma, L.; Fan, L.; Yan, L.; Zhao, X.; Li, Y. 2020: LINC01410 accelerated the invasion and proliferation of osteosarcoma by sponging miR-3128. Aging 12(24): 24957-24966

Guo, W.; Gai, Q.; Ma, Y.; Shan, Z.; Wu, J. 2021: LINC01410 leads the migration, invasion and EMT of bladder cancer cells by modulating miR-4319 / Snail1. Cancer Cell International 21(1): 429

Zhang, G.; Chen, X.; Ma, L.; Ding, R.; Zhao, L.; Ma, F.; Deng, X. 2020: LINC01419 facilitates hepatocellular carcinoma growth and metastasis through targeting EZH2-regulated RECK. Aging 12(11): 11071-11084

Dang, H.; Chen, L.; Tang, P.; Cai, X.; Zhang, W.; Zhang, R.; Huang, A.; Tang, H. 2020: LINC01419 promotes cell proliferation and metastasis in hepatocellular carcinoma by enhancing NDRG1 promoter activity. Cellular Oncology 43(5): 931-947

Zhou, M.; Dong, Z.; Hu, S.; Xiao, M. 2021: LINC01433 targets miR-506-3p to promote the biological progress of nasopharyngeal carcinoma cells. European Archives of Oto-Rhino-Laryngology: Official Journal of the European Federation of Oto-Rhino-Laryngological Societies: Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery 278(9): 3363-3374

Lu, M.-D.; Liu, D.; Li, Y.-X. 2020: LINC01436 Promotes the Progression of Gastric Cancer via Regulating miR-513a-5p/APE1 Axis. Oncotargets and Therapy 13: 10607-10619

Shi, H.; Xie, J.; Wang, K.; Li, W.; Yin, L.; Wang, G.; Wu, Z.; Ni, J.; Mao, W.; Guo, C.; Peng, B. 2021: LINC01451 drives epithelial-mesenchymal transition and progression in bladder cancer cells via LIN28/TGF-β/Smad pathway. Cellular Signalling 81: 109932

Shen, Q.; Sun, Y.; Xu, S. 2020: LINC01503/miR-342-3p facilitates malignancy in non-small-cell lung cancer cells via regulating LASP1. Respiratory Research 21(1): 235

Yao, X.; Wu, L.; Gu, Z.; Li, J. 2020: LINC01535 Promotes the Development of Osteosarcoma Through Modulating miR-214-3p/KCNC4 Axis. Cancer Management and Research 12: 5575-5585

Li, H.; Liu, J.; Lai, Y.; Huang, S.; Zheng, L.; Fan, N. 2021: LINC01559 promotes colorectal cancer via sponging miR-1343-3p to modulate PARP1/PTEN/AKT pathway. Pathology Research and Practice 224: 153521

Hu, S.-S.; Fu, L.; Han, S.-Y.; Li, X.-L.; Zhang, L.-D. 2021: LINC01605 regulates proliferation, migration and invasion of colorectal cancer cells via targeting miR-3960/SOX11. European Review for Medical and Pharmacological Sciences 25(3): 1322-1329

Yue, M.; Liu, T.; Yan, G.; Luo, X.; Wang, L. 2021: LINC01605, regulated by the EP300-SMYD2 complex, potentiates the binding between METTL3 and SPTBN2 in colorectal cancer. Cancer Cell International 21(1): 504

Cai, Q.; Zhao, X.; Wang, Y.; Li, S.; Wang, J.; Xin, Z.; Li, F. 2021: LINC01614 promotes osteosarcoma progression via miR-520a-3p/SNX3 axis. Cellular Signalling 83: 109985

Liu, Z.; Han, L.; Yu, H.; Gao, N.; Xin, H. 2020: LINC01619 promotes non-small cell lung cancer development via regulating PAX6 by suppressing microRNA-129-5p. American Journal of Translational Research 12(6): 2538-2553

Deng, Y.; Zhang, L.; Luo, R. 2021: LINC01783 facilitates cell proliferation, migration and invasion in non-small cell lung cancer by targeting miR-432-5p to activate the notch pathway. Cancer Cell International 21(1): 234

Chen, M.; Fan, L.; Zhang, S-Min.; Li, Y.; Chen, P.; Peng, X.; Liu, D-Bo.; Ma, C.; Zhang, W-Jie.; Zou, Z-Wei.; Li, P-Dong. 2019: LINC01939 inhibits the metastasis of gastric cancer by acting as a molecular sponge of miR-17-5p to regulate EGR2 expression. Cell Death and Disease 10(2): 70

Zang, Y.; Yi, Q.; Pan, J.; Ding, M.; Zuo, X.; Hu, X. 2020: LINC01980 stimulates the progression of hepatocellular carcinoma via downregulating caspase 9. Journal of Buon: Official Journal of the Balkan Union of Oncology 25(3): 1395-1403

Ma, J.; Zhang, L.; Shang, A.; Song, H.; Huo, J.; Zhang, M.; Jiang, L. 2020: LINC02163 promotes colorectal cancer progression via miR-511-3p/AKT3 axis. Artificial Cells Nanomedicine and Biotechnology 48(1): 961-968

Xiao, J.; Liu, Y.; Yi, J.; Liu, X. 2021: LINC02257, an Enhancer RNA of Prognostic Value in Colon Adenocarcinoma, Correlates with Multi-Omics Immunotherapy-Related Analysis in 33 Cancers. Frontiers in Molecular Biosciences 8: 646786

Fu, Q.; Zhu, J.; Wang, B.; Wu, J.; Li, H.; Han, Y.; Xiang, D.; Chen, Y.; Li, L. 2021: LINC02288 promotes chondrocyte apoptosis and inflammation through miR-374a-3p targeting RTN3. Journal of Gene Medicine 23(5): E3314

Chen, X.; Zhang, Z.; Ma, Y.; Su, H.; Xie, P.; Ran, J. 2020: LINC02381 Promoted Cell Viability and Migration via Targeting miR-133b in Cervical Cancer Cells. Cancer Management and Research 12: 3971-3979

Tian, J.; Cui, P.; Li, Y.; Yao, X.; Wu, X.; Wang, Z.; Li, C. 2020: LINC02418 promotes colon cancer progression by suppressing apoptosis via interaction with miR-34b-5p/BCL2 axis. Cancer Cell International 20: 460

Wang, T.; Zhai, R.; Lv, X.; Wang, K.; Xu, J. 2020: LINC02418 promotes malignant behaviors in lung adenocarcinoma cells by sponging miR-4677-3p to upregulate KNL1 expression. Bmc Pulmonary Medicine 20(1): 217

Wu, J.; Gao, L.; Chen, H.; Zhou, X.; Lu, X.; Mao, Z. 2021: LINC02535 promotes cell growth in poorly differentiated gastric cancer. Journal of clinical laboratory analysis 35(8): e23877

Jia, D.; Xing, Y.; Zhan, Y.; Cao, M.; Tian, F.; Fan, W.; Huang, J.; Cui, Y.; Gu, R.; Cui, Y.; Liu, Y.; Zhang, S.; Cai, L.; Li, X. 2021: LINC02678 as a Novel Prognostic Marker Promotes Aggressive Non-small-cell Lung Cancer. Frontiers in Cell and Developmental Biology 9: 686975

Fattahi, S.; Nikbakhsh, N.; Taheri, H.; Ghadami, E.; Ranaee, M.; Akhavan-Niaki, H. 2021: LINC02688 and PP7080 as novel biomarkers in early diagnosis of gastric cancer. Non-Coding Rna Research 6(2): 86-91

Han, C.; Xu, B.; Zhou, L.; Li, L.; Lu, C.; Yu, G.-P.; Liu, Y.-S. 2020: LINC02738 Participates in the Development of Kidney Cancer Through the miR-20b/Sox4 Axis. Oncotargets and Therapy 13: 10185-10196

Peng, W.; He, D.; Shan, B.; Wang, J.; Shi, W.; Zhao, W.; Peng, Z.; Luo, Q.; Duan, M.; Li, B.; Cheng, Y.; Dong, Y.; Tang, F.; Zhang, C.; Duan, C. 2019: LINC81507 act as a competing endogenous RNA of miR-199b-5p to facilitate NSCLC proliferation and metastasis via regulating the CAV1/STAT3 pathway. Cell Death and Disease 10(7): 533

Han, H-Wook.; Hahn, S.; Jeong, H.Yun.; Jee, J-Hyun.; Nam, M-Ok.; Kim, H.Kyung.; Lee, D.Hyeon.; Lee, S-Young.; Choi, D.Kyu.; Yu, J.Hoon.; Min, S-Hyun.; Yoo, J. 2018: LINCS L1000 dataset-based repositioning of CGP-60474 as a highly potent anti-endotoxemic agent. Scientific Reports 8(1): 14969

Zhang, J.; Lv, W.; Liu, Y.; Fu, W.; Chen, B.; Ma, Q.; Gao, X. 2021: LINC_00355 promotes gastric cancer progression by upregulating PHF19 expression through sponging miR-15a-5p. Bmc Cancer 21(1): 657

Van Ingen, M.J.A.; Kirby, T.J. 2021: LINCing Nuclear Mechanobiology with Skeletal Muscle Mass and Function. Frontiers in Cell and Developmental Biology 9: 690577

Croce, C.M. 2010: LINCing chromatin remodeling to metastasis. Nature Biotechnology 28(9): 931-932

Roller, M.ša.; Stamper, E.; Villar, D.; Izuogu, O.; Martin, F.; Redmond, A.M.; Ramachanderan, R.; Harewood, L.; Odom, D.T.; Flicek, P. 2021: LINE retrotransposons characterize mammalian tissue-specific and evolutionarily dynamic regulatory regions. Genome Biology 22(1): 62

Kitahara, H.; Okamoto, T.; Shimamatsu, S.; Kohno, M.; Morodomi, Y.; Tagawa, T.; Kitao, H.; Okano, S.; Oda, Y.; Maehara, Y.; Mori, M. 2020: LINE-1 Hypomethylation Is Associated with Malignant Traits and Cell Proliferation in Lung Adenocarcinoma. Anticancer Research 40(10): 5659-5666

Jachowicz, J.W.; Bing, X.; Pontabry, J.; Bošković, A.; Rando, O.J.; Torres-Padilla, M-Elena. 2017: LINE-1 activation after fertilization regulates global chromatin accessibility in the early mouse embryo. Nature Genetics 49(10): 1502-1510

Marques, D.F.; Ota, V.K.; Santoro, M.L.; Talarico, F.; Costa, G.O.; Spindola, L.M.; Cogo-Moreira, H.; Carvalho, C.M.; Xavier, G.; Cavalcante, D.A.; Gadelha, A.; Noto, C.; Cordeiro, Q.; Bressan, R.A.; Moretti, P.N.; Belangero, S.I. 2020: LINE-1 hypomethylation is associated with poor risperidone response in a first episode of psychosis cohort. Epigenomics 12(12): 1041-1051

Xiao-Jie, L.; Hui-Ying, X.; Qi, X.; Jiang, X.; Shi-Jie, M. 2016: LINE-1 in cancer: multifaceted functions and potential clinical implications. Genetics in Medicine: Official Journal of the American College of Medical Genetics 18(5): 431-439

Aschacher, T.; Wolf, B.; Enzmann, F.; Kienzl, P.; Messner, B.; Sampl, S.; Svoboda, M.; Mechtcheriakova, D.; Holzmann, K.; Bergmann, M. 2016: LINE-1 induces hTERT and ensures telomere maintenance in tumour cell lines. Oncogene 35(1): 94-104

Tajuddin, S.M.; Amaral, A.F.S.; Fernández, A.F.; Chanock, S.; Silverman, D.T.; Tardón, A.; Carrato, A.; García-Closas, M.; Jackson, B.P.; Toraño, E.G.; Márquez, M.; Urdinguio, R.G.; García-Closas, R.; Rothman, N.; Kogevinas, M.; Real, F.X.; Fraga, M.F.; Malats, N.; Kogevinas, M.; Malats, N.; Real, F.X.; Sala, M.; Castaño, G.; Torà, M.; Puente, D.; Villanueva, C.; Murta-Nascimento, C.; Fortuny, J.; López, E.; Hernández, S.; Jaramillo, R.; Vellalta, G.; Palencia, L.; Fermández, F.; Amorós, A.; Alfaro, A.; Carretero, G.; Lloreta, J.; Serrano, S.; Ferrer, L.; Gelabert, A.; Carles, J.; Bielsa, O.; Villadiego, K.; Cecchini, L.; Saladié, J.M.; Ibarz, L.; Céspedes, M.; Serra, C.; García, D.; Pujadas, J.; Hernando, R.; Cabezuelo, A.;, 2014: LINE-1 methylation in leukocyte DNA, interaction with phosphatidylethanolamine N-methyltransferase variants and bladder cancer risk. British Journal of Cancer 110(8): 2123-2130

Blythe, M.J.; Kocer, A.; Rubio-Roldan, A.; Giles, T.; Abakir, A.; Ialy-Radio, Côme.; Wheldon, L.M.; Bereshchenko, O.; Bruscoli, S.; Kondrashov, A.; Drevet, Jël.R.; Emes, R.D.; Johnson, A.D.; McCarrey, J.R.; Gackowski, D.; Olinski, R.; Cocquet, J.; Garcia-Perez, J.L.; Ruzov, A. 2021: LINE-1 transcription in round spermatids is associated with accretion of 5-carboxylcytosine in their open reading frames. Communications Biology 4(1): 691

Zheng, F.; Kawabe, Y.; Murakami, M.; Takahashi, M.; Nishihata, K.; Yoshida, S.; Ito, A.; Kamihira, M. 2021: LINE-1 vectors mediate recombinant antibody gene transfer by retrotransposition in Chinese hamster ovary cells. Biotechnology Journal 16(7): E2000620

Dewannieux, M.; Esnault, Cécile.; Heidmann, T. 2003: LINE-mediated retrotransposition of marked Alu sequences. Nature Genetics 35(1): 41-48

Boeke, J.D. 1997: LINEs and Alus--the polyA connection. Nature Genetics 16(1): 6-7

Guillemain, A.; Laouarem, Y.; Cobret, L.; Štefok, D.; Chen, W.; Bloch, S.; Zahaf, A.; Blot, L.; Reverchon, F.; Normand, T.; Decoville, M.; Grillon, C.; Traiffort, E.; Morisset-Lopez, Séverine. 2020: LINGO family receptors are differentially expressed in the mouse brain and form native multimeric complexes. FASEB journal: official publication of the Federation of American Societies for Experimental Biology 34(10): 13641-13653

Mi, S.; Hu, B.; Hahm, K.; Luo, Y.; Kam Hui, E.Sai.; Yuan, Q.; Wong, W.Man.; Wang, L.; Su, H.; Chu, T-Ho.; Guo, J.; Zhang, W.; So, K-Fai.; Pepinsky, B.; Shao, Z.; Graff, C.; Garber, E.; Jung, V.; Wu, E.Xuekui.; Wu, W. 2007: LINGO-1 antagonist promotes spinal cord remyelination and axonal integrity in MOG-induced experimental autoimmune encephalomyelitis. Nature Medicine 13(10): 1228-1233

Sun, J-Jun.; Ren, Q-Guo.; Xu, L.; Zhang, Z-Jun. 2015: LINGO-1 antibody ameliorates myelin impairment and spatial memory deficits in experimental autoimmune encephalomyelitis mice. Scientific Reports 5: 14235

Mi, S.; Lee, X.; Shao, Z.; Thill, G.; Ji, B.; Relton, J.; Levesque, M.; Allaire, N.; Perrin, S.; Sands, B.; Crowell, T.; Cate, R.L.; McCoy, J.M.; Pepinsky, R.Blake. 2004: LINGO-1 is a component of the Nogo-66 receptor/p75 signaling complex. Nature Neuroscience 7(3): 221-228

Mi, S.; Miller, R.H.; Lee, X.; Scott, M.L.; Shulag-Morskaya, S.; Shao, Z.; Chang, J.; Thill, G.; Levesque, M.; Zhang, M.; Hession, C.; Sah, D.; Trapp, B.; He, Z.; Jung, V.; McCoy, J.M.; Pepinsky, R.Blake. 2005: LINGO-1 negatively regulates myelination by oligodendrocytes. Nature Neuroscience 8(6): 745-751

Zhao, C.-G.; Qin, J.; Li, J.; Jiang, S.; Ju, F.; Sun, W.; Ren, Z.; Ji, Y.-Q.; Wang, R.; Sun, X.-L.; Mou, X.; Yuan, H. 2021: LINGO-1 regulates Wnt5a signaling during neural stem and progenitor cell differentiation by modulating miR-15b-3p levels. Stem Cell Research and Therapy 12(1): 372

Tan, E-King. 2010: LINGO1 and essential tremor: linking the shakes. Linking LINGO1 to essential tremor. European Journal of Human Genetics: Ejhg 18(7): 739-740

De Alwis, A.Chandima.; Kwon, S. 2021: Lingual Tonsillitis: An Under-Recognised Manifestation of Infectious Mononucleosis. Journal of Paediatrics and Child Health 57(3): 459

Ahmed, M.; Kim, D.R. 2021: LINPS: a database for cancer-cell-specific perturbations of biological networks. Database: the Journal of Biological Databases and Curation 2021

Neuhofer, C.M.; Catarino, C.B.; Schmidt, H.; Seelos, K.; Alhaddad, B.; Haack, T.B.; Klopstock, T. 2020: LINS1-associated neurodevelopmental disorder: Family with novel mutation expands the phenotypic spectrum. NEUROLOGY. Genetics 6(5): E500

Tian, L.; Mazloom, R.; Heath, L.S.; Vinatzer, B.A. 2021: LINflow: a computational pipeline that combines an alignment-free with an alignment-based method to accelerate generation of similarity matrices for prokaryotic genomes. Peerj 9: E10906

La Manna, M.P.; Tamburini, B.; Orlando, V.; Badami, G.D.; Di Carlo, P.; Cascio, A.; Singh, M.; Dieli, F.; Caccamo, N. 2021: LIODetect®TB-ST: Evaluation of novel blood test for a rapid diagnosis of active pulmonary and extra-pulmonary tuberculosis in IGRA confirmed patients. Tuberculosis 130: 102119

Hodgson, J. 1998: LION and Degussa apply genomics to fermentation. Nature Biotechnology 16(8): 715

Hasenburg, A.; Sehouli, J.; Lampe, B.; Reuss, A.; Schmalfeld, B.; Belau, A.K.; Bossart, M.; Mahner, S.; Hillemanns, P.; Petry, U.; du Bois, A.; Herwig, U.; Hilpert, F.; Gropp-Meier, M.; Hanf, V.; Greimel, E.; Wagner, U.; Harter, P. 2020: LION-PAW (lymphadenectomy in ovarian neoplasm) sexual function assessment: a prospective sub-study of the LION trial. International Journal of Gynecological Cancer: Official Journal of the International Gynecological Cancer Society 30(10): 1548-1553

Petersen, K.Dinesen.; Schiffer, C.; Nagel, T. 2018: LIP formation and protracted lower mantle upwelling induced by rifting and delamination. Scientific Reports 8(1): 16578

Ipata, A.E.; Gee, A.L.; Gottlieb, J.; Bisley, J.W.; Goldberg, M.E. 2006: LIP responses to a popout stimulus are reduced if it is overtly ignored. Nature Neuroscience 9(8): 1071-1076

Lee, M-Hee.; Hook, B.; Lamont, L.B.; Wickens, M.; Kimble, J. 2006: LIP-1 phosphatase controls the extent of germline proliferation in Caenorhabditis elegans. EMBO Journal 25(1): 88-96

Braunsteiner, H.; Dienstl, F.; Sailer, S.; Sandhofer, F. 1964: Lipase Activity in Leukocytes and Macrophages. Wiener Zeitschrift für Innere Medizin und ihre Grenzgebiete 45: 253-258

Sollier, C.; Capel, E.; Aguilhon, C.; Smirnov, V.; Auclair, M.; Douillard, C.; Ladsous, M.; Defoort-Dhellemmes, S.; Gorwood, J.; Braud, L.; Motterlini, R.; Vatier, C.; Lascols, O.; Renard, E.; Vigouroux, C.; Jéru, I. 2021: LIPE-related lipodystrophic syndrome: clinical features and disease modeling using adipose stem cells. European Journal of Endocrinology 184(1): 155-168

Gago-Dominguez, M.; Redondo, C.M.; Calaza, M.; Matabuena, M.; Bermudez, M.A.; Perez-Fernandez, R.; Torres-Español, Mía.; Carracedo, Ángel.; Castelao, J.Esteban. 2021: LIPG endothelial lipase and breast cancer risk by subtypes. Scientific Reports 11(1): 10436

Zhang, Y.; Zhu, X.; Qiao, X.; Gu, X.; Xue, J.; Han, Y.; Sun, L.; Cui, M.; Liu, C. 2020: LIPH promotes metastasis by enriching stem-like cells in triple-negative breast cancer. Journal of cellular and molecular medicine 24(16): 9125-9134

Seedat, F.; Raal, F.; Martinson, N.; Variava, E. 2020: Lipid and Lipoprotein Levels in Hiv-Infected Adults with Sepsis Compared to Healthy Hiv- Infected Controls. African Journal of Infectious Diseases 14(2): 1-9

Strong, F.E. 1964: Lipid Composition of the Eggs from An Aphid. Nature 202: 622

Qamar, Z.; Ashhar, M.U.; Annu; Qizilibash, F.F.; Sahoo, P.K.; Ali, A.; Ali, J.; Baboota, S. 2021: Lipid nanocarrier of selegiline augmented anti-Parkinson's effect via P-gp modulation using quercetin. International Journal of Pharmaceutics 609: 121131

Murakami, M. 2020: Lipids in Allergic Diseases. Arerugi 69(4): 250-255

Gracé, J.; Connor, D.; Bester, L.; Rogan, C.; Parsi, K. 2021: LIPIODOL reduces the lytic activity of detergent sclerosants in vitro. Phlebology 36(10): 771-778

Krakovskii, A.I.; Liubchanskaia, S.I. 1963: Lipoma of the Mediastinum. Grudnaia Khirurgiia 5: 114-115

Lee, H.; Kim, M.H.; Jin, S.C.; Choi, L.Y.; Nam, Y.K.; Yang, W.M. 2021: LIPOSA pharmacopuncture, a new herbal formula, affects localized adiposity by regulating lipid metabolism in vivo. Experimental and Therapeutic Medicine 22(5): 1290

Jeremić, D.; Maletin, M.š; Vojinov, S.ša.; Levakov, I.; Grbić, D.; Lakić, T.; Trivunić Dajko, S. 2021: Liposarcoma of the Spermatic Cord - Diagnostic and Therapeutic Issue. Acta Clinica Croatica 60(1): 50-54

Haljasmägi, L.; Remm, A.; Rumm, A.P.; Krassohhina, E.; Sein, H.; Tamm, A.; Kisand, K.; Peterson, P.är. 2020: LIPS method for the detection of SARS-CoV-2 antibodies to spike and nucleocapsid proteins. European Journal of Immunology 50(8): 1234-1236

Yi, W.; Chen, Q.; Liu, C.; Li, K.; Tao, B.; Tian, G.; Zhou, L.; Li, X.; Shen, J.; Liu, B.; Hu, Z.; Wang, D.; Bai, D. 2021: LIPUS inhibits inflammation and catabolism through the NF-κB pathway in human degenerative nucleus pulposus cells. Journal of Orthopaedic Surgery and Research 16(1): 619

Xu, X.; Wang, F.; Yang, Y.; Zhou, X.; Cheng, Y.; Wei, X.; Li, M. 2016: LIPUS promotes spinal fusion coupling proliferation of type H microvessels in bone. Scientific Reports 6: 20116

Hu, Y.; Fang, L.; Chen, X.; Zhong, J.F.; Li, M.; Wang, K. 2021: LIQA: long-read isoform quantification and analysis. Genome Biology 22(1): 182

Leijonhufvud, C.; Reger, R.; Segerberg, F.; Theorell, J.; Schlums, H.; Bryceson, Y.T.; Childs, R.W.; Carlsten, M. 2021: LIR-1 educates expanded human NK cells and defines a unique antitumor NK cell subset with potent antibody-dependent cellular cytotoxicity. Clinical and Translational Immunology 10(10): E1346

Freitas, M.; Xavier, S.; Magalhães, R.; Magalhães, J.; Marinho, C.; Cotter, Jé. 2020: LIRER score - a valuable tool to predict medium-long-term outcomes in hepatic cirrhosis decompensation. Scandinavian Journal of Gastroenterology 55(9): 1079-1086

Yamada, M.; Toba, S.; Yoshida, Y.; Haratani, K.; Mori, D.; Yano, Y.; Mimori-Kiyosue, Y.; Nakamura, T.; Itoh, K.; Fushiki, S.; Setou, M.; Wynshaw-Boris, A.; Torisawa, T.; Toyoshima, Y.Y.; Hirotsune, S. 2008: LIS1 and NDEL1 coordinate the plus-end-directed transport of cytoplasmic dynein. EMBO Journal 27(19): 2471-2483

McKenney, R.J. 2020: LIS1 cracks open dynein. Nature Cell Biology 22(5): 515-517

Htet, Z.Min.; Gillies, J.P.; Baker, R.W.; Leschziner, A.E.; DeSantis, M.E.; Reck-Peterson, S.L. 2020: LIS1 promotes the formation of activated cytoplasmic dynein-1 complexes. Nature Cell Biology 22(5): 518-525

Kawabata, I.; Kashiwagi, Y.; Obashi, K.; Ohkura, M.; Nakai, J.; Wynshaw-Boris, A.; Yanagawa, Y.; Okabe, S. 2012: LIS1-dependent retrograde translocation of excitatory synapses in developing interneuron dendrites. Nature Communications 3: 722

Reiner, O.; Cahana, A.; Escamez, T.; Martinez, S. 2002: LIS1-no more no less. Molecular Psychiatry 7(1): 12-16

Lohmann, G.; Stelzer, J.; Lacosse, E.; Kumar, V.J.; Mueller, K.; Kuehn, E.; Grodd, W.; Scheffler, K. 2018: LISA improves statistical analysis for fMRI. Nature Communications 9(1): 4014

De Luca, D.; Shankar-Aguilera, S.; Bancalari, E. 2021: LISA/MIST: Complex clinical problems almost never have easy solutions. Seminars in Fetal and Neonatal Medicine 26(2): 101230

Chen, Y.; Zhang, Y.; Li, J.Y.H.; Ouyang, Z. 2021: LISA2: Learning Complex Single-Cell Trajectory and Expression Trends. Frontiers in Genetics 12: 681206

Habib, A.; Sawmiller, D.; Li, S.; Xiang, Y.; Rongo, D.; Tian, J.; Hou, H.; Zeng, J.; Smith, A.; Fan, S.; Giunta, B.; Mori, T.; Currier, G.; Shytle, D.Ronald.; Tan, J. 2017: LISPRO mitigates β-amyloid and associated pathologies in Alzheimer's mice. Cell Death and Disease 8(6): E2880

Illingworth, C.F.; Lister 1961: LISTER and the Glasgow School of Surgery. Scottish Medical Journal 6: 1-5

Grandguillaume, P. 1963: Listeriosis. Revue Medicale de la Suisse Romande 83: 749-757

Alex, R. 1964: Listeriosis. GYNAECOLOGIA. International Monthly Review of Obstetrics and Gynecology. Revue Internationale Mensuelle d'Obstetrique et de Gynecologie. Monatsschrift für Geburtshilfe und Gynakologie 157: 123-125

Walsh, C.A. 1998: LISsen up!. Nature Genetics 19(4): 307-308

Zhou, J.; Yang, Z.; Tsuji, T.; Gong, J.; Xie, J.; Chen, C.; Li, W.; Amar, S.; Luo, Z. 2011: LITAF and TNFSF15, two downstream targets of AMPK, exert inhibitory effects on tumor growth. Oncogene 30(16): 1892-1900

Tatarov, B.; Müller, D. 2021: LITES: rotational Raman spectra of air molecules measured by high-resolution-spectroscopy lidar. Optics Letters 46(20): 5173-5176

Lindner, F.; Milne-Davies, B.; Langenfeld, K.; Stiewe, T.; Diepold, A. 2020: LITESEC-T3SS - Light-controlled protein delivery into eukaryotic cells with high spatial and temporal resolution. Nature Communications 11(1): 2381

Liu, L.; Lei, X.; Fang, Z.; Tang, Y.; Meng, J.; Wei, Z. 2020: LITHOPHONE: Improving lncRNA Methylation Site Prediction Using an Ensemble Predictor. Frontiers in Genetics 11: 545

Kiefer, J.H. 1964: Lithotomy Set to Music: An Historical Interlude. Urological Survey 14: 2-7

Lindenmeyer, C.C.; Flocco, G.; Sanghi, V.; Lopez, R.; Kim, A.J.; Niyazi, F.; Mehta, N.A.; Kapoor, A.; Carey, W.D.; Mireles-Cabodevila, E.; Romero-Marrero, C. 2020: LIV-4: a novel model for predicting transplant-free survival in critically ill cirrhotics. World Journal of Hepatology 12(6): 298-311

Oi, C.; Gidden, Z.; Holyoake, L.; Kantelberg, O.; Mochrie, S.; Horrocks, M.H.; Regan, L. 2020: LIVE-PAINT allows super-resolution microscopy inside living cells using reversible peptide-protein interactions. Communications Biology 3(1): 458

Patarashvili, L.; Azmaipharashvili, E.; Jandieri, K.; Gvidiani, S.; Tsomaia, K.; Kikalishvili, L.; Sareli, M.; Chanukvadze, I.; Kordzaia, D. 2021: Liver Extracellular Matrix Peculiarities in Mammals and Avians. Georgian Medical News 310: 124-133

Guerra Veloz, M.ía.F.; Cordero Ruiz, P.; Ríos-Villegas, M.ía.J.é; Del Pino Bellido, P.; Bravo-Ferrer, J.é; Galvés Cordero, R.ío.; Cadena Herrera, M.ía.L.; Vías Parrado, C.; Bellido Muñoz, F.; Vega Rodríguez, F.; Caunedo Álvarez, Án.; Rodríguez-Baño, J.ús.; Carmona Soria, I. 2021: Liver manifestations in COVID-19 and the influence of pre-existing liver disease in the course of the infection. Revista Espanola de Enfermedades Digestivas: Organo Oficial de la Sociedad Espanola de Patologia Digestiva 113(2): 103-109

Gorbon, B.; Taspinar, A.H. 1963: Liver Metastases Due to Carcinoid of the Appendix. Turk Tip Cemiyeti Mecmuasi 29: 602-607

Jackson, B.; Bohnel, E. 1964: Liver Mitotic Rates and Weights in Young, Rapidly Growing Rats After Serum Injection. Nature 203: 892-893

Guo, X.; Wang, F.; Teodoro, G.; Farris, A.B.; Kong, J. 2019: Liver Steatosis Segmentation with Deep Learning Methods. PROCEEDINGS. IEEE International Symposium on Biomedical Imaging 2019: 24-27

Carithers, R.L. 2020: Liver Transplantation: will Xenotransplantation be the Answer to the Donor Organ Shortage?. Transactions of the American Clinical and Climatological Association 131: 270-285

Guérin, A.; Martire, D.; Trenquier, E.; Lesluyes, T.; Sagnol, S.éb.; Pratlong, M.; Lefebvre, E.; Chibon, F.éd.; de Santa Barbara, P.; Faure, S. 2020: LIX1 regulates YAP activity and controls gastrointestinal cancer cell plasticity. Journal of Cellular and Molecular Medicine 24(16): 9244-9254

Zhu, X.; Zhang, Y.; Zhao, Y.; Xiang, D.; Zou, J.; Andrisani, O.; Zhang, H.; Kong, L. 2021: LIX1-like protein drives hepatic stellate cell activation to promote liver fibrosis by regulation of chemokine mRNA stability. Signal Transduction and Targeted Therapy 6(1): 319

Zou, J.; Zhu, X.; Xiang, D.; Zhang, Y.; Li, J.; Su, Z.; Kong, L.; Zhang, H. 2021: LIX1-like protein promotes liver cancer progression via miR-21-3p-mediated inhibition of fructose-1,6-bisphosphatase. Acta Pharmaceutica Sinica. B 11(6): 1578-1591

Boo, H.-J.; Park, S.J.; Noh, M.; Min, H.-Y.; Jeong, L.S.; Lee, H.-Y. 2020: LJ-529, a partial peroxisome proliferator-activated receptor gamma (PPARγ) agonist and adenosine A3 receptor agonist, ameliorates elastase-induced pulmonary emphysema in mice. Archives of Pharmacal Research 43(5): 540-552

Zhang, T.; Huang, L.; Peng, J.; Zhang, J.H.; Zhang, H. 2021: LJ529 attenuates mast cell-related inflammation via A3R-PKCε-ALDH2 pathway after subarachnoid hemorrhage in rats. Experimental Neurology 340: 113686

Zhang, S.; Xie, J.; Xia, Y.; Yu, S.; Gu, Z.; Feng, R.; Luo, G.; Wang, D.; Wang, K.; Jiang, M.; Cheng, X.; Huang, H.; Zhang, W.; Wen, T. 2015: LK6/Mnk2a is a new kinase of alpha synuclein phosphorylation mediating neurodegeneration. Scientific Reports 5: 12564

Ossipova, O.; Bardeesy, N.; DePinho, R.A.; Green, J.B.A. 2003: LKB1 (XEEK1) regulates Wnt signalling in vertebrate development. Nature Cell Biology 5(10): 889-894

Jiang, R.; Yang, T.; Zhang, Y.; Wang, Z.; Zhang, T. 2020: LKB1 Promotes the Transformation of Bone Marrow Mesenchymal Stem Cells into Adipocytes Under Oxidative Stress via AMPK-mTOR Signaling Pathway. Journal of Interferon and Cytokine Research: the Official Journal of the International Society for Interferon and Cytokine Research 40(7): 370-376

Burger, C.A.; Albrecht, N.E.; Jiang, D.; Liang, J.H.; Poché, R.A.; Samuel, M.A. 2021: LKB1 and AMPK instruct cone nuclear position to modify visual function. Cell Reports 34(5): 108698

Samuel, M.A.; Voinescu, P.Emanuela.; Lilley, B.N.; de Cabo, R.; Foretz, M.; Viollet, B.; Pawlyk, B.; Sandberg, M.A.; Vavvas, D.G.; Sanes, J.R. 2014: LKB1 and AMPK regulate synaptic remodeling in old age. Nature Neuroscience 17(9): 1190-1197

Li, T.-T.; Zhu, H.-B. 2020: LKB1 and cancer: the dual role of metabolic regulation. Biomedicine and PharmacoTherapy 132: 110872

Whang, Y.M.; Park, S.I.; Trenary, I.A.; Egnatchik, R.A.; Fessel, J.P.; Kaufman, J.M.; Carbone, D.P.; Young, J.D. 2016: LKB1 deficiency enhances sensitivity to energetic stress induced by erlotinib treatment in non-small-cell lung cancer (NSCLC) cells. Oncogene 35(7): 856-866

Borzi, C.; Ganzinelli, M.; Caiola, E.; Colombo, M.; Centonze, G.; Boeri, M.; Signorelli, D.; Caleca, L.; Rulli, E.; Busico, A.; Capone, I.; Pastorino, U.; Marabese, M.; Milione, M.; Broggini, M.; Garassino, M.C.; Sozzi, G.; Moro, M. 2021: LKB1 Down-Modulation by miR-17 Identifies Patients with NSCLC Having Worse Prognosis Eligible for Energy-Stress-Based Treatments. Journal of Thoracic Oncology: Official Publication of the International Association for the Study of Lung Cancer 16(8): 1298-1311

Pelgrom, L.R.; Patente, T.A.; Sergushichev, A.; Esaulova, E.; Otto, F.; Ozir-Fazalalikhan, A.; van der Zande, H.J.P.; van der Ham, A.J.; van der Stel, S.; Artyomov, M.N.; Everts, B. 2019: LKB1 expressed in dendritic cells governs the development and expansion of thymus-derived regulatory T cells. Cell Research 29(5): 406-419

Xiao, P.; Sun, L-lin.; Wang, J.; Han, R-li.; Ma, Q.; Zhong, D-sheng. 2015: LKB1 gene inactivation does not sensitize non-small cell lung cancer cells to mTOR inhibitors in vitro. Acta Pharmacologica Sinica 36(9): 1107-1112

Jin, L.-Y.; Zhao, K.; Xu, L.-J.; Zhao, R.-X.; Werle, K.D.; Wang, Y.; Liu, X.-L.; Chen, Q.; Wu, Z.-J.; Zhang, K.; Zhao, Y.; Jiang, G.-Q.; Cui, F.-M.; Xu, Z.-X. 2020: LKB1 inactivation leads to centromere defects and genome instability via p53-dependent upregulation of survivin. Aging 12(14): 14341-14354

Zeng, Q.; Chen, J.; Li, Y.; Werle, K.D.; Zhao, R-X.; Quan, C-S.; Wang, Y-S.; Zhai, Y-X.; Wang, J-W.; Youssef, M.; Cui, R.; Liang, J.; Genovese, N.; Chow, L.T.; Li, Y-L.; Xu, Z-X. 2017: LKB1 inhibits HPV-associated cancer progression by targeting cellular metabolism. Oncogene 36(9): 1245-1255

Liu, Z.; Li, S.; Zeng, J.; Zhou, X.; Li, H.; Liu, X.; Li, F.; Jiang, B.; Zhao, M.; Ma, T. 2020: LKB1 inhibits intrahepatic cholangiocarcinoma by repressing the transcriptional activity of the immune checkpoint PD-L1. Life Sciences 257: 118068

Lizcano, J.M.; Göransson, O.; Toth, R.; Deak, M.; Morrice, N.A.; Boudeau, Jérôme.; Hawley, S.A.; Udd, L.; Mäkelä, T.P.; Hardie, D.Grahame.; Alessi, D.R. 2004: LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR-1. EMBO Journal 23(4): 833-843

Taliaferro-Smith, L.; Nagalingam, A.; Zhong, D.; Zhou, W.; Saxena, N.K.; Sharma, D. 2009: LKB1 is required for adiponectin-mediated modulation of AMPK-S6K axis and inhibition of migration and invasion of breast cancer cells. Oncogene 28(29): 2621-2633

Tsai, L-H.; Chen, P-M.; Cheng, Y-W.; Chen, C-Y.; Sheu, G-T.; Wu, T-C.; Lee, H. 2014: LKB1 loss by alteration of the NKX2-1/p53 pathway promotes tumor malignancy and predicts poor survival and relapse in lung adenocarcinomas. Oncogene 33(29): 3851-3860

Kottakis, F.; Nicolay, B.N.; Roumane, A.; Karnik, R.; Gu, H.; Nagle, J.M.; Boukhali, M.; Hayward, M.C.; Li, Y.Y.; Chen, T.; Liesa, M.; Hammerman, P.S.; Wong, K.Kin.; Hayes, D.Neil.; Shirihai, O.S.; Dyson, N.J.; Haas, W.; Meissner, A.; Bardeesy, N. 2016: LKB1 loss links serine metabolism to DNA methylation and tumorigenesis. Nature 539(7629): 390-395

Ji, H.; Ramsey, M.R.; Hayes, D.Neil.; Fan, C.; McNamara, K.; Kozlowski, P.; Torrice, C.; Wu, M.C.; Shimamura, T.; Perera, S.A.; Liang, M-Chih.; Cai, D.; Naumov, G.N.; Bao, L.; Contreras, C.M.; Li, D.; Chen, L.; Krishnamurthy, J.; Koivunen, J.; Chirieac, L.R.; Padera, R.F.; Bronson, R.T.; Lindeman, N.I.; Christiani, D.C.; Lin, X.; Shapiro, G.I.; Jänne, P.A.; Johnson, B.E.; Meyerson, M.; Kwiatkowski, D.J.; Castrillon, D.H.; Bardeesy, N.; Sharpless, N.E.; Wong, K-Kin. 2007: LKB1 modulates lung cancer differentiation and metastasis. Nature 448(7155): 807-810

Sitthideatphaiboon, P.; Galan-Cobo, A.; Negrao, M.V.; Qu, X.; Poteete, A.; Zhang, F.; Liu, D.D.; Lewis, W.E.; Kemp, H.N.; Lewis, J.; Rinsurongkawong, W.; Giri, U.; Lee, J.Jack.; Zhang, J.; Roth, J.A.; Swisher, S.G.; Heymach, J.V. 2020: LKB1 mutations in NSCLC are associated with KEAP1/NRF2-dependent radiotherapy resistance targetable by glutaminase inhibition. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 2020

Wang, Y.; Du, X.; Wei, J.; Long, L.; Tan, H.; Guy, C.; Dhungana, Y.; Qian, C.; Neale, G.; Fu, Y-Xin.; Yu, J.; Peng, J.; Chi, H. 2019: LKB1 orchestrates dendritic cell metabolic quiescence and anti-tumor immunity. Cell Research 29(5): 391-405

Xu, H-G.; Zhai, Y-X.; Chen, J.; Lu, Y.; Wang, J-W.; Quan, C-S.; Zhao, R-X.; Xiao, X.; He, Q.; Werle, K.D.; Kim, H-G.; Lopez, R.; Cui, R.; Liang, J.; Li, Y-L.; Xu, Z-X. 2015: LKB1 reduces ROS-mediated cell damage via activation of p38. Oncogene 34(29): 3848-3859

Wculek, S.K.; Sancho, D. 2019: LKB1 restrains dendritic cell function. Cell Research 29(6): 429-431

Katajisto, P.; Vaahtomeri, K.; Ekman, N.; Ventelä, E.; Ristimäki, A.; Bardeesy, N.; Feil, R.; DePinho, R.A.; Mäkelä, T.P. 2008: LKB1 signaling in mesenchymal cells required for suppression of gastrointestinal polyposis. Nature Genetics 40(4): 455-459

Nguyen, H.B.; Babcock, J.T.; Wells, C.D.; Quilliam, L.A. 2013: LKB1 tumor suppressor regulates AMP kinase/mTOR-independent cell growth and proliferation via the phosphorylation of Yap. Oncogene 32(35): 4100-4109

Wu, Z.; Xi, P.; Zhang, Y.; Wang, H.; Xue, J.; Sun, X.; Tian, D. 2021: LKB1 up-regulation inhibits hypothalamic inflammation and attenuates diet-induced obesity in mice. Metabolism, Clinical and Experimental 116: 154694

Just, P.-A.; Perret, C. 2021: LKB1, a gatekeeper of amino-acid driven gluconeogenesis. Medecine Sciences: M/S 37(10): 833-835

Yoo, L.I.; Chung, D.C.; Yuan, J. 2002: LKB1--a master tumour suppressor of the small intestine and beyond. Nature Reviews. Cancer 2(7): 529-535

Li, C.; Dong, X.; Du, W.; Shi, X.; Chen, K.; Zhang, W.; Gao, M. 2020: LKB1-AMPK axis negatively regulates ferroptosis by inhibiting fatty acid synthesis. Signal Transduction and Targeted Therapy 5(1): 187

Kottakis, F.; Bardeesy, N. 2012: LKB1-AMPK axis revisited. Cell Research 22(12): 1617-1620

Deng, J.; Wen, C.; Ding, X.; Zhang, X.; Hou, G.; Liu, A.; Xu, H.; Cao, X.; Bai, Y. 2020: LKB1-MARK2 signalling mediates lipopolysaccharide-induced production of cytokines in mouse macrophages. Journal of Cellular and Molecular Medicine 24(19): 11307-11317

Jin, C.; Xue, W.; Liu, Q.; Han, J.; Luo, R.; Feng, J.; Liu, J.; Guo, T.; Peng, X.; Hu, T. 2021: LKB1/AMPKα signaling pathway and mitochondrial fission/fusion dynamics regulate apoptosis induced by 3-chlorpropane-1,2-diol in HEK293 cells. Food and Chemical Toxicology: An International Journal Published for the British Industrial Biological Research Association 154: 112350

Mahoney, C.L.; Choudhury, B.; Davies, H.; Edkins, S.; Greenman, C.; Haaften, G.van.; Mironenko, T.; Santarius, T.; Stevens, C.; Stratton, M.R.; Futreal, P.A. 2009: LKB1/KRAS mutant lung cancers constitute a genetic subset of NSCLC with increased sensitivity to MAPK and mTOR signalling inhibition. British Journal of Cancer 100(2): 370-375

Hezel, A.F.; Bardeesy, N. 2008: LKB1; linking cell structure and tumor suppression. Oncogene 27(55): 6908-6919

Sun, C.; Zhu, M.; Yang, Z.; Pan, X.; Zhang, Y.; Wang, Q.; Xiao, W. 2014: LL-37 secreted by epithelium promotes fibroblast collagen production: a potential mechanism of small airway remodeling in chronic obstructive pulmonary disease. Laboratory Investigation; a Journal of Technical Methods and Pathology 94(9): 991-1002

Bankell, E.; Dahl, S.; Gidlöf, O.; Svensson, D.; Nilsson, B.-O. 2021: LL-37-induced caspase-independent apoptosis is associated with plasma membrane permeabilization in human osteoblast-like cells. Peptides 135: 170432

Biswas, D.; Ambalavanan, P.; Ravins, M.; Anand, A.; Sharma, A.; Lim, K.X.Z.; Tan, R.Y.M.; Lim, H.Y.; Sol, A.; Bachrach, G.; Angeli, V.; Hanski, E. 2021: LL-37-mediated activation of host receptors is critical for defense against group a streptococcal infection. Cell Reports 34(9): 108766

Hosono, K.; Ogihara, J.; Ohdake, T.; Masuda, S. 2009: LL-Z1272alpha epoxide, a precursor of ascochlorin produced by a mutant of Ascochyta viciae. Journal of Antibiotics 62(10): 571-574

Elbasani, E.; Kim, J.-D. 2021: LLAD: Life-Log Anomaly Detection Based on Recurrent Neural Network LSTM. Journal of Healthcare Engineering 2021: 8829403

Lefevre, J.G.; Koh, Y.W.H.; Wall, A.A.; Condon, N.D.; Stow, J.L.; Hamilton, N.A. 2021: LLAMA: a robust and scalable machine learning pipeline for analysis of large scale 4D microscopy data: analysis of cell ruffles and filopodia. Bmc Bioinformatics 22(1): 410

Onuora, S. 2019: LLDAS is an attainable SLE treatment target. Nature Reviews. Rheumatology 15(11): 636

Wu, D-Dong.; Huang, L.; Zhang, L.; Wu, L-Yu.; Li, Y-Chao.; Feng, L. 2012: LLDT-67 attenuates MPTP-induced neurotoxicity in mice by up-regulating NGF expression. Acta Pharmacologica Sinica 33(9): 1187-1194

Leng, S.; Xie, F.; Liu, J.; Shen, J.; Quan, G.; Wen, T. 2021: LLGL2 Increases Ca2+ Influx and Exerts Oncogenic Activities via PI3K/AKT Signaling Pathway in Hepatocellular Carcinoma. Frontiers in Oncology 11: 683629

Saito, Y.; Li, L.; Coyaud, E.; Luna, A.; Sander, C.; Raught, B.; Asara, J.M.; Brown, M.; Muthuswamy, S.K. 2019: LLGL2 rescues nutrient stress by promoting leucine uptake in ER + breast cancer. Nature 569(7755): 275-279

Fuh, B.; Sobo, M.; Cen, L.; Josiah, D.; Hutzen, B.; Cisek, K.; Bhasin, D.; Regan, N.; Lin, L.; Chan, C.; Caldas, H.; DeAngelis, S.; Li, C.; Li, P-K.; Lin, J. 2009: LLL-3 inhibits STAT3 activity, suppresses glioblastoma cell growth and prolongs survival in a mouse glioblastoma model. British Journal of Cancer 100(1): 106-112

Chen, X.; Pan, L.; Wei, J.; Zhang, R.; Yang, X.; Song, J.; Bai, R-Yuan.; Fu, S.; Pierson, C.R.; Finlay, J.L.; Li, C.; Lin, J. 2021: LLL12B, a small molecule STAT3 inhibitor, induces growth arrest, apoptosis, and enhances cisplatin-mediated cytotoxicity in medulloblastoma cells. Scientific Reports 11(1): 6517

Murakami, M.; Kano, F.; Murata, M. 2018: LLO-mediated Cell Resealing System for Analyzing Intracellular Activity of Membrane-impermeable Biopharmaceuticals of Mid-sized Molecular Weight. Scientific Reports 8(1): 1946

Taylor, C.L.; Wilson, S.R.; Burgoyne, L.L.; Endlich, Y. 2021: LMA® Gastro™: a paediatric experience. Anaesthesia and Intensive Care 49(2): 119-124

Wong, M-Liang. 2012: LMB Cambridge: Bureaucracy bypass let research flourish. Nature 490(7421): 487

Zhu, B.; Xue, F.; Zhang, C.; Li, G. 2019: LMCD1 promotes osteogenic differentiation of human bone marrow stem cells by regulating BMP signaling. Cell Death and Disease 10(9): 647

Sarkar, T.; Bhattacharyya, A.; Banerjee, S.; Hussain, A. 2020: LMCT transition-based red-light photochemotherapy using a tumour-selective ferrocenyl iron(iii) coumarin conjugate. Chemical Communications 56(57): 7981-7984

Fan, C.-H.; Lin, C.-W.; Huang, H.-J.; Lee-Chen, G.-J.; Sun, Y.-C.; Lin, W.; Chen, C.-M.; Chang, K.-H.; Su, M.-T.; Hsieh-Li, H.M. 2020: LMDS-1, a potential TrkB receptor agonist provides a safe and neurotrophic effect for early-phase Alzheimer's disease. Psychopharmacology 237(10): 3173-3190

Wang, W.; Guan, X.; Khan, M.T.; Xiong, Y.; Wei, D.-Q. 2020: LMI-DForest: a deep forest model towards the prediction of lncRNA-miRNA interactions. Computational Biology and Chemistry 89: 107406

Mazzocchi, M.; Goulding, S.R.; Wyatt, S.L.; Collins, L.M.; Sullivan, A.M.; O'Keeffe, G.W. 2021: LMK235, a small molecule inhibitor of HDAC4/5, protects dopaminergic neurons against neurotoxin- and α-synuclein-induced degeneration in cellular models of Parkinson's disease. Molecular and Cellular Neurosciences 115: 103642

Kato, K.; Ohno, S.; Sonoda, K.; Fukuyama, M.; Makiyama, T.; Ozawa, T.; Horie, M. 2020: LMNA Missense Mutation Causes Nonsense-Mediated mRNA Decay and Severe Dilated Cardiomyopathy. CIRCULATION. Genomic and Precision Medicine 13(5): 435-443

Liu, H.; Li, D.; Zhou, L.; Kan, S.; He, G.; Zhou, K.; Wang, L.; Chen, M.; Shu, W. 2020: LMNA functions as an oncogene in hepatocellular carcinoma by regulating the proliferation and migration ability. Journal of Cellular and Molecular Medicine 24(20): 12008-12019

Miranda, M.; Chacón, M.R.; Gutiérrez, C.; Vilarrasa, N.; Gómez, J.M.; Caubet, E.; Megía, A.; Vendrell, J. 2008: LMNA mRNA expression is altered in human obesity and type 2 diabetes. Obesity 16(8): 1742-1748

Shackleton, S.; Lloyd, D.J.; Jackson, S.N.; Evans, R.; Niermeijer, M.F.; Singh, B.M.; Schmidt, H.; Brabant, G.; Kumar, S.; Durrington, P.N.; Gregory, S.; O'Rahilly, S.; Trembath, R.C. 2000: LMNA, encoding lamin A/C, is mutated in partial lipodystrophy. Nature Genetics 24(2): 153-156

Bijarnia-Mahay, S.; Roy, G.; Padiath, Q.S.; Saxena, R.; Verma, I.C. 2021: LMNB1 Duplication-Mediated Autosomal Dominant Adult-Onset Leukodystrophy in an Indian Family. Annals of Indian Academy of Neurology 24(3): 413-416

Kong, W.; Wu, Z.; Yang, M.; Zuo, X.; Yin, G.; Chen, W. 2020: LMNB2 is a prognostic biomarker and correlated with immune infiltrates in hepatocellular carcinoma. Iubmb Life 72(12): 2672-2685

Dong, C-Hua.; Jiang, T.; Yin, H.; Song, H.; Zhang, Y.; Geng, H.; Shi, P-Cong.; Xu, Y-Xin.; Gao, H.; Liu, L-Yu.; Zhou, L.; Zhang, Z-Hui.; Song, J. 2021: LMNB2 promotes the progression of colorectal cancer by silencing p21 expression. Cell Death and Disease 12(4): 331

Ruggero, K.; Al-Assar, O.; Chambers, J.S.; Codrington, R.; Brend, T.; Rabbitts, T.H. 2016: LMO2 and IL2RG synergize in thymocytes to mimic the evolution of SCID-X1 gene therapy-associated T-cell leukaemia. Leukemia 30(9): 1959-1962

Liu, Y.; Huang, D.; Wang, Z.; Wu, C.; Zhang, Z.; Wang, D.; Li, Z.; Zhu, T.; Yang, S.; Sun, W. 2016: LMO2 attenuates tumor growth by targeting the Wnt signaling pathway in breast and colorectal cancer. Scientific Reports 6: 36050

Cheng, Y.; Hou, T.; Ping, J.; Chen, T.; Yin, B. 2018: LMO3 promotes hepatocellular carcinoma invasion, metastasis and anoikis inhibition by directly interacting with LATS1 and suppressing Hippo signaling. Journal of Experimental and Clinical Cancer Research: Cr 37(1): 228

Lu, Z.; Lam, K.S.; Wang, N.; Xu, X.; Cortes, M.; Andersen, B. 2006: LMO4 can interact with Smad proteins and modulate transforming growth factor-beta signaling in epithelial cells. Oncogene 25(20): 2920-2930

Montañez-Wiscovich, M.E.; Seachrist, D.D.; Landis, M.D.; Visvader, J.; Andersen, B.; Keri, R.A. 2009: LMO4 is an essential mediator of ErbB2/HER2/Neu-induced breast cancer cell cycle progression. Oncogene 28(41): 3608-3618

Liu, X.; Yuan, H.; Zhou, J.; Wang, Q.; Qi, X.; Bernal, C.; Avella, D.; Kaifi, J.T.; Kimchi, E.T.; Timothy, P.; Cheng, K.; Miao, Y.; Jiang, K.; Li, G. 2021: LMO7 as an Unrecognized Factor Promoting Pancreatic Cancer Progression and Metastasis. Frontiers in Cell and Developmental Biology 9: 647387

Du, T-Ting.; Dewey, J.B.; Wagner, E.L.; Cui, R.; Heo, J.; Park, J-Jin.; Francis, S.P.; Perez-Reyes, E.; Guillot, S.J.; Sherman, N.E.; Xu, W.; Oghalai, J.S.; Kachar, B.; Shin, J-Bum. 2019: LMO7 deficiency reveals the significance of the cuticular plate for hearing function. Nature Communications 10(1): 1117

Mowery, Y.M.; Weinberg, J.B.; Kennedy, M.N.; Bond, K.M.; Moore, J.O.; Lanasa, M.C.; Gockerman, J.P.; Diehl, L.F.; Pizzo, S.V.; Cianciolo, G.J.; Friedman, D.R. 2010: LMP-420: a novel purine nucleoside analog with potent cytotoxic effects for CLL cells and minimal toxicity for normal hematopoietic cells. Leukemia 24(9): 1580-1587

Yang, X.; He, Z.; Xin, B.; Cao, L. 2000: LMP1 of Epstein-Barr virus suppresses cellular senescence associated with the inhibition of p16INK4a expression. Oncogene 19(16): 2002-2013

Li, Z.; Zhou, Z.; Wu, X.; Zhou, Q.; Liao, C.; Liu, Y.; Li, D.; Shen, L.; Feng, D.; Yang, L. 2020: LMP1 promotes nasopharyngeal carcinoma metastasis through NTRK2-mediated anoikis resistance. American Journal of Cancer Research 10(7): 2083-2099

Thornburg, N.J.; Kulwichit, W.; Edwards, R.H.; Shair, K.H.Y.; Bendt, K.M.; Raab-Traub, N. 2006: LMP1 signaling and activation of NF-kappaB in LMP1 transgenic mice. Oncogene 25(2): 288-297

Wang, L.; Ren, J.; Li, G.; Moorman, J.P.; Yao, Z.Q.; Ning, S. 2017: LMP1 signaling pathway activates IRF4 in latent EBV infection and a positive circuit between PI3K and Src is required. Oncogene 36(16): 2265-2274

Vargas-Alarcón, G.; Gamboa, R.; Vergara, Y.; Rodriguez-Zepeda, J.M.; de la Peña, A.; Izaguirre, R.; Zuñiga, J.; Ruiz-Morales, J.A.; Granados, J. 2002: LMP2 and LMP7 gene polymorphism in Mexican populations: Mestizos and Amerindians. Genes and Immunity 3(6): 373-377

Kessler, B.M.; Lennon-Duménil, A.M.; Shinohara, M.L.; Lipes, M.A.; Ploegh, H.L. 2000: LMP2 expression and proteasome activity in NOD mice. Nature Medicine 6(10): 1064; Author Reply 1065-6

Runnels, H.A.; Watkins, W.A.; Monaco, J.J. 2000: LMP2 expression and proteasome activity in NOD mice. Nature Medicine 6(10): 1064-5; Author Reply 1065-6

Zeng, Y.; Si, Y.F.; Lan, G.P.; Wang, Z.; Zhou, L.; Tang, M.Z.; Sj, O.B.; Lan, J.; Zhou, X.Y.; Wang, Y.L.; Tang, J.; Zhou, Z.X.; Du, H.J.; Lin, H. 2020: LMP2-DC Vaccine Elicits Specific EBV-LMP2 Response to Effectively Improve Immunotherapy in Patients with Nasopharyngeal Cancer. Biomedical and Environmental Sciences: Bes 33(11): 849-856

Jiang, Y.; Xiao, H.; Sun, L.; Zhang, Y.; Liu, S.; Luo, B. 2021: LMP2A suppresses the role of AHR pathway through ERK signal pathway in EBV-associated gastric cancer. Virus Research 297: 198399

Jin, J.; Wang, W.; Li, A.; Wu, J. 2020: LMP7 inhibits the activation of NLRP3 inflammasome through interaction with NLRP3. Biochemical and Biophysical Research Communications 531(2): 152-159

Ramírez-Vélez, R.; Correa-Bautista, J.E.; Martínez-Torres, J.; Méneses-Echavez, J.F.; González-Ruiz, K.; González-Jiménez, E.; Schmidt-RioValle, J.; Lobelo, F. 2016: LMS tables for waist circumference and waist-height ratio in Colombian adults: analysis of nationwide data 2010. European Journal of Clinical Nutrition 70(10): 1189-1196

Mitteldorf, P.M. 1984: LMT's buyer's guide to porcelain furnaces. Dental Lab Management Today 1(2): Front Cover 35

Hisanaga, S.-I.; Wei, R.; Huo, A.; Tomomura, M. 2020: LMTK1, a Novel Modulator of Endosomal Trafficking in Neurons. Frontiers in Molecular Neuroscience 13: 112

Vezelis, A.; Simiene, J.; Dabkeviciene, D.; Kincius, M.; Ulys, A.; Suziedelis, K.; Jarmalaite, S.; Jankevicius, F. 2021: LMTK2 as Potential Biomarker for Stratification between Clinically Insignificant and Clinically Significant Prostate Cancer. Journal of Oncology 2021: 8820366

Rui, Q.; Cao, S.; Wang, X.; Duan, X.; Iao, X.; Dong, W.; Fang, Q.; Zhang, X.; Xue, Q. 2021: LMTK2 regulates inflammation in lipopolysaccharide-stimulated BV2 cells. Experimental and Therapeutic Medicine 21(3): 219

Stebbing, J.; Shah, K.; Lit, L.Cheng.; Gagliano, T.; Ditsiou, A.; Wang, T.; Wendler, F.; Simon, T.; Szabó, K.Sára.; O'Hanlon, T.; Dean, M.; Roslani, A.Camilla.; Cheah, S.Hung.; Lee, S-Chin.; Giamas, G. 2018: LMTK3 confers chemo-resistance in breast cancer. Oncogene 37(23): 3113-3130

Cilibrasi, C.; Ditsiou, A.; Papakyriakou, A.; Mavridis, G.; Eravci, M.; Stebbing, J.; Gagliano, T.; Giamas, G. 2021: LMTK3 inhibition affects microtubule stability. Molecular Cancer 20(1): 53

Klug, L.R.; Bannon, A.E.; Javidi-Sharifi, N.; Town, A.; Fleming, W.H.; VanSlyke, J.K.; Musil, L.S.; Fletcher, J.A.; Tyner, J.W.; Heinrich, M.C. 2019: LMTK3 is essential for oncogenic KIT expression in KIT-mutant GIST and melanoma. Oncogene 38(8): 1200-1210

Stebbing, J.; Filipovic, A.; Lit, L.C.; Blighe, K.; Grothey, A.; Xu, Y.; Miki, Y.; Chow, L.W.; Coombes, R.C.; Sasano, H.; Shaw, J.A.; Giamas, G. 2013: LMTK3 is implicated in endocrine resistance via multiple signaling pathways. Oncogene 32(28): 3371-3380

Jiang, T.; Lu, X.; Yang, F.; Wang, M.; Yang, H.; Xing, N. 2020: LMTK3 promotes tumorigenesis in bladder cancer via the ERK/MAPK pathway. Febs Open Bio 10(10): 2107-2121

Lulla, A.R.; Akli, S.; Karakas, C.; Ha, M.Jin.; Fowlkes, N.W.; Mitani, Y.; Bui, T.; Wang, J.; Rao, X.; Hunt, K.K.; Meijer, L.; El-Naggar, A.K.; Keyomarsi, K. 2021: LMW cyclin E and its novel catalytic partner CDK5 are therapeutic targets and prognostic biomarkers in salivary gland cancers. Oncogenesis 10(5): 40

Chiarugi, P.; Taddei, M.Letizia.; Schiavone, N.; Papucci, L.; Giannoni, E.; Fiaschi, T.; Capaccioli, S.; Raugei, G.; Ramponi, G. 2004: LMW-PTP is a positive regulator of tumor onset and growth. Oncogene 23(22): 3905-3914

Thomas, G.; Frederick, E.; Thompson, L.; Bar-Or, R.; Mulugeta, Y.; Hausburg, M.; Roshon, M.; Mains, C.; Bar-Or, D. 2020: LMWF5A suppresses cytokine release by modulating select inflammatory transcription factor activity in stimulated PBMC. Journal of Translational Medicine 18(1): 452

Guo, X.; Piao, H.; Xue, Y.; Liu, Y.; Zhao, H. 2020: LMX1B-associated gankyrin expression predicts poor prognosis in glioma patients. Journal of International Medical Research 48(9): 300060520954764

Tewari, A.; Prabagar, M.G.; Gibbings, S.L.; Rawat, K.; Jakubzick, C.V. 2021: LN Monocytes Limit DC-Poly I:C Induced Cytotoxic T Cell Response via IL-10 and Induction of Suppressor CD4 T Cells. Frontiers in Immunology 12: 763379

Pabon-Martinez, Y.Vladimir.; Xu, Y.; Villa, A.; Lundin, K.E.; Geny, S.; Nguyen, C-Hung.; Pedersen, E.B.; Jørgensen, P.T.; Wengel, J.; Nilsson, L.; Smith, C.I.Edvard.; Zain, R. 2017: LNA effects on DNA binding and conformation: from single strand to duplex and triplex structures. Scientific Reports 7(1): 11043

Chabot, S.; Orio, J.; Castanier, R.; Bellard, E.; Nielsen, Søren.J.; Golzio, M.; Teissié, J. 2012: LNA-based oligonucleotide electrotransfer for miRNA inhibition. Molecular Therapy: the Journal of the American Society of Gene Therapy 20(8): 1590-1598

Elmén, J.; Lindow, M.; Schütz, S.; Lawrence, M.; Petri, A.; Obad, S.; Lindholm, M.; Hedtjärn, M.; Hansen, H.Frydenlund.; Berger, U.; Gullans, S.; Kearney, P.; Sarnow, P.; Straarup, E.Marie.; Kauppinen, S. 2008: LNA-mediated microRNA silencing in non-human primates. Nature 452(7189): 896-899

Touznik, A.; Maruyama, R.; Hosoki, K.; Echigoya, Y.; Yokota, T. 2017: LNA/DNA mixmer-based antisense oligonucleotides correct alternative splicing of the SMN2 gene and restore SMN protein expression in type 1 SMA fibroblasts. Scientific Reports 7(1): 3672

Sun, T.; Wu, Z.; Wang, X.; Wang, Y.; Hu, X.; Qin, W.; Lu, S.; Xu, D.; Wu, Y.; Chen, Q.; Ding, X.; Guo, H.; Li, Y.; Wang, Y.; Fu, B.; Yao, W.; Wei, M.; Wu, H. 2020: LNC942 promoting METTL14-mediated m 6 A methylation in breast cancer cell proliferation and progression. Oncogene 39(31): 5358-5372

Jia, G.; Wang, Y.; Lin, C.; Lai, S.; Dai, H.; Wang, Z.; Dai, L.; Su, H.; Song, Y.; Zhang, N.; Feng, Y.; Tang, B. 2021: LNCAROD enhances hepatocellular carcinoma malignancy by activating glycolysis through induction of pyruvate kinase isoform PKM2. Journal of Experimental and Clinical Cancer Research: Cr 40(1): 299

Pedrosa, J.ão.; Aresta, G.; Ferreira, C.; Atwal, G.; Phoulady, H.A.; Chen, X.; Chen, R.; Li, J.; Wang, L.; Galdran, A.; Bouchachia, H.; Kaluva, K.C.; Vaidhya, K.; Chunduru, A.; Tarai, S.; Nadimpalli, S.P.P.; Vaidya, S.; Kim, I.; Rassadin, A.; Tian, Z.; Sun, Z.; Jia, Y.; Men, X.; Ramos, I.; Cunha, A.ón.; Campilho, A.él. 2021: LNDb challenge on automatic lung cancer patient management. Medical Image Analysis 70: 102027

Fang, F.; Xu, H.; Wu, L.; Hu, L.; Liu, Y.; Li, Y.; Zhang, C. 2021: LNG-IUS combined with progesterone ameliorates endometrial thickness and pregnancy outcomes of patients with early-stage endometrial cancer or atypical hyperplasia. American Journal of Translational Research 13(5): 5412-5419

Li, G.; Liu, J.; Wang, Y.; Yang, K.; Zhao, M.; Xiao, Y.; Wen, X.; Liu, L. 2017: LNGFR targets the Wnt/β-catenin pathway and promotes the osteogenic differentiation in rat ectomesenchymal stem cells. Scientific Reports 7(1): 11021

Ding, L-W.; Sun, Q-Y.; Lin, D-C.; Chien, W.; Hattori, N.; Dong, X-M.; Gery, S.; Garg, M.; Doan, N.B.; Said, J.W.; Xiao, J-F.; Yang, H.; Liu, L-Z.; Meng, X.; Huang, R.Y-J.; Tang, K.; Koeffler, H.P. 2015: LNK (SH2B3): paradoxical effects in ovarian cancer. Oncogene 34(11): 1463-1474

Zhong, X.; Ke, C.; Cai, Z.; Wu, H.; Ye, Y.; Liang, X.; Yu, L.; Jiang, S.; Shen, J.; Wang, L.; Xie, M.; Wang, G.; Zhao, X. 2020: LNK deficiency decreases obesity-induced insulin resistance by regulating GLUT4 through the PI3K-Akt-AS160 pathway in adipose tissue. Aging 12(17): 17150-17166

Pardanani, A.; Lasho, T.; Finke, C.; Oh, S.T.; Gotlib, J.; Tefferi, A. 2010: LNK mutation studies in blast-phase myeloproliferative neoplasms, and in chronic-phase disease with TET2, IDH, JAK2 or MPL mutations. Leukemia 24(10): 1713-1718

Ding, L-Wen.; Sun, Q-Yang.; Edwards, J.J.; Fernández, L.Torres.; Ran, X-Bin.; Zhou, S-Qin.; Scolyer, R.A.; Wilmott, J.S.; Thompson, J.F.; Doan, N.; Said, J.W.; Venkatachalam, N.; Xiao, J-Fen.; Loh, X-Yi.; Pein, M.; Xu, L.; Mullins, D.W.; Yang, H.; Lin, D-Chen.; Koeffler, H.Phillip. 2019: LNK suppresses interferon signaling in melanoma. Nature Communications 10(1): 2230

Chen, C.; He, W.; Huang, J.; Wang, B.; Li, H.; Cai, Q.; Su, F.; Bi, J.; Liu, H.; Zhang, B.; Jiang, N.; Zhong, G.; Zhao, Y.; Dong, W.; Lin, T. 2018: LNMAT1 promotes lymphatic metastasis of bladder cancer via CCL2 dependent macrophage recruitment. Nature Communications 9(1): 3826

Urosevic, D.; Dragan, U.; Schann, S.; Stephan, S.; Ehrhardt, J-Daniel.; Jean-Daniel, E.; Bousquet, P.; Pascal, B.; Greney, H.; Hugues, G. 2004: LNP 906, the first high-affinity photoaffinity ligand selective for I1 imidazoline receptors. British Journal of Pharmacology 142(3): 609-617

Calabrese, E.J. 2021: LNT and cancer risk assessment: its flawed foundations part 1: Radiation and leukemia: Where LNT began. Environmental Research 197: 111025

Calabrese, E.J. 2021: LNT and cancer risk assessment: its flawed foundations part 2: how unsound LNT science became accepted. Environmental Research 197: 111041

Young, P.W. 2018: LNX1/LNX2 proteins: functions in neuronal signalling and beyond. Neuronal Signaling 2(2): Ns20170191

Hasani, F.; Haines, T.; Munteanu, S.E.; Schoch, P.; Vicenzino, B.; Malliaras, P. 2021: LOAD-intensity and time-under-tension of exercises for men who have Achilles tendinopathy (the LOADIT trial): a randomised feasibility trial. Bmc Sports Science Medicine and Rehabilitation 13(1): 57

Nelson, R.; Ertural, C.; George, J.; Deringer, V.L.; Hautier, G.; Dronskowski, R. 2020: LOBSTER: Local orbital projections, atomic charges, and chemical-bonding analysis from projector-augmented-wave-based density-functional theory. Journal of Computational Chemistry 41(21): 1931-1940

Li, N.; Ma, Y.; Wang, W.; Yin, C.C.; Wu, W.; Sun, R.; Zhao, G.; Li, S.; Wang, X. 2020: LOC101928834, a novel lncRNA in Wnt/β-catenin signaling pathway, promotes cell proliferation and predicts poor clinical outcome in myelodysplastic syndromes. Clinical Science 134(11): 1279-1293

Lin, J.; Fang, Y.; Tao, M.; Ma, L.; Cao, Y.; Li, Y.; Ji, C.; Yang, J.; Yang, X. 2020: LOC285194 inhibits proliferation of human keratinocytes through regulating miR-616/GATA3 pathway. Molecular and Cellular Probes 53: 101598

Chen, C.-Z.; Wen, J.-L.; Lin, B.-Y.; Zheng, C.; Quan, R.-d.; Zhang, X.-H.; Qu, J.-M. 2020: LOC389641 promotes papillary thyroid cancer progression by regulating the EMT pathway. Biomarkers in Medicine 14(11): 969-980

Hu, W.; Chen, Z.; Chen, J.; Cai, D.; Chen, C.; Fang, T. 2020: LOC441178 Overexpression Inhibits the Proliferation and Migration of Esophageal Carcinoma Cells via Methylation of miR-182. Oncotargets and Therapy 13: 11253-11263

Tsai, K.-W.; Chong, K.-H.; Li, C.-H.; Tu, Y.-T.; Chen, Y.-R.; Lee, M.-C.; Chan, S.-H.; Wang, L.-H.; Chang, Y.-J. 2021: LOC550643, a Long Non-coding RNA, Acts as Novel Oncogene in Regulating Breast Cancer Growth and Metastasis. Frontiers in Cell and Developmental Biology 9: 695632

Shimabukuro, T.; Ohmi, C.; Nagamitsu, R.; Shiraishi, K.; Matsuyama, H. 2020: Local Reactions of Luteinizing Hormone-Releasing Hormone Agents and its effects on Clinical Outcomes in Prostate Cancer Patients. Nihon Hinyokika Gakkai Zasshi. Japanese Journal of Urology 111(4): 120-129

Passy, S. 1965: Local Treatment of Burns. Folha Medica 50: 227-230

Gluck, B. 1946: Localisation of Intra-Ocular Foreign Bodies. British Journal of Ophthalmology 30(7): 434-435

Fujimoto, K.; Matsuyama, S.; Matsui, F.; Yazawa, K.; Matsumoto, F. 2019: Localized Cystic Disease of the Kidney in a 6-Year-Old Girl. Nihon Hinyokika Gakkai Zasshi. Japanese Journal of Urology 110(3): 215-218

Haje, D.D.P.á; Haje, S.A.ão.; Volpon, J.é B.; Silva, A.C.O.D.; Lima, L.F.B.; Huang, W. 2021: Localized Pectus Excavatum Treated with Brace and Exercise: Long Term Results of a Brazilian Technique. Acta Ortopedica Brasileira 29(3): 143-148

Ugolev, A.M.; Iesuitova, N.N.; Timofeeva, N.M.; Fediushina, I.N. 1964: Location of Hydrolysis of Certain Disaccharides and Peptides in the Small Intestine. Nature 202: 807-809

Sakurai, T. 2020: LOCATION, LOCATION, LOCATION: Location of neuroinflammation is important in pathogenesis of schizophrenia. Brain Behavior and Immunity 88: 842-843

Zhang, X.; Tan, X.; Weng, J.; Li, Y. 2016: LOCC indistinguishable orthogonal product quantum states. Scientific Reports 6: 28864

Da Conceição Pereira, S.; Manhães-de-Castro, R.; Visco, D.B.ão.; de Albuquerque, G.L.; da Silva Calado, C.M.S.; da Silva Souza, V.; Toscano, A.E. 2021: Locomotion is impacted differently according to the perinatal brain injury model: Meta-analysis of preclinical studies with implications for cerebral palsy. Journal of Neuroscience Methods 360: 109250

Hu, W.; Lagarias, J.Clark. 2019: LOF and GOF Alleles Shed Light on the Molecular Basis of phyB Signaling in Plants. Plant Cell 31(7): 1400-1401

Sun, Z.; Xu, W.; Cong, X.; Li, G.; Chen, K. 2020: Log-Contrast Regression with Functional Compositional Predictors: Linking Preterm Infant's Gut Microbiome Trajectories to Neurobehavioral Outcome. Annals of Applied Statistics 14(3): 1535-1556

Partridge, M.; Emilion, G.; Langdon, J.D. 1996: LOH at 3p correlates with a poor survival in oral squamous cell carcinoma. British Journal of Cancer 73(3): 366-371

Ruivenkamp, C.; Hermsen, M.; Postma, C.; Klous, A.; Baak, J.; Meijer, G.; Demant, P. 2003: LOH of PTPRJ occurs early in colorectal cancer and is associated with chromosomal loss of 18q12-21. Oncogene 22(22): 3472-3474

Li, J.; Zhang, Z.; Dai, Z.; Plass, C.; Morrison, C.; Wang, Y.; Wiest, J.S.; Anderson, M.W.; You, M. 2003: LOH of chromosome 12p correlates with Kras2 mutation in non-small cell lung cancer. Oncogene 22(8): 1243-1246

Bezawork-Geleta, A.; Brodie, E.J.; Dougan, D.A.; Truscott, K.N. 2015: LON is the master protease that protects against protein aggregation in human mitochondria through direct degradation of misfolded proteins. Scientific Reports 5: 17397

Stessman, J.; Jacobs, J.M.; Rottenberg, Y. 2020: Loneliness, Function and Longevity: the Jerusalem Longitudinal Cohort Study. Harefuah 159(9): 666-671

Rakowska, M.; Abdellahi, M.E.A.; Bagrowska, P.; Navarrete, M.; Lewis, P.A. 2021: Long term effects of cueing procedural memory reactivation during NREM sleep. Neuroimage 244: 118573

Hawco, C.; Houlden, R.L. 2020: Long Term Follow-Up of one of the first Patients to Receive Human Growth Hormone Therapy. Aace Clinical Case Reports 6(5): E262-E264

Takao, M.M.V.; Sandy, N.S.; Riccetto, A.G.L.; Tommaso, A.M.A.D. 2021: Long Term Management of Glycogen Storage Disease type 1b: a Brazilian Tertiary Center Experience. Arquivos de Gastroenterologia 58(1): 87-92

Demir, S.; Gülhan, B.; Özen, S.; Çeleğen, K.üb.; Batu, E.D.; Taş, N.; Orhan, D.; Bilginer, Y.; Düzova, A.; Ozaltin, F.; Topaloğlu, R. 2022: Long-term renal survival of paediatric patients with lupus nephritis. Nephrology Dialysis Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 37(6): 1069-1077

Goldman, A.; Wollina, U.; Machado, D.; Marinowic, D. 2021: Long-Pulsed Nd:yag Laser to Treat Telangiectasia of the Nose: a Comprehensive 5-Year Single Center Study. Georgian Medical News 314: 7-12

Ozorhan, U.; Tuna, B.G.; Cicekdal, M.B.; Kuskucu, A.; Bayrak, O.F.; Yilmaz, B.; Demirel, P.B.; Cleary, M.P.; Dogan, S. 2022: Long-term chronic caloric restriction alters miRNA profiles in the brain of ageing mice. British Journal of Nutrition 127(5): 641-652

Alis, A.; Guler Alis, M. 2021: Long-term effect of intravitreal aflibercept treatment on choroidal vascularity index in neovascular age-related macular degeneration. Photodiagnosis and Photodynamic Therapy 36: 102582

Otellin, V.A.; Khozhai, L.I.; Sishko, T.T.; Tyurenkov, I.N. 2017: Long-Term Effects of Exposure to Perinatal Hypoxia on Microvascular Endothelium of Neocortex in Rats. Zhurnal Evoliutsionnoi Biokhimii i Fiziologii 53(1): 49-54

Radi, G.; Campanati, A.; Diotallevi, F.; Rizzetto, G.; Martina, E.; Bobyr, I.; Giannoni, M.; Offidani, A. 2021: Long-term efficacy and safety of apremilast in the treatment of plaques psoriasis: a real-world, single-center experience. Dermatologic Therapy 34(6): E15179

Travisano, M.; Vasi, F.; Lenski, R.E. 1995: Long-Term Experimental Evolution in Escherichia Coli. Iii. Variation Among Replicate Populations in Correlated Responses to Novel Environments. Evolution; International Journal of Organic Evolution 49(1): 189-200

LoGiurato, D.; Antal, Z.; Zhou, P. 2020: Long-Term Follow up and Treatment Outcomes of a 2 Year-Old-Boy with Metastatic Testosterone-Secreting Adrenocortical Carcinoma. Aace Clinical Case Reports 6(6): E300-E304

Gorriz, J.é L.; D'Marco, L.; Pastor-González, A.; Molina, P.; Gonzalez-Rico, M.; Puchades, M.ía.J.ús.; Sanchis, I.; Escudero, V.ón.; Estañ, N.; de la Espriella, R.; Nuñez, E.; Pallardó, L.; Núñez, J. 2022: Long-term mortality and trajectory of potassium measurements following an episode of acute severe hyperkalaemia. Nephrology Dialysis Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 37(3): 522-530

Sinanović, O. 2021: Long-Term Neuropsychiatric Consequences of Sars-Cov Infections. Psychiatria Danubina 33(Suppl 3): S309-S317

Robson, D.C. 1964: Long-Term Preservation of Blood. Proceedings of the Royal Society of Medicine 57: 628-631

Whitcher, H.W. 1964: Long-Term Preservation of Blood. Proceedings of the Royal Society of Medicine 57: 631-633

Macfarlane, L.R. 1964: Long-Term Preservation of Blood. Proceedings of the Royal Society of Medicine 57: 633-634

Chatchen, S.; Ibrahim, S.; Wisetsing, P.; Limkittikul, K. 2017: Long-Term Protective Rabies Antibodies in Thai Children After Pre-Exposure Rabies Vaccination. Southeast Asian Journal of Tropical Medicine and Public Health 48(2): 306-312

Sandbu, A. 1965: Long-Term Psychiatric Patients and their Contact with Relatives. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 85: 553-554

Ciuca, A. 1964: Longevity and Environmental Conditions. Zeitschrift für Arztliche Fortbildung 58: 230-238

Sauer, L.; Vitale, A.S.; Modersitzki, N.K.; Bernstein, P.S. 2021: Longitudinal Fluorescence Lifetime Imaging Ophthalmoscopy Analysis in Patients with Macular Telangiectasia type 2 (Mactel). Retina 41(7): 1416-1427

Lee, Y.Geon.; Kim, H.Won.; Nam, Y.; Shin, K.Jin.; Lee, Y.Jin.; Park, D.Hong.; Rhee, H-Woo.; Seo, J.Kon.; Chae, Y.Chan. 2021: LONP1 and ClpP cooperatively regulate mitochondrial proteostasis for cancer cell survival. Oncogenesis 10(2): 18

Shin, C-Shik.; Meng, S.; Garbis, S.D.; Moradian, A.; Taylor, R.W.; Sweredoski, M.J.; Lomenick, B.; Chan, D.C. 2021: LONP1 and mtHSP70 cooperate to promote mitochondrial protein folding. Nature Communications 12(1): 265

Xu, L.; Wu, Z.; Wang, Y.; Dai, Z.; Feng, Z.; Sun, X.; Liu, Z.; Cheng, J.; Qiu, Y.; Zhu, Z. 2021: LONP1 is associated with the incidence of idiopathic scoliosis possibly via defective mitochondrial function. Studies in Health Technology and Informatics 280: 253

Rоsul, Мa.М; Bletskan, Мi.М; Ivano, N.V.; Korabelschykova, M.O. 2021: Loop Diuretics in Heart Failure: Evidence-Based Choice. Wiadomosci Lekarskie 74(4): 1003-1006

Horta, R.S.; Souza, L.M.; Sena, B.V.; Almeida, I.O.; Jaretta, T.âm.A.; Pimenta, M.M.; Reche Júnior, A. 2021: LOPH: a novel chemotherapeutic protocol for feline high-grade multicentric or mediastinal lymphoma, developed in an area endemic for feline leukemia virus. Journal of Feline Medicine and Surgery 23(2): 86-97

Horder, T.J. 1955: LORD HORDER of Ashford. British Medical Journal 2(4938): 565-566

Pkhakadze, G.; Bokhua, Z.; Asatiani, T.; Muzashvili, T.; Burkadze, G. 2021: Loss of Cas3 and Increase of Bax Expression Associated with Progression of Cervical Intraepithelial Neoplasia. Georgian Medical News 311: 147-151

Kalnins, V.I.; Stich, H.F. 1963: Loss of Liver Cell Antigens in Azo-Dye Induced Hepatomas of Rats. Nature 200: 189-190

Abdollahi, A.; Bao, R.; Hamilton, T.C. 1999: LOT1 is a growth suppressor gene down-regulated by the epidermal growth factor receptor ligands and encodes a nuclear zinc-finger protein. Oncogene 18(47): 6477-6487

Chen, X.; Leischner, U.; Varga, Z.; Jia, H.; Deca, D.; Rochefort, N.L.; Konnerth, A. 2012: LOTOS-based two-photon calcium imaging of dendritic spines in vivo. Nature Protocols 7(10): 1818-1829

Ding, D.; Wei, C.; Dong, K.; Liu, J.; Stanton, A.; Xu, C.; Min, J.; Hu, J.; Chen, C. 2020: LOTUS domain is a novel class of G-rich and G-quadruplex RNA binding domain. Nucleic Acids Research 48(16): 9262-9272

Zhu, L.; Kandasamy, S.K.; Liao, S.E.; Fukunaga, R. 2018: LOTUS domain protein MARF1 binds CCR4-NOT deadenylase complex to post-transcriptionally regulate gene expression in oocytes. Nature Communications 9(1): 4031

Nishida, R.; Kawaguchi, Y.; Matsubayashi, J.; Ishikawa, R.; Kida, S.; Takei, K. 2021: LOTUS, an endogenous Nogo receptor antagonist, is involved in synapse and memory formation. Scientific Reports 11(1): 5085

Kubíková, J.; Reinig, R.; Salgania, H.K.; Jeske, M. 2020: LOTUS-domain proteins - developmental effectors from a molecular perspective. Biological Chemistry 402(1): 7-23

Klindžić, D.; Stam, D.M.; Snik, F.; Keller, C.U.; Hoeijmakers, H.J.; van Dam, D.M.; Willebrands, M.; Karalidi, T.; Pallichadath, V.; van Dijk, C.N.; Esposito, M. 2021: LOUPE: observing Earth from the Moon to prepare for detecting life on Earth-like exoplanets. Philosophical Transactions. Series a Mathematical Physical and Engineering Sciences 379(2188): 20190577

Ytrehus, B.ør.; Rocchi, M.; Brandsegg, H.; Turnbull, D.; Miller, A.; Pedersen, H.C.; Kålås, J.A.; Nilsen, E.B. 2021: Louping-Ill Virus Serosurvey of Willow Ptarmigan (Lagopus Lagopus Lagopus) in Norway. Journal of Wildlife Diseases 57(2): 282-291

Grosse, R. 2015: LOV is all we need. Nature Reviews. Molecular Cell Biology 16(4): 206

Kar Ray, M.; Chow, K.K.; Theodoros, T.; Wyder, M.; Steginga, A.; Sorrensen, R.; Hickey, P.; Lau, G.; Kinsella, K.; Lombardo, C. 2021: LOVE in the time of Covid-19: a brief mental health intervention to overcome loneliness. Australasian Psychiatry: Bulletin of Royal Australian and New Zealand College of Psychiatrists 29(5): 529-534

Bauer, J.Edgar. 2020: Love's Body and the Body of Love: On Norman O. Brown's Eschatological Hermaphrodite and the Darwinian Continuities of Nature. Journal of Homosexuality 2020: 1-32

Wang, H.; Vilela, M.; Winkler, A.; Tarnawski, M.; Schlichting, I.; Yumerefendi, H.; Kuhlman, B.; Liu, R.; Danuser, G.; Hahn, K.M. 2016: LOVTRAP: an optogenetic system for photoinduced protein dissociation. Nature Methods 13(9): 755-758

Henn, E.D.; Smith, T.; Ambegaonkar, J.P.; Wyon, M. 2020: Low Back Pain and Injury in Ballet, Modern, and Hip-Hop Dancers: a Systematic Review. International Journal of Sports Physical Therapy 15(5): 671-687

Efthymiou, F.O.; Metaxas, V.I.; Dimitroukas, C.P.; Panayiotakis, G.S. 2020: Low Bmi Patient Dose in Digital Radiography. Radiation Protection Dosimetry 189(1): 1-12

Ribovski, L.ís.; de Jong, E.; Mergel, O.; Zu, G.; Keskin, D.; van Rijn, P.; Zuhorn, I.S. 2021: Low nanogel stiffness favors nanogel transcytosis across an in vitro blood-brain barrier. Nanomedicine: Nanotechnology Biology and Medicine 34: 102377

Galvin, A.N.; Bradshaw, A.C.; Myers, B.M.; Tell, L.A.; Ernest, H.B.; Sehgal, R.N.M. 2021: Low Prevalence of Haemosporidians in Blood and Tissue Samples from Hummingbirds. Journal of Parasitology 107(5): 794-798

De Oliveira, C.L.; Medeiros, L.F.; de Souza, V.S.; Lopes, B.C.; de Oliveira, F.F.; Marques, L.X.; da Silva Torres, I.L.; de Souza, A. 2020: Low-Dose Naltrexone Reverses Facial Mechanical Allodynia in a Rat Model of Trigeminal Neuralgia. Neuroscience Letters 736: 135248

Francois, P.; Woillez, M.; Wannebroucq, C.; Guyon, P. 1964: Lowe's Syndrome. Bulletin des Societes d'Ophtalmologie de France 64: 570-575

Soangra, R.; Moon, S.; Rezvanian, S.; Lockhart, T.E. 2017: Lower Extremity Muscle Fatigue Influences Nonlinear Variability in Trunk Accelerations. Biomedical Sciences Instrumentation 53: 47-54

Xiao, W.; Shen, Y.; Xu, Y. 2021: LOXG473A induces the formation of osteoclasts in RAW264.7 cells via IL-6/JAK2/STAT3 signaling. Experimental Cell Research 409(1): 112890

Liang, Y.-Q.; Kakino, A.; Matsuzaka, Y.; Mashimo, T.; Isono, M.; Akamatsu, T.; Shimizu, H.; Tajima, M.; Kaneko, T.; Li, L.; Takeuchi, F.; Sawamura, T.; Kato, N. 2020: LOX-1 (Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1) Deletion Has Protective Effects on Stroke in the Genetic Background of Stroke-Prone Spontaneously Hypertensive Rat. Stroke 51(6): 1835-1843

Amati, F.; Diano, L.; Vecchione, L.; Norata, G.Danilo.; Koyama, Y.; Cutuli, L.; Catapano, A.Luigi.; Romeo, F.; Ando, H.; Novelli, G. 2012: LOX-1 Inhibition in ApoE KO Mice Using a Schizophyllan-based Antisense Oligonucleotide Therapy. Molecular Therapy. Nucleic Acids 1: E58

Li, Q.; Liu, J.; Liu, W.; Chu, Y.; Zhong, J.; Xie, Y.; Lou, X.; Ouyang, X. 2020: LOX-1 Regulates P. gingivalis-Induced Monocyte Migration and Adhesion to Human Umbilical Vein Endothelial Cells. Frontiers in Cell and Developmental Biology 8: 596

Lu, J.; Wang, X.; Wang, W.; Muniyappa, H.; Hu, C.; Mitra, S.; Long, B.; Das, K.; Mehta, J.L. 2012: LOX-1 abrogation reduces cardiac hypertrophy and collagen accumulation following chronic ischemia in the mouse. Gene Therapy 19(5): 522-531

De Alwis, N.; Beard, S.; Binder, N.K.; Pritchard, N.; Kaitu'u-Lino, T.'u.J.; Walker, S.P.; Stock, O.; Groom, K.M.; Petersen, S.; Henry, A.; Said, J.M.; Seeho, S.; Kane, S.C.; Tong, S.; Hannan, N.J. 2021: LOX-1 expression is reduced in placenta from pregnancies complicated by preeclampsia and in hypoxic cytotrophoblast. Pregnancy Hypertension 25: 255-261

Combadière, B.; Adam, L.; Guillou, N.ël.; Quentric, P.; Rosenbaum, P.; Dorgham, K.; Bonduelle, O.; Parizot, C.; Sauce, D.; Mayaux, J.; Luyt, C.-E.; Boissonnas, A.; Amoura, Z.; Pourcher, V.ér.; Miyara, M.; Gorochov, G.; Guihot, A.él.; Combadière, C. 2021: LOX-1-Expressing Immature Neutrophils Identify Critically-Ill COVID-19 Patients at Risk of Thrombotic Complications. Frontiers in Immunology 12: 752612

Rossow, L.; Veitl, S.; Vorlová, S.; Wax, J.K.; Kuhn, A.E.; Maltzahn, V.; Upcin, B.; Karl, F.; Hoffmann, H.; Gätzner, S.; Kallius, M.; Nandigama, R.; Scheld, D.; Irmak, S.; Herterich, S.; Zernecke, A.; Ergün, Süleyman.; Henke, E. 2018: LOX-catalyzed collagen stabilization is a proximal cause for intrinsic resistance to chemotherapy. Oncogene 37(36): 4921-4940

Yu, H.; Ding, J.; Zhu, H.; Jing, Y.; Zhou, H.; Tian, H.; Tang, K.; Wang, G.; Wang, X. 2020: LOXL1 confers antiapoptosis and promotes gliomagenesis through stabilizing BAG2. Cell Death and Differentiation 27(11): 3021-3036

Yuan, R.; Li, Y.; Yang, B.; Jin, Z.; Xu, J.; Shao, Z.; Miao, H.; Ren, T.; Yang, Y.; Li, G.; Song, X.; Hu, Y.; Wang, X.'a.; Huang, Y.; Liu, Y. 2021: LOXL1 exerts oncogenesis and stimulates angiogenesis through the LOXL1-FBLN5/αvβ3 integrin/FAK-MAPK axis in ICC. Molecular Therapy. Nucleic Acids 23: 797-810

Eliseeva, N.; Ponomarenko, I.; Reshetnikov, E.; Dvornyk, V.; Churnosov, M. 2021: LOXL1 gene polymorphism candidates for exfoliation glaucoma are also associated with a risk for primary open-angle glaucoma in a Caucasian population from central Russia. Molecular Vision 27: 262-269

Hu, L.; Wang, J.; Wang, Y.; Wu, L.; Wu, C.; Mao, B.; Maruthi Prasad, E.; Wang, Y.; Chin, Y.E. 2020: LOXL1 modulates the malignant progression of colorectal cancer by inhibiting the transcriptional activity of YAP. Cell Communication and Signaling: Ccs 18(1): 148

Wu, Y.; Can, J.; Hao, S.; Qiang, X.; Ning, Z. 2022: LOXL2 Inhibitor Attenuates Angiotensin II-Induced Atrial Fibrosis and Vulnerability to Atrial Fibrillation through Inhibition of Transforming Growth Factor Beta-1 Smad2/3 Pathway. Cerebrovascular Diseases 51(2): 188-198

Zhang, C.; Zhu, M.; Wang, H.; Wen, J.; Huang, Z.; Chen, S.; Zhao, H.; Li, H. 2021: LOXL2 attenuates osteoarthritis through inactivating Integrin/FAK signaling. Scientific Reports 11(1): 17020

Cuevas, E.P.; Eraso, P.; Mazón, Mía.J.; Santos, V.; Moreno-Bueno, G.; Cano, A.; Portillo, F. 2017: LOXL2 drives epithelial-mesenchymal transition via activation of IRE1-XBP1 signalling pathway. Scientific Reports 7: 44988

He, D.; Zhao, F.; Jiang, H.; Kang, Y.; Song, Y.; Lin, X.; Shi, P.; Zhang, T.; Pang, X. 2020: LOXL2 from human amniotic mesenchymal stem cells accelerates wound epithelialization by promoting differentiation and migration of keratinocytes. Aging 12(13): 12960-12986

Wen, B.; Xu, L.-Y.; Li, E.-M. 2020: LOXL2 in cancer: regulation, downstream effectors and novel roles. Biochimica et Biophysica Acta. Reviews on Cancer 1874(2): 188435

Tashkandi, M.M.; Alsaqer, S.F.; Alhousami, T.; Ali, F.; Wu, Y-Chiao.; Shin, J.; Mehra, P.; Wolford, L.M.; Gerstenfeld, L.C.; Goldring, M.B.; Bais, M.V. 2020: LOXL2 promotes aggrecan and gender-specific anabolic differences to TMJ cartilage. Scientific Reports 10(1): 20179

Zhu, G.; Wang, L.; Meng, W.; Lu, S.; Cao, B.; Liang, X.; He, C.; Hao, Y.; Du, X.; Wang, X.; Li, L.; Li, L. 2021: LOXL2-enriched small extracellular vesicles mediate hypoxia-induced premetastatic niche and indicates poor outcome of head and neck cancer. Theranostics 11(19): 9198-9216

Cebrià-Costa, J.P.; Pascual-Reguant, L.; Gonzalez-Perez, A.; Serra-Bardenys, G.; Querol, J.; Cosín, M.; Verde, G.; Cigliano, R.A.; Sanseverino, W.; Segura-Bayona, S.; Iturbide, A.; Andreu, D.; Nuciforo, P.; Bernado-Morales, C.; Rodilla, V.; Arribas, J.; Yelamos, J.; de Herreros, A.Garcia.; Stracker, T.H.; Peiró, S. 2020: LOXL2-mediated H3K4 oxidation reduces chromatin accessibility in triple-negative breast cancer cells. Oncogene 39(1): 79-121

Namsolleck, P.; Richardson, A.; Moll, G.N.; Mescheder, A. 2021: LP2, the first lanthipeptide GPCR agonist in a human pharmacokinetics and safety study. Peptides 136: 170468

Calik, I.; Yayla, M.; Cinar, I.; Cadirci, E.; Albayrak, A.; Sirin, B.; Calik, M.; Halici, Z. 2020: LP44 (4-[2-(methylthio)phenyl]-N-(1,2,3,4-tetrahydronaphthalen-1-yl)-1-piperazinehexanamide) exerts anti-ulcer effects via 5-hydroxytryptamine receptor 7 activation on indomethacin-induced gastric ulcers in rats. Inflammopharmacology 28(4): 893-902

Hao, F.; Liu, Q.; Zhang, F.; Du, J.; Dumire, A.; Xu, X.; Cui, M.-Z. 2021: LPA1-mediated PKD2 activation promotes LPA-induced tissue factor expression via the p38α and JNK2 MAPK pathways in smooth muscle cells. Journal of Biological Chemistry 297(4): 101152

Wang, F.; Liu, S.; Pei, J.; Cai, L.; Liu, N.; Liang, T.; Dong, X.; Cong, X.; Chun, J.; Chen, J.; Hu, S.; Chen, X. 2020: LPA3-mediated lysophosphatidic acid signaling promotes postnatal heart regeneration in mice. Theranostics 10(24): 10892-10907

Yang, L.; Kraemer, M.; Fang, X.Frank.; Angel, P.M.; Drake, R.R.; Morris, A.J.; Smyth, S.S. 2019: LPA receptor 4 deficiency attenuates experimental atherosclerosis. Journal of Lipid Research 60(5): 972-980

Acosta, D.; Bagchi, S.; Broin, P.Ó.; Hollern, D.; Racedo, S.E.; Morrow, B.; Sellers, R.S.; Greally, J.M.; Golden, A.; Andrechek, E.; Wood, T.; Montagna, C. 2016: LPA receptor activity is basal specific and coincident with early pregnancy and involution during mammary gland postnatal development. Scientific Reports 6: 35810

Hu, H-Bin.; Song, Z-Qing.; Song, G-Ping.; Li, S.; Tu, H-Qing.; Wu, M.; Zhang, Y-Cheng.; Yuan, J-Feng.; Li, T-Ting.; Li, P-Yao.; Xu, Y-Ling.; Shen, X-Lin.; Han, Q-Ying.; Li, A-Ling.; Zhou, T.; Chun, J.; Zhang, X-Min.; Li, H-Yan. 2021: LPA signaling acts as a cell-extrinsic mechanism to initiate cilia disassembly and promote neurogenesis. Nature Communications 12(1): 662

Mirendil, H.; Thomas, E.A.; De Loera, C.; Okada, K.; Inomata, Y.; Chun, J. 2015: LPA signaling initiates schizophrenia-like brain and behavioral changes in a mouse model of prenatal brain hemorrhage. Translational Psychiatry 5: E541

Loskutov, Y.V.; Griffin, C.L.; Marinak, K.M.; Bobko, A.; Margaryan, N.V.; Geldenhuys, W.J.; Sarkaria, J.N.; Pugacheva, E.N. 2018: LPA signaling is regulated through the primary cilium: a novel target in glioblastoma. Oncogene 37(11): 1457-1471

Inoue, A.; Arima, N.; Ishiguro, J.; Prestwich, G.D.; Arai, H.; Aoki, J. 2011: LPA-producing enzyme PA-PLA₁α regulates hair follicle development by modulating EGFR signalling. EMBO Journal 30(20): 4248-4260

Cecchin, M.; Jeong, J.; Son, W.; Kim, M.; Park, S.; Zuliani, L.; Cazzaniga, S.; Pompa, A.; Young Kang, C.; Bae, S.; Ballottari, M.; Jin, E. 2021: LPA2 protein is involved in photosystem Ii assembly in Chlamydomonas reinhardtii. Plant Journal: for Cell and Molecular Biology 107(6): 1648-1662

Ye, X.; Hama, K.; Contos, J.J.A.; Anliker, B.; Inoue, A.; Skinner, M.K.; Suzuki, H.; Amano, T.; Kennedy, G.; Arai, H.; Aoki, J.; Chun, J. 2005: LPA3-mediated lysophosphatidic acid signalling in embryo implantation and spacing. Nature 435(7038): 104-108

Shi, J.; Jiang, D.; Yang, S.; Zhang, X.; Wang, J.; Liu, Y.; Sun, Y.; Lu, Y.; Yang, K. 2020: LPAR1, Correlated with Immune Infiltrates, Is a Potential Prognostic Biomarker in Prostate Cancer. Frontiers in Oncology 10: 846

Shukla, P.K.; Meena, A.S.; Gangwar, R.; Szabo, E.; Balogh, A.; Chin Lee, S.; Vandewalle, A.; Tigyi, G.; Rao, R. 2020: LPAR2 receptor activation attenuates radiation-induced disruption of apical junctional complexes and mucosal barrier dysfunction in mouse colon. Faseb Journal: Official Publication of the Federation of American Societies for Experimental Biology 34(9): 11641-11657

Zhang, H.-P.; Chen, Q.-K.; Xu, J.-F. 2020: LPAR5 stimulates the malignant progression of non-small-cell lung carcinoma by upregulating MLLT11. European Review for Medical and Pharmacological Sciences 24(17): 8902-8910

Scheinman, S.B.; Sugasini, D.; Zayed, M.; Yalagala, P.C.R.; Marottoli, F.M.; Subbaiah, P.V.; Tai, L.M. 2021: LPC-DHA/EPA-Enriched Diets Increase Brain DHA and Modulate Behavior in Mice that Express Human APOE4. Frontiers in Neuroscience 15: 690410

Han, C.; Yu, G.; Mao, Y.; Song, S.; Li, L.; Zhou, L.; Wang, Z.; Liu, Y.; Li, M.; Xu, B. 2020: LPCAT1 enhances castration resistant prostate cancer progression via increased mRNA synthesis and PAF production. Plos one 15(11): E0240801

He, R.-Q.; Li, J.-D.; Du, X.-F.; Dang, Y.-W.; Yang, L.-J.; Huang, Z.-G.; Liu, L.-M.; Liao, L.-F.; Yang, H.; Chen, G. 2021: LPCAT1 overexpression promotes the progression of hepatocellular carcinoma. Cancer Cell International 21(1): 442

Oliver, G.R.; Marcano-Bonilla, S.; Quist, J.; Tolosa, E.J.; Iguchi, E.; Swanson, A.A.; Hoppman, N.L.; Schwab, T.; Sigafoos, A.; Prodduturi, N.; Voss, J.S.; Knight, S.M.; Zhang, J.; Fadra, N.; Urrutia, R.; Zimmerman, M.; Egan, J.B.; Bilyeu, A.G.; Jen, J.; Veras, E.; Al-Safi, R.'a.; Block, M.; Kerr, S.; Fernandez-Zapico, M.E.; Schoolmeester, J.K.; Klee, E.W. 2021: LPCAT1-TERT fusions are uniquely recurrent in epithelioid trophoblastic tumors and positively regulate cell growth. Plos one 16(5): E0250518

Watanabe, H.; Miyake, K.; Matsuoka, T.; Kojima, R.; Sakurai, D.; Masuyama, K.; Yamagata, Z. 2021: LPCAT2 Methylation, a Novel Biomarker for the Severity of Cedar Pollen Allergic Rhinitis in Japan. American Journal of Rhinology and Allergy 35(5): 631-639

Albhaisi, S.; Kim, K.; Baker, J.; Chidambaram, N.; Patel, M.V.; Charlton, M.; Sanyal, A.J. 2020: LPCN 1144 Resolves NAFLD in Hypogonadal Males. Hepatology Communications 4(10): 1430-1440

Whitmore, M.; Li, S.; Huang, L. 1999: LPD lipopolyplex initiates a potent cytokine response and inhibits tumor growth. Gene Therapy 6(11): 1867-1875

Chowdhury, T.; Baindara, P.; Mandal, S.M. 2021: LPD-12: a promising lipopeptide to control COVID-19. International Journal of Antimicrobial Agents 57(1): 106218

Chegodaev, D.; Pavlova, N.V.; Pavlova, P.; Lvova, O. 2020: LPDs - «Linked to penumbra» discharges or EEG correlate of excitotoxicity: a review based hypothesis. Epilepsy Research 166: 106429

Gould, C.F.; Urpelainen, J. 2018: LPG as a Clean Cooking Fuel: Adoption, Use, and Impact in Rural India. Energy Policy 122: 395-408

Jesus-Santos, F.áv.H.; Lobo-Silva, J.és.; Ramos, P.I.P.; Descoteaux, A.; Lima, J.B.; Borges, V.ér.M.; Farias, L.P. 2020: LPG2 Gene Duplication in Leishmania infantum: a Case for CRISPR-Cas9 Gene Editing. Frontiers in Cellular and Infection Microbiology 10: 408

Zhang, S.-W.; Zhang, X.-X.; Fan, X.-N.; Li, W.-N. 2020: LPI-CNNCP: Prediction of lncRNA-protein interactions by using convolutional neural network with the copy-padding trick. Analytical Biochemistry 601: 113767

Zhou, Y.-K.; Hu, J.; Shen, Z.-A.; Zhang, W.-Y.; Du, P.-F. 2020: LPI-SKF: Predicting lncRNA-Protein Interactions Using Similarity Kernel Fusions. Frontiers in Genetics 11: 615144

Zhou, L.; Wang, Z.; Tian, X.; Peng, L. 2021: LPI-deepGBDT: a multiple-layer deep framework based on gradient boosting decision trees for lncRNA-protein interaction identification. Bmc Bioinformatics 22(1): 479

Caddeo, A.; Hedfalk, K.; Romeo, S.; Pingitore, P. 2021: LPIAT1/MBOAT7 contains a catalytic dyad transferring polyunsaturated fatty acids to lysophosphatidylinositol. Biochimica et Biophysica Acta. Molecular and Cell Biology of Lipids 1866(5): 158891

Adiyeva, M.; Aukenov, N.; Kazymov, M.; Shakhanova, A.; Massabayeva, M. 2020: Lpl and Adrb2 Gene Polymorphisms: Relationship with Lipids and Obesity in Kazakh Adolescents. Georgian Medical News 2020(309): 94-99

Liu, W.; Burger, J.A.; Xu, J.; Tang, Z.; Toruner, G.; Khanlari, M.; Medeiros, L.J.; Tang, G. 2020: LPL deletion is associated with poorer response to ibrutinib-based treatments and overall survival in TP53-deleted chronic lymphocytic leukemia. Annals of Hematology 99(10): 2343-2349

Wang, H.; Zhou, Y.; Oyang, L.; Han, Y.; Xia, L.; Lin, J.; Tang, Y.; Su, M.; Tan, S.; Tian, Y.; Chen, X.; Luo, X.; Liang, J.; Rao, S.; Wang, Y.; Xiong, W.; Zeng, Z.; Wang, H.; Li, G.; Liao, Q. 2019: LPLUNC1 stabilises PHB1 by counteracting TRIM21-mediated ubiquitination to inhibit NF-κB activity in nasopharyngeal carcinoma. Oncogene 38(25): 5062-5075

Liao, Q.; Zeng, Z.; Guo, X.; Li, X.; Wei, F.; Zhang, W.; Li, X.; Chen, P.; Liang, F.; Xiang, B.; Ma, J.; Wu, M.; Tang, H.; Deng, M.; Zeng, X.; Tang, K.; Xiong, W.; Li, G. 2014: LPLUNC1 suppresses IL-6-induced nasopharyngeal carcinoma cell proliferation via inhibiting the Stat3 activation. Oncogene 33(16): 2098-2109

Zarattini, M.; Corso, M.; Kadowaki, M.Antonio.; Monclaro, A.; Magri, S.; Milanese, I.; Jolivet, S.; de Godoy, M.Ortiz.; Hermans, C.; Fagard, M.; Cannella, D. 2021: LPMO-oxidized cellulose oligosaccharides evoke immunity in Arabidopsis conferring resistance towards necrotrophic fungus B. cinerea. Communications Biology 4(1): 727

Kuriyama, S.; Yoshida, M.; Yano, S.; Aiba, N.; Kohno, T.; Minamiya, Y.; Goto, A.; Tanaka, M. 2016: LPP inhibits collective cell migration during lung cancer dissemination. Oncogene 35(8): 952-964

Ngan, E.; Stoletov, K.; Smith, H.W.; Common, J.; Muller, W.J.; Lewis, J.D.; Siegel, P.M. 2017: LPP is a Src substrate required for invadopodia formation and efficient breast cancer lung metastasis. Nature Communications 8: 15059

Ni, Z.; Angelidou, G.; Hoffmann, R.; Fedorova, M. 2017: LPPtiger software for lipidome-specific prediction and identification of oxidized phospholipids from LC-MS datasets. Scientific Reports 7(1): 15138

Wu, L.-S.; Liu, Y.; Wang, X.-W.; Xu, B.; Lin, Y.-L.; Song, Y.; Dong, Y.; Liu, J.-L.; Wang, X.-J.; Liu, S.; Kong, P.; Han, M.; Li, B.-H. 2020: LPS Enhances the Chemosensitivity of Oxaliplatin in HT29 Cells via GSDMD-Mediated Pyroptosis. Cancer Management and Research 12: 10397-10409

Ma, X.; Li, Y.; Shen, W.; Oladejo, A.O.; Yang, J.; Jiang, W.; Imam, B.H.; Wu, X.; Ding, X.; Yang, Y.; Wang, S.; Yan, Z. 2021: LPS Mediates Bovine Endometrial Epithelial Cell Pyroptosis Directly Through Both NLRP3 Classical and Non-Classical Inflammasome Pathways. Frontiers in Immunology 12: 676088

Chen, S.; Xie, J.; Zhao, K.; Ren, L.; Deng, Y.; Xie, X.; Chen, S.; Xu, H.; Long, X.; Liu, E. 2020: LPS aggravates lung inflammation induced by RSV by promoting the ERK-MMP-12 signaling pathway in mice. Respiratory Research 21(1): 193

Liu, Q.; Yang, W.; Luo, N.; Liu, J.; Wu, Y.; Ding, J.; Li, C.; Cheng, Z. 2020: LPS and IL-8 activated umbilical cord blood-derived neutrophils inhibit the progression of ovarian cancer. Journal of Cancer 11(15): 4413-4420

Zeng, H.; He, X.; Tuo, Q-Hui.; Liao, D-Fang.; Zhang, G-Qiang.; Chen, J-Xiong. 2016: LPS causes pericyte loss and microvascular dysfunction via disruption of Sirt3/angiopoietins/Tie-2 and HIF-2α/Notch3 pathways. Scientific Reports 6: 20931

Cho, D.Y.; Zhang, S.; Lazrak, A.; Skinner, D.; Thompson, H.M.; Grayson, J.; Guroji, P.; Aggarwal, S.; Bebok, Z.; Rowe, S.M.; Matalon, S.; Sorscher, E.J.; Woodworth, B.A. 2021: LPS decreases CFTR open probability and mucociliary transport through generation of reactive oxygen species. Redox Biology 43: 101998

Greenhill, C.J.; Gould, J.; Ernst, M.; Jarnicki, A.; Hertzog, P.J.; Mansell, A.; Jenkins, B.J. 2012: LPS hypersensitivity of gp130 mutant mice is independent of elevated haemopoietic TLR4 signaling. Immunology and Cell Biology 90(5): 559-563

Wang, G.; Cheng, S.; Zhang, S.; Zhu, Y.; Xiao, Y.; Ju, L. 2020: LPS impairs steroidogenesis and ROS metabolism and induces PPAR transcriptional activity to disturb estrogen/androgen receptor expression in testicular cells. Molecular Biology Reports 47(2): 1045-1056

Suh, H.C.; Benoukraf, T.; Shyamsunder, P.; Yin, T.; Cao, Q.; Said, J.; Lee, S.; Lim, R.; Yang, H.; Salotti, J.; Johnson, P.F.; Madan, V.; Koeffler, H.Phillip. 2017: LPS independent activation of the pro-inflammatory receptor Trem1 by C/EBPε in granulocytes. Scientific Reports 7: 46440

Hui-Heng, L.; Jun-Sheng, W.; Jin-Zhou, L.; Jia-Wei, S.; Jiu-Bing, G.; Zhifeng, L.; Lei, S. 2021: LPS induced PCT production via TLR-4/NF-кB passway:it is the difference of G-/G+ bacteremia rats. Cytokine 137: 155317

Fu, G.; Wang, B.; He, B.; Feng, M.; Yu, Y. 2020: LPS induces cardiomyocyte necroptosis through the Ripk3/Pgam5 signaling pathway. Journal of Receptor and Signal Transduction Research 2020: 1-6

Moll, S.; Schifferli, J.A.; Huarte, J.; Lemoine, R.; Vassalli, J.D.; Sappino, A.P. 1994: LPS induces major changes in the extracellular proteolytic balance in the murine kidney. Kidney International 45(2): 500-508

Jeljeli, M.; Chêne, C.; Chouzenoux, S.; Thomas, M.; Segain, B.; Doridot, L.; Nicco, C.; Batteux, F.éd.ér. 2021: LPSlow-Macrophages Alleviate the Outcome of Graft-Versus-Host Disease Without Aggravating Lymphoma Growth in Mice. Frontiers in Immunology 12: 670776

Rodriguez, M.J.; Aranda, A.; Fernandez, T.D.; Cubells-Baeza, N.; Torres, M.J.; Gomez, F.; Palomares, F.; Perkins, J.R.; Rojo, J.; Diaz-Perales, A.; Mayorga, C. 2017: LPS promotes Th2 dependent sensitisation leading to anaphylaxis in a Pru p 3 mouse model. Scientific Reports 7: 40449

Kew, V.G.; Wills, M.R.; Reeves, M.B. 2017: LPS promotes a monocyte phenotype permissive for human cytomegalovirus immediate-early gene expression upon infection but not reactivation from latency. Scientific Reports 7(1): 810

Kuo, W-T.; Lee, T-C.; Yang, H-Y.; Chen, C-Y.; Au, Y-C.; Lu, Y-Z.; Wu, L-L.; Wei, S-C.; Ni, Y-H.; Lin, B-R.; Chen, Y.; Tsai, Y-H.; Kung, J.T.; Sheu, F.; Lin, L-W.; Yu, L.C-H. 2015: LPS receptor subunits have antagonistic roles in epithelial apoptosis and colonic carcinogenesis. Cell Death and Differentiation 22(10): 1590-1604

Fang, F.; Ge, Q.; Li, R.; Lv, J.; Zhang, Y.; Feng, A.; Kelly, G.T.; Wang, H.; Wang, X.; Song, C.; Wang, T.; Qian, Z. 2020: LPS restores protective immunity in macrophages against Mycobacterium tuberculosis via autophagy. Molecular Immunology 124: 18-24

Zhou, K.; Sun, M.; Xia, Y.; Xie, Y.; Shu, R. 2021: LPS stimulates gingival fibroblasts to express PD-L1 via the p38 pathway under periodontal inflammatory conditions. Archives of Oral Biology 129: 105161

Miller, S.I.; Ernst, R.K.; Bader, M.W. 2005: LPS, TLR4 and infectious disease diversity. Nature Reviews. Microbiology 3(1): 36-46

Yoo, J.-Y.; Cha, D.R.; Kim, B.; An, E.J.; Lee, S.R.; Cha, J.J.; Kang, Y.S.; Ghee, J.Y.; Han, J.Y.; Bae, Y.S. 2020: LPS-Induced Acute Kidney Injury Is Mediated by Nox4-SH3YL1. Cell Reports 33(3): 108245

Zheng, Y.; Ye, P.-P.; Zhou, Y.; Wu, S.-Y.; Liu, X.-T.; Du, B.; Tang, B.-H.; Kan, M.; Nie, A.-Q.; Yin, R.; Wang, M.; Hao, G.-X.; Song, L.-L.; Yang, X.-M.; Huang, X.; Su, L.-Q.; Wang, W.-Q.; van den Anker, J.; Zhao, W. 2021: LPS-Induced Inflammation Affects Midazolam Clearance in Juvenile Mice in an Age-Dependent Manner. Journal of Inflammation Research 14: 3697-3706

Mendez, M.E.; Sebastian, A.; Murugesh, D.K.; Hum, N.R.; McCool, J.L.; Hsia, A.W.; Christiansen, B.A.; Loots, G.G. 2020: LPS-Induced Inflammation Prior to Injury Exacerbates the Development of Post-Traumatic Osteoarthritis in Mice. Journal of Bone and Mineral Research: the Official Journal of the American Society for Bone and Mineral Research 35(11): 2229-2241

Ye, M.; Xie, M.; Zhu, J.; Wang, C.; Zhou, R.; Li, X. 2020: LPS-Inducible lncRNA TMC3-AS1 Negatively Regulates the Expression of IL-10. Frontiers in Immunology 11: 1418

Odena, G.; Chen, J.; Lozano, J.Jose.; Altamirano, J.; Rodrigo-Torres, D.; Affo, S.; Morales-Ibanez, O.; Matsushita, H.; Zou, J.; Dumitru, R.; Caballeria, J.; Gines, P.; Arroyo, V.; You, M.; Rautou, P-Emmanuel.; Valla, D.; Crews, F.; Seki, E.; Sancho-Bru, P.; Bataller, R. 2016: LPS-TLR4 Pathway Mediates Ductular Cell Expansion in Alcoholic Hepatitis. Scientific Reports 6: 35610

Yuan, D.-H.; Jia, Y.; Hassan, O.M.; Xu, L.-Y.; Wu, X.-C. 2020: LPS-Treated Podocytes Polarize Naive CD4+ T Cells into Th17 and Treg Cells. Biomed Research International 2020: 8587923

Schroeder, H.A.; Newby, J.; Schaefer, A.; Subramani, B.; Tubbs, A.; Gregory Forest, M.; Miao, E.; Lai, S.K. 2020: LPS-binding IgG arrests actively motile Salmonella Typhimurium in gastrointestinal mucus. Mucosal Immunology 13(5): 814-823

Ali, S.; Malloci, M.; Safiedeen, Z.; Soleti, R.; Vergori, L.; Vidal-Gómez, X.; Besnard, Cène.; Dubois, Séverine.; Le Lay, S.; Boursier, Jérôme.; Chevrollier, A.; Gagnadoux, Fédéric.; Simard, G.; Andriantsitohaina, R.; Martinez, M.Carmen. 2021: LPS-enriched small extracellular vesicles from metabolic syndrome patients trigger endothelial dysfunction by activation of TLR4. Metabolism, Clinical and Experimental 118: 154727

Bihl, F.; Larivière, L.; Qureshi, S.T.; Flaherty, L.; Malo, D. 2001: LPS-hyporesponsiveness of mnd mice is associated with a mutation in Toll-like receptor 4. Genes and Immunity 2(1): 56-59

Lee, H.Hee.; Sanada, S.; An, S.Min.; Ye, B.Jin.; Lee, J.Ho.; Seo, Y-Kyo.; Lee, C.; Lee-Kwon, W.; Küper, C.; Neuhofer, W.; Choi, S.Youn.; Kwon, H.Moo. 2016: LPS-induced NFκB enhanceosome requires TonEBP/NFAT5 without DNA binding. Scientific Reports 6: 24921

Geng, Z.; Shan, X.; Lian, S.; Wang, J.; Wu, R. 2021: LPS-induced SOCS3 antagonizes the JAK2-STAT5 pathway and inhibits β-casein synthesis in bovine mammary epithelial cells. Life Sciences 278: 119547

Zhao, B.; Li, R.; Yang, F.; Yu, F.; Xu, N.; Zhang, F.; Ge, X.; Du, J. 2018: LPS-induced Vitamin D Receptor Decrease in Oral Keratinocytes Is Associated With Oral Lichen Planus. Scientific Reports 8(1): 763

Holstein, K.; Matysiak, A.; Witt, L.; Sievers, B.; Beckmann, L.; Haddad, M.; Renné, T.; Voigtlaender, M.; Langer, F. 2020: LPS-induced expression and release of monocyte tissue factor in patients with haemophilia. Annals of Hematology 99(7): 1531-1542

Tong, X.; Zhang, J.; Li, J. 2020: LPS-induced inflammation disorders bone modeling and remodeling by inhibiting angiogenesis and disordering osteogenesis in chickens. Inflammation Research: Official Journal of the European Histamine Research Society . 69(8): 765-777

Hudalla, H.; Karenberg, K.; Kuon, R-Jeremias.; Pöschl, J.; Tschada, R.; Frommhold, D. 2018: LPS-induced maternal inflammation promotes fetal leukocyte recruitment and prenatal organ infiltration in mice. Pediatric Research 84(5): 757-764

Zhan, X.; Cui, R.; Geng, X.; Li, J.; Zhou, Y.; He, L.; Cao, C.; Zhang, C.; Chen, Z.; Ying, S. 2021: LPS-induced mitochondrial DNA synthesis and release facilitate RAD50-dependent acute lung injury. Signal Transduction and Targeted Therapy 6(1): 103

Qiu, X.; Liang, X.; Li, H.; Sun, R. 2021: LPS-induced vein endothelial cell injury and acute lung injury have Btk and Orai 1 to regulate SOC-mediated calcium influx. International Immunopharmacology 90: 107039

Niu, S.; Paluszynski, J.; Bian, Z.; Shi, L.; Kidder, K.; Liu, Y. 2018: LPS-primed CD11b + leukocytes serve as an effective carrier of Shiga toxin 2 to cause hemolytic uremic syndrome in mice. Scientific Reports 8(1): 3994

He, Y.; Ou, Z.; Chen, X.; Zu, X.; Liu, L.; Li, Y.; Cao, Z.; Chen, M.; Chen, Z.; Chen, H.; Qi, L.; Wang, L. 2016: LPS/TLR4 Signaling Enhances TGF-β Response Through Downregulating BAMBI During Prostatic Hyperplasia. Scientific Reports 6: 27051

Guo, J.; Chen, L.; Luo, N.; Li, C.; Chen, R.; Qu, X.; Liu, M.; Kang, L.; Cheng, Z. 2016: LPS/TLR4-mediated stromal cells acquire an invasive phenotype and are implicated in the pathogenesis of adenomyosis. Scientific Reports 6: 21416

Wang, B.; Zhang, Y.; Cui, A.; Xu, Y.; Jiang, Y.; Wang, L.; Liu, X. 2021: LPXRFa and its receptor in yellowtail kingfish (Seriola lalandi): Molecular cloning, ontogenetic expression profiles, and stimulatory effects on growth hormone and gonadotropin gene expression. General and Comparative Endocrinology 312: 113872

Zhang, H.; Chen, H.; Yang, G.; Zhang, L. 2021: LR-Net: Low-Rank Spatial-Spectral Network for Hyperspectral Image Denoising. IEEE Transactions on Image Processing: a Publication of the IEEE Signal Processing Society 30: 8743-8758

Golczak, M.; Sears, A.E.; Kiser, P.D.; Palczewski, K. 2015: LRAT-specific domain facilitates vitamin A metabolism by domain swapping in HRASLS3. Nature Chemical Biology 11(1): 26-32

Park, M.Young.; Sudan, R.; Srivastava, N.; Neelam, S.; Youngs, C.; Wang, J-Wang.; Engelman, R.W.; Kerr, W.G. 2016: LRBA is Essential for Allogeneic Responses in Bone Marrow Transplantation. Scientific Reports 6: 36568

Liu, C.; Xu, X.; Han, L.; Wan, X.; Zheng, L.; Li, C.; Liao, Z.; Xiao, J.; Zhong, R.; Zheng, X.; Wang, Q.; Li, Z.; Chen, H.; Wei, B.; Wang, H. 2020: LRCH1 deficiency enhances LAT signalosome formation and CD8+ T cell responses against tumors and pathogens. Proceedings of the National Academy of Sciences of the United States of America 117(32): 19388-19398

Fink, G.; Smith, G.C.; Tibballs, J.; Lee, V.W. 1972: LRF and CRF release in subcellular fractions of bovine median eminence. Nature: new Biology 239(89): 57-59

Liu, X-Song.; Chandramouly, G.; Rass, E.; Guan, Y.; Wang, G.; Hobbs, R.M.; Rajendran, A.; Xie, A.; Shah, J.V.; Davis, A.J.; Scully, R.; Lunardi, A.; Pandolfi, P.Paolo. 2015: LRF maintains genome integrity by regulating the non-homologous end joining pathway of DNA repair. Nature Communications 6: 8325

Chondrou, V.; Markopoulos, G.S.; Patrinos, G.P.; Kouraklis-Symeonidis, A.; Symeonidis, A.; Papachatzopoulou, A.; Sgourou, A. 2020: LRF/ZBTB7A conservation accentuates its potential as a therapeutic target for the hematopoietic disorders. Gene 760: 145020

Liu, T.-T.; Luo, R.; Yang, Y.; Cheng, Y.-C.; Chang, D.; Dai, W.; Li, Y.-Q.; Ge, S.-W.; Xu, G. 2021: LRG1 Mitigates Renal Interstitial Fibrosis through Alleviating Capillary Rarefaction and Inhibiting Inflammatory and Pro-Fibrotic Cytokines. American Journal of Nephrology 52(3): 228-238

Wang, X.; Abraham, S.; McKenzie, J.A.G.; Jeffs, N.; Swire, M.; Tripathi, V.B.; Luhmann, U.F.O.; Lange, C.A.K.; Zhai, Z.; Arthur, H.M.; Bainbridge, J.; Moss, S.E.; Greenwood, J. 2013: LRG1 promotes angiogenesis by modulating endothelial TGF-β signalling. Nature 499(7458): 306-311

Zhou, L.; Shi, D.-P.; Chu, W.-J.; Yang, L.-L.; Xu, H.-F. 2021: LRG1 promotes epithelial-mesenchymal transition of retinal pigment epithelium cells by activating NOX4. International Journal of Ophthalmology 14(3): 349-355

Pouraghajan, K.; Mahdiuni, H.; Ghobadi, S.; Khodarahmi, R. 2020: LRH-1 (liver receptor homolog-1) derived affinity peptide ligand to inhibit interactions between β-catenin and LRH-1 in pancreatic cancer cells: from computational design to experimental validation. Journal of Biomolecular Structure and Dynamics 2020: 1-16

Cobo-Vuilleumier, N.; Lorenzo, P.I.; Rodríguez, N.García.; Herrera Gómez, I.de.Gracia.; Fuente-Martin, E.; López-Noriega, L.; Mellado-Gil, Jé.Manuel.; Romero-Zerbo, S-Yanina.; Baquié, M.; Lachaud, C.Claude.; Stifter, K.; Perdomo, G.; Bugliani, M.; De Tata, V.; Bosco, D.; Parnaud, G.; Pozo, D.; Hmadcha, A.; Florido, J.P.; Toscano, M.G.; de Haan, P.; Schoonjans, K.; Sánchez Palazón, L.; Marchetti, P.; Schirmbeck, R.; Martín-Montalvo, A.; Meda, P.; Soria, B.; Bermúdez-Silva, F-Javier.; St-Onge, L.; Gauthier, B.R. 2018: LRH-1 agonism favours an immune-islet dialogue which protects against diabetes mellitus. Nature Communications 9(1): 1488

Bianco, S.; Jangal, M.; Garneau, D.; Gévry, N. 2015: LRH-1 controls proliferation in breast tumor cells by regulating CDKN1A gene expression. Oncogene 34(34): 4509-4518

Lefèvre, L.; Authier, Hélène.; Stein, S.; Majorel, C.; Couderc, B.; Dardenne, C.; Eddine, M.Ala.; Meunier, E.; Bernad, Jé.; Valentin, A.; Pipy, B.; Schoonjans, K.; Coste, Aès. 2015: LRH-1 mediates anti-inflammatory and antifungal phenotype of IL-13-activated macrophages through the PPARγ ligand synthesis. Nature Communications 6: 6801

Bayrer, J.R.; Wang, H.; Nattiv, R.; Suzawa, M.; Escusa, H.S.; Fletterick, R.J.; Klein, O.D.; Moore, D.D.; Ingraham, H.A. 2018: LRH-1 mitigates intestinal inflammatory disease by maintaining epithelial homeostasis and cell survival. Nature Communications 9(1): 4055

Cai, Y.Ning.; Zhou, Q.; Kong, Y.Ying.; Li, M.; Viollet, B.; Xie, Y.Hua.; Wang, Y. 2003: LRH-1/hB1F and HNF1 synergistically up-regulate hepatitis B virus gene transcription and DNA replication. Cell Research 13(6): 451-458

Brosens, J.J.; Blanks, A.M.; Lucas, E.S. 2013: LRH-1: orphaned, adopted and needed for pregnancy. Nature Medicine 19(8): 968-969

Zheng, P.; Huang, H.; Li, X.; Huang, F.; Adeniran, S.O.; Wang, Z.; Feng, R.; Zhang, G. 2021: LRH-A3 and HCG increase pregnancy rate during timed artificial insemination in dairy cows. Animal Science Journal 92(1): E13549

Song, Y.; An, W.; Wang, H.; Gao, Y.; Han, J.; Hao, C.; Chen, L.; Liu, S.; Xing, Y. 2021: LRH1 Acts as an Oncogenic Driver in Human Osteosarcoma and Pan-Cancer. Frontiers in Cell and Developmental Biology 9: 643522

Sun, W.; Shi, Q.; Li, J.; Li, J.; Yu, L. 2020: LRH1 Promotes Tumor Cell Proliferation and Migration and Is Correlated with Poor Prognosis in Ovarian Cancer. Frontiers in Oncology 10: 583566

Wang, S.; Zou, Z.; Luo, X.; Mi, Y.; Chang, H.; Xing, D. 2018: LRH1 enhances cell resistance to chemotherapy by transcriptionally activating MDC1 expression and attenuating DNA damage in human breast cancer. Oncogene 37(24): 3243-3259

Herdenberg, C.; Mutie, P.M.; Billing, O.; Abdullah, A.; Strawbridge, R.J.; Dahlman, I.; Tuck, S.; Holmlund, C.; Arner, P.; Henriksson, R.; Franks, P.W.; Hedman, Håkan. 2021: LRIG proteins regulate lipid metabolism via BMP signaling and affect the risk of type 2 diabetes. Communications Biology 4(1): 90

Thomasson, M.; Hedman, H.; Guo, D.; Ljungberg, B.; Henriksson, R. 2003: LRIG1 and epidermal growth factor receptor in renal cell carcinoma: a quantitative RT--PCR and immunohistochemical analysis. British Journal of Cancer 89(7): 1285-1289

Bakherad, M.; Salimi, M.; Angaji, S.A.; Mahjoubi, F.; Majidizadeh, T. 2021: LRIG1 expression and colorectal cancer prognosis. Bmc Medical Genomics 14(1): 20

Faraz, M.; Tellström, A.; Ardnor, C.E.; Grankvist, K.; Huminiecki, L.; Tavelin, B.ör.; Henriksson, R.; Hedman, H.åk.; Ljuslinder, I. 2020: LRIG1 gene copy number analysis by ddPCR and correlations to clinical factors in breast cancer. Bmc Cancer 20(1): 459

Marqués-Torrejón, Mía.Ángeles.; Williams, C.A.C.; Southgate, B.; Alfazema, N.; Clements, M.P.; Garcia-Diaz, C.; Blin, C.; Arranz-Emparan, N.; Fraser, J.; Gammoh, N.; Parrinello, S.; Pollard, S.M. 2021: LRIG1 is a gatekeeper to exit from quiescence in adult neural stem cells. Nature Communications 12(1): 2594

Sundqvist, B.; Sihto, H.; von Willebrand, M.; Böhling, T.; Koljonen, V. 2021: LRIG1 is a positive prognostic marker in Merkel cell carcinoma and Merkel cell carcinoma expresses epithelial stem cell markers. Virchows Archiv: An International Journal of Pathology 479(6): 1197-1207

Wang, Y.; Poulin, E.J.; Coffey, R.J. 2013: LRIG1 is a triple threat: ERBB negative regulator, intestinal stem cell marker and tumour suppressor. British Journal of Cancer 108(9): 1765-1770

Sheu, J.J-C.; Lee, C-C.; Hua, C-H.; Li, C-I.; Lai, M-T.; Lee, S-C.; Cheng, J.; Chen, C-M.; Chan, C.; Chao, S.C-C.; Chen, J-Y.; Chang, J-Y.; Lee, C-H. 2014: LRIG1 modulates aggressiveness of head and neck cancers by regulating EGFR-MAPK-SPHK1 signaling and extracellular matrix remodeling. Oncogene 33(11): 1375-1384

Stutz, M.A.; Shattuck, D.L.; Laederich, M.B.; Carraway, K.L.; Sweeney, C. 2008: LRIG1 negatively regulates the oncogenic EGF receptor mutant EGFRvIII. Oncogene 27(43): 5741-5752

Yokdang, N.; Hatakeyama, J.; Wald, J.H.; Simion, C.; Tellez, J.D.; Chang, D.Z.; Swamynathan, M.M.; Chen, M.; Murphy, W.J.; Carraway Iii, K.L.; Sweeney, C. 2016: LRIG1 opposes epithelial-to-mesenchymal transition and inhibits invasion of basal-like breast cancer cells. Oncogene 35(22): 2932-2947

Gur, G.; Rubin, C.; Katz, M.; Amit, I.; Citri, A.; Nilsson, J.; Amariglio, N.; Henriksson, R.; Rechavi, G.; Hedman, Håkan.; Wides, R.; Yarden, Y. 2004: LRIG1 restricts growth factor signaling by enhancing receptor ubiquitylation and degradation. EMBO Journal 23(16): 3270-3281

Jeong, D.; Lozano Casasbuenas, D.; Gengatharan, A.; Edwards, K.; Saghatelyan, A.; Kaplan, D.R.; Miller, F.D.; Yuzwa, S.A. 2020: LRIG1-Mediated Inhibition of EGF Receptor Signaling Regulates Neural Precursor Cell Proliferation in the Neocortex. Cell Reports 33(2): 108257

Suh, D-Shik.; Park, S.Eun.; Jin, H.; Lee, K.; Bae, J. 2018: LRIG2 is a growth suppressor of Hec-1A and Ishikawa endometrial adenocarcinoma cells by regulating PI3K/AKT- and EGFR-mediated apoptosis and cell-cycle. Oncogenesis 7(1): 3

Wang, D.; Zhou, Z.; Wu, E.; Ouyang, C.; Wei, G.; Wang, Y.; He, D.; Cui, Y.; Zhang, D.; Chen, X.; Reed, S.H.; Luo, J.; Chen, R. 2020: LRIK interacts with the Ku70-Ku80 heterodimer enhancing the efficiency of NHEJ repair. Cell Death and Differentiation 27(12): 3337-3353

Luo, J.; Chen, R.; Zhang, X.; Wang, Y.; Luo, H.; Yan, C.; Huo, Z. 2020: LROD: An Overlap Detection Algorithm for Long Reads Based on k-mer Distribution. Frontiers in Genetics 11: 632

Kim, E-Sun.; Kim, D.; Nyberg, S.; Poma, A.; Cecchin, D.; Jain, S.A.; Kim, K-A.; Shin, Y-Jun.; Kim, E-Hye.; Kim, M.; Baek, S-Hoon.; Kim, J-Ki.; Doeppner, T.R.; Ali, A.; Redgrave, J.; Battaglia, G.; Majid, A.; Bae, O-Nam. 2020: LRP-1 functionalized polymersomes enhance the efficacy of carnosine in experimental stroke. Scientific Reports 10(1): 699

Tian, X.; Nyberg, S.; S Sharp, P.; Madsen, J.; Daneshpour, N.; Armes, S.P.; Berwick, J.; Azzouz, M.; Shaw, P.; Abbott, N.Joan.; Battaglia, G. 2015: LRP-1-mediated intracellular antibody delivery to the Central Nervous System. Scientific Reports 5: 11990

Calvier, L.; Boucher, P.; Herz, J.; Hansmann, G. 2019: LRP1 Deficiency in Vascular SMC Leads to Pulmonary Arterial Hypertension That Is Reversed by PPARγ Activation. Circulation Research 124(12): 1778-1785

Kadurin, I.; Rothwell, S.W.; Lana, B.; Nieto-Rostro, M.; Dolphin, A.C. 2017: LRP1 influences trafficking of N-type calcium channels via interaction with the auxiliary α 2 δ-1 subunit. Scientific Reports 7: 43802

Rauch, J.N.; Luna, G.; Guzman, E.; Audouard, M.; Challis, C.; Sibih, Y.E.; Leshuk, C.; Hernandez, I.; Wegmann, S.; Hyman, B.T.; Gradinaru, V.; Kampmann, M.; Kosik, K.S. 2020: LRP1 is a master regulator of tau uptake and spread. Nature 580(7803): 381-385

Boel, N.Marie-Eraine.; Hunter, M.Campbell.; Edkins, A.Lesley. 2018: LRP1 is required for novobiocin-mediated fibronectin turnover. Scientific Reports 8(1): 11438

He, Y.; Ruganzu, J.B.; Jin, H.; Peng, X.; Ji, S.; Ma, Y.; Zheng, L.; Yang, W. 2020: LRP1 knockdown aggravates Aβ1-42-stimulated microglial and astrocytic neuroinflammatory responses by modulating TLR4/NF-κB/MAPKs signaling pathways. Experimental Cell Research 394(2): 112166

Actis Dato, V.; Sánchez, Mía.Cecilia.; Chiabrando, G.Alberto. 2021: LRP1 mediates the IGF-1-induced GLUT1 expression on the cell surface and glucose uptake in Müller glial cells. Scientific Reports 11(1): 4742

Li, D.; Zhu, H.; Luo, Z.-Y.; Chen, Y.; Song, G.-B.; Zhou, X.-M.; Yan, H.; Zhou, H.-H.; Zhang, W.; Li, X. 2020: LRP1 polymorphisms associated with warfarin stable dose in Chinese patients: a stepwise conditional analysis. Pharmacogenomics 21(16): 1169-1178

He, C.; Zhang, Z.; Ding, Y.; Xue, K.; Wang, X.; Yang, R.; An, Y.; Liu, D.; Hu, C.; Tang, Q. 2021: LRP1-mediated pH-sensitive polymersomes facilitate combination therapy of glioblastoma in vitro and in vivo. Journal of Nanobiotechnology 19(1): 29

Vergouw, L.J.M.; Melhem, S.; Donker Kaat, L.; Chiu, W.Z.; Kuipers, D.J.S.; Breedveld, G.; Boon, A.J.W.; Wang, L.-S.; Naj, A.C.; Mlynarksi, E.; Cantwell, L.; Quadri, M.; Ross, O.A.; Dickson, D.W.; Schellenberg, G.D.; van Swieten, J.C.; Bonifati, V.; de Jong, F.J. 2020: LRP10 variants in progressive supranuclear palsy. Neurobiology of Aging 94: 311.E5-311.E10

T Marvian, A.; Stamelou, M.; U Höglinger, G.ün. 2020: LRP1: a Novel Mediator of Tau Uptake. Movement Disorders: Official Journal of the Movement Disorder Society 35(7): 1136

Dionísio de Sousa, I.J.; Cunha, A.I.; Saraiva, I.ês.A.; Portugal, R.V.; Gimba, E.R.P.; Guimarães, M.; Prazeres, H.; Lopes, J.é M.; Soares, P.; Lima, R.T. 2021: LRP1B Expression as a Putative Predictor of Response to Pegylated Liposomal Doxorubicin Treatment in Ovarian Cancer. Pathobiology: Journal of Immunopathology Molecular and Cellular Biology 88(6): 400-411

Cao, C.-H.; Liu, R.; Lin, X.-R.; Luo, J.-Q.; Cao, L.-J.; Zhang, Q.-J.; Lin, S.-R.; Geng, L.; Sun, Z.-Y.; Ye, S.-K.; Yu, Z.-Y.; Shi, Y.; Xia, X. 2021: LRP1B mutation is associated with tumor HPV status and promotes poor disease outcomes with a higher mutation count in HPV-related cervical carcinoma and head and neck squamous cell carcinoma. International Journal of Biological Sciences 17(7): 1744-1756

Liu, F.; Hou, W.; Liang, J.; Zhu, L.; Luo, C. 2021: LRP1B mutation: a novel independent prognostic factor and a predictive tumor mutation burden in hepatocellular carcinoma. Journal of Cancer 12(13): 4039-4048

Wang, L.; Yan, K.; He, X.; Zhu, H.; Song, J.; Chen, S.; Cai, S.; Zhao, Y.; Wang, L. 2021: LRP1B or TP53 mutations are associated with higher tumor mutational burden and worse survival in hepatocellular carcinoma. Journal of Cancer 12(1): 217-223

Christ, A.; Marczenke, M.; Willnow, T.E. 2020: LRP2 controls sonic hedgehog-dependent differentiation of cardiac progenitor cells during outflow tract formation. Human Molecular Genetics 29(19): 3183-3196

Yan, M.; Guo, A.; Chen, P.; Jing, H.; Ren, D.; Zhong, Y.; Wu, Y.; Fei, E.; Lai, X.; Zou, S.; Wang, S. 2020: LRP4 LDLα repeats of astrocyte enhance dendrite arborization of the neuron. Molecular Brain 13(1): 166

Mao, Z.; Wang, Z.; Zhang, S.; Pu, Y.; Wang, J.; Zhang, T.; Long, Y.; Liu, Y.; Ma, Y.; Zhu, J. 2020: LRP4 promotes migration and invasion of gastric cancer under the regulation of microRNA-140-5p. Cancer Biomarkers: Section a of Disease Markers 29(2): 245-253

Ren, Q.; Chen, J.; Liu, Y. 2021: LRP5 and LRP6 in Wnt Signaling: Similarity and Divergence. Frontiers in Cell and Developmental Biology 9: 670960

Johnson, M.L. 2012: LRP5 and bone mass regulation: Where are we now?. Bonekey Reports 1: 1

Borrell-Pages, M.; Carolina Romero, J.; Badimon, L. 2015: LRP5 and plasma cholesterol levels modulate the canonical Wnt pathway in peripheral blood leukocytes. Immunology and Cell Biology 93(7): 653-661

Li, J.; Li, C.; Liang, D.; Lv, F.; Yuan, T.; The, E.; Ma, X.; Wu, Y.; Zhen, L.; Xie, D.; Wang, S.; Liu, Y.; Huang, J.; Shi, J.; Liu, Y.; Shi, D.; Xu, L.; Lin, L.; Peng, L.; Cui, J.; Zhu, W.; Chen, Y-Han. 2016: LRP6 acts as a scaffold protein in cardiac gap junction assembly. Nature Communications 7: 11775

Zhang, Y.; Shu, C.; Maimaiti, Y.; Wang, S.; Lu, C.; Zhou, J. 2021: LRP6 as a biomarker of poor prognosis of breast cancer. Gland Surgery 10(8): 2414-2427

Li, Y.; Lu, W.; He, X.; Schwartz, A.L.; Bu, G. 2004: LRP6 expression promotes cancer cell proliferation and tumorigenesis by altering beta-catenin subcellular distribution. Oncogene 23(56): 9129-9135

Li, C.; Williams, B.O.; Cao, X.; Wan, M. 2014: LRP6 in mesenchymal stem cells is required for bone formation during bone growth and bone remodeling. Bone Research 2: 14006

Yuan, Y.; Xie, X.; Jiang, Y.; Wei, Z.; Wang, P.; Chen, F.; Li, X.; Sun, C.; Zhao, H.; Zeng, X.; Jiang, L.; Zhou, Y.; Dan, H.; Feng, M.; Liu, R.; Wang, Z.; Chen, Q. 2017: LRP6 is identified as a potential prognostic marker for oral squamous cell carcinoma via MALDI-IMS. Cell Death and Disease 8(9): E3035

Wong, K.K.L.; Verheyen, E.M. 2020: LRP6 lets Merlin go in times of nutrient scarcity. Embo Reports 21(9): E51358

Zheng, S.; Wei, Y.; Jiang, Y.; Hao, Y. 2021: LRP8 activates STAT3 to induce PD-L1 expression in osteosarcoma. Tumori 107(3): 238-246

Cuttler, K.; Bignoux, M.J.; Otgaar, T.C.; Chigumba, S.; Ferreira, E.; Weiss, S.F.T. 2020: LRP::FLAG Reduces Phosphorylated Tau Levels in Alzheimer's Disease Cell Culture Models. Journal of Alzheimer's Disease: Jad 76(2): 753-768

Thurner, L.; Hartmann, S.; Fadle, N.; Kemele, M.; Bock, T.; Bewarder, M.; Regitz, E.; Neumann, F.; Nimmesgern, A.; von Müller, L.; Pott, C.; Kim, Y-Jin.; Bohle, R.Maria.; Wasik, M.; Schuster, S.J.; Hansmann, M-Leo.; Preuss, K-Dieter.; Pfreundschuh, M. 2019: LRPAP1 is a frequent proliferation-inducing antigen of BCRs of mantle cell lymphomas and can be used for specific therapeutic targeting. Leukemia 33(1): 148-158

Song, K.; Li, B.; Chen, Y.-Y.; Wang, H.; Liu, K.-C.; Tan, W.; Zou, J. 2021: LRPPRC regulates metastasis and glycolysis by modulating autophagy and the ROS/HIF1-α pathway in retinoblastoma. Molecular Therapy Oncolytics 22: 582-591

Li, W.; Dai, Y.; Shi, B.; Yue, F.; Zou, J.; Xu, G.; Jiang, X.; Wang, F.; Zhou, X.; Liu, L. 2020: LRPPRC sustains Yap-P27-mediated cell ploidy and P62-HDAC6-mediated autophagy maturation and suppresses genome instability and hepatocellular carcinomas. Oncogene 39(19): 3879-3892

Siira, S.J.; Spåhr, H.; Shearwood, A-Marie.J.; Ruzzenente, B.; Larsson, N-Göran.; Rackham, O.; Filipovska, A. 2017: LRPPRC-mediated folding of the mitochondrial transcriptome. Nature Communications 8(1): 1532

Tsuboi, A. 2020: LRR-Containing Oncofetal Trophoblast Glycoprotein 5T4 Shapes Neural Circuits in Olfactory and Visual Systems. Frontiers in Molecular Neuroscience 13: 581018

Slemmons, K.K.; Mukherjee, S.; Meltzer, P.; Purcell, J.W.; Helman, L.J. 2021: LRRC15 antibody-drug conjugates show promise as osteosarcoma therapeutics in preclinical studies. Pediatric Blood and Cancer 68(2): E28771

Oh, C.-K.; Park, J.J.; Ha, M.; Heo, H.J.; Kang, J.; Kwon, E.J.; Kang, J.W.; Kim, Y.; Kang, J.M.; Yoon, S.Z.; Ko, Y.; Ko, D.S.; Kim, Y.H. 2020: LRRC17 Is Linked to Prognosis of Ovarian Cancer Through a p53-dependent Anti-apoptotic Function. Anticancer Research 40(10): 5601-5609

Yan, J.; Aldrich, R.W. 2010: LRRC26 auxiliary protein allows BK channel activation at resting voltage without calcium. Nature 466(7305): 513-516

Chen, Y.; Jiang, T.; Zhang, H.; Gou, X.; Han, C.; Wang, J.; Chen, A.T.; Ma, J.; Liu, J.; Chen, Z.; Jing, X.; Lei, H.; Wang, Z.; Bao, Y.; Baqri, M.; Zhu, Y.; Bindra, R.S.; Hansen, J.E.; Dou, J.; Huang, C.; Zhou, J. 2020: LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. Nature Cell Biology 22(10): 1276-1285

D'Mello, R.J.; Caldwell, J.M.; Azouz, N.P.; Wen, T.; Sherrill, J.D.; Hogan, S.P.; Rothenberg, M.E. 2016: LRRC31 is induced by IL-13 and regulates kallikrein expression and barrier function in the esophageal epithelium. Mucosal Immunology 9(3): 744-756

Zhang, Y.; Li, D.; Zeng, Q.; Feng, J.; Fu, H.; Luo, Z.; Xiao, B.; Yang, H.; Wu, M. 2021: LRRC4 functions as a neuron-protective role in experimental autoimmune encephalomyelitis. Molecular Medicine 27(1): 44

Feng, J.; Ren, X.; Fu, H.; Li, D.; Chen, X.; Zu, X.; Liu, Q.; Wu, M. 2021: LRRC4 mediates the formation of circular RNA CD44 to inhibitGBM cell proliferation. Molecular Therapy. Nucleic Acids 26: 473-487

Pang, Q.; Wang, Y.; Bi, D.; Lu, H. 2020: LRRC75A-AS1 targets miR-199b-5p/PDCD4 axis to repress multiple myeloma. Cancer Biology and Therapy 21(11): 1051-1059

Chen, L.; König, B.; Stauber, T. 2020: LRRC8 channel activation and reduction in cytosolic chloride concentration during early differentiation of C2C12 myoblasts. Biochemical and Biophysical Research Communications 532(3): 482-488

Li, P.; Hu, M.; Wang, C.; Feng, X.; Zhao, Z.; Yang, Y.; Sahoo, N.; Gu, M.; Yang, Y.; Xiao, S.; Sah, R.; Cover, T.L.; Chou, J.; Geha, R.; Benavides, F.; Hume, R.I.; Xu, H. 2020: LRRC8 family proteins within lysosomes regulate cellular osmoregulation and enhance cell survival to multiple physiological stresses. Proceedings of the National Academy of Sciences of the United States of America 117(46): 29155-29165

Friard, J.; Laurain, A.; Rubera, I.; Duranton, C. 2021: LRRC8/VRAC Channels and the Redox Balance: a Complex Relationship. Cellular Physiology and Biochemistry: International Journal of Experimental Cellular Physiology Biochemistry and Pharmacology 55(S1): 106-118

Stuhlmann, T.; Planells-Cases, R.; Jentsch, T.J. 2018: LRRC8/VRAC anion channels enhance β-cell glucose sensing and insulin secretion. Nature Communications 9(1): 1974

Friard, J.; Corinus, A.; Cougnon, M.; Tauc, M.; Pisani, D.F.; Duranton, C.; Rubera, I. 2019: LRRC8/VRAC channels exhibit a noncanonical permeability to glutathione, which modulates epithelial-to-mesenchymal transition (EMT). Cell Death and Disease 10(12): 925

Lahey, L.J.; Mardjuki, R.E.; Wen, X.; Hess, G.T.; Ritchie, C.; Carozza, J.A.; Böhnert, V.; Maduke, M.; Bassik, M.C.; Li, L. 2020: LRRC8A:C/E Heteromeric Channels Are Ubiquitous Transporters of cGAMP. Molecular Cell 80(4): 578-591.E5

Soler, G.; Nusbaum, S.; Varet, B.; Macintyre, E.A.; Vekemans, M.; Romana, S.P.; Radford-Weiss, I. 2009: LRRFIP1, a new FGFR1 partner gene associated with 8p11 myeloproliferative syndrome. Leukemia 23(7): 1359-1361

Jin, J.; Yu, Q.; Han, C.; Hu, X.; Xu, S.; Wang, Q.; Wang, J.; Li, N.; Cao, X. 2013: LRRFIP2 negatively regulates NLRP3 inflammasome activation in macrophages by promoting Flightless-I-mediated caspase-1 inhibition. Nature Communications 4: 2075

Morimoto, K.; Baba, Y.; Shinohara, H.; Kang, S.; Nojima, S.; Kimura, T.; Ito, D.; Yoshida, Y.; Maeda, Y.; Sarashina-Kida, H.; Nishide, M.; Hosokawa, T.; Kato, Y.; Hayama, Y.; Kinehara, Y.; Okuno, T.; Takamatsu, H.; Hirano, T.; Shima, Y.; Narazaki, M.; Kurosaki, T.; Toyofuku, T.; Kumanogoh, A. 2016: LRRK1 is critical in the regulation of B-cell responses and CARMA1-dependent NF-κB activation. Scientific Reports 6: 25738

Van der Perren, A.; Cabezudo, D.; Gelders, G.ér.; Peralta Ramos, J.M.; Van den Haute, C.; Baekelandt, V.; Lobbestael, E. 2021: LRRK2 Ablation Attenuates Αlpha-Synuclein-Induced Neuroinflammation Without Affecting Neurodegeneration or Neuropathology in Vivo. Neurotherapeutics: the Journal of the American Society for Experimental Neurotherapeutics 18(2): 949-961

Pischedda, F.; Cirnaru, M.D.; Ponzoni, L.; Sandre, M.; Biosa, A.; Carrion, M.P.; Marin, O.; Morari, M.; Pan, L.; Greggio, E.; Bandopadhyay, R.; Sala, M.; Piccoli, G. 2021: LRRK2 G2019S kinase activity triggers neurotoxic NSF aggregation. Brain: a Journal of Neurology 144(5): 1509-1525

Chen, X.; Le, W. 2021: LRRK2 G2019S mutation amplifies protein aggregate propagation. Brain: a Journal of Neurology 144(5): 1289-1290

Choi, I.; Kim, B.; Byun, J-Won.; Baik, S.Hoon.; Huh, Y.Hyun.; Kim, J-Hyeon.; Mook-Jung, I.; Song, W.Keun.; Shin, J-Ho.; Seo, H.; Suh, Y.Ho.; Jou, I.; Park, S.Myun.; Kang, H.Chul.; Joe, E-Hye. 2015: LRRK2 G2019S mutation attenuates microglial motility by inhibiting focal adhesion kinase. Nature Communications 6: 8255

Oliveira, P.R.S.; de Matos, L.O.; Araujo, N.M.; Sant Anna, H.ís.P.; da Silva E Silva, D.A.; Damasceno, A.K.A.; Martins de Carvalho, L.; Horta, B.L.; Lima-Costa, M.F.; Barreto, M.L.; Wiers, C.E.; Volkow, N.D.; Brunialti Godard, A.L.úc. 2021: LRRK2 Gene Variants Associated with a Higher Risk for Alcohol Dependence in Multiethnic Populations. Frontiers in Psychiatry 12: 665257

Sanyal, A.; Novis, H.S.; Gasser, E.; Lin, S.; LaVoie, M.J. 2020: LRRK2 Kinase Inhibition Rescues Deficits in Lysosome Function Due to Heterozygous GBA1 Expression in Human iPSC-Derived Neurons. Frontiers in Neuroscience 14: 442

Ho, D.H.; Nam, D.; Seo, M.K.; Park, S.W.; Seol, W.; Son, I. 2021: LRRK2 Kinase Inhibitor Rejuvenates Oxidative Stress-Induced Cellular Senescence in Neuronal Cells. Oxidative Medicine and Cellular Longevity 2021: 9969842

Beetz, C.; Westenberger, A.; Al-Ali, R.; Ameziane, N.; Alhashmi, N.; Boustany, R.-M.; Al Mutairi, F.; Alfadhel, M.; Al-Hassnan, Z.; AlSayed, M.; Kandaswamy, K.K.; Paknia, O.; Skrahina, V.; Rolfs, A.; Bauer, P. 2021: LRRK2 Loss-of-Function Variants in Patients with Rare Diseases: no Evidence for a Phenotypic Impact. Movement Disorders: Official Journal of the Movement Disorder Society 36(4): 1029-1031

Usnich, T.; Westenberger, A. 2020: LRRK2 Loss-of-Function Variants: when Less Is more. Movement Disorders: Official Journal of the Movement Disorder Society 35(10): 1754

Marchand, A.; Drouyer, M.; Sarchione, A.; Chartier-Harlin, M.-C.; Taymans, J.-M. 2020: LRRK2 Phosphorylation, more than an Epiphenomenon. Frontiers in Neuroscience 14: 527

Herbst, S.; Campbell, P.; Harvey, J.; Bernard, E.M.; Papayannopoulos, V.; Wood, N.W.; Morris, H.R.; Gutierrez, M.G. 2020: LRRK2 activation controls the repair of damaged endomembranes in macrophages. EMBO Journal 39(18): E104494

Rocha, J.D.B.; Schlossmacher, M.G.; Philpott, D.J. 2015: LRRK2 and Nod2 promote lysozyme sorting in Paneth cells. Nature Immunology 16(9): 898-900

Dues, D.J.; Moore, D.J. 2020: LRRK2 and Protein Aggregation in Parkinson's Disease: Insights from Animal Models. Frontiers in Neuroscience 14: 719

Kuwahara, T.; Inoue, K.; D'Agati, V.D.; Fujimoto, T.; Eguchi, T.; Saha, S.; Wolozin, B.; Iwatsubo, T.; Abeliovich, A. 2016: LRRK2 and RAB7L1 coordinately regulate axonal morphology and lysosome integrity in diverse cellular contexts. Scientific Reports 6: 29945

Liu, Z.; Xu, E.; Zhao, H.Tran.; Cole, T.; West, A.B. 2020: LRRK2 and Rab10 coordinate macropinocytosis to mediate immunological responses in phagocytes. EMBO Journal 39(20): E104862

Erb, M.L.; Moore, D.J. 2020: LRRK2 and the Endolysosomal System in Parkinson's Disease. Journal of Parkinson's Disease 10(4): 1271-1291

O'Hara, D.M.; Pawar, G.; Kalia, S.K.; Kalia, L.V. 2020: LRRK2 and α-Synuclein: Distinct or Synergistic Players in Parkinson's Disease?. Frontiers in Neuroscience 14: 577

Wallings, R.L.; Herrick, M.K.; Tansey, M.ú G.ám. 2020: LRRK2 at the Interface Between Peripheral and Central Immune Function in Parkinson's. Frontiers in Neuroscience 14: 443

Tolosa, E.; Vila, M.; Klein, C.; Rascol, O. 2020: LRRK2 in Parkinson disease: challenges of clinical trials. Nature Reviews. Neurology 16(2): 97-107

Chen, L.; Hou, J.; Zeng, X.; Guo, Q.; Deng, M.; Kloeber, J.A.; Tu, X.; Zhao, F.; Wu, Z.; Huang, J.; Luo, K.; Kim, W.; Lou, Z. 2021: LRRK2 inhibition potentiates PARP inhibitor cytotoxicity through inhibiting homologous recombination-mediated DNA double strand break repair. Clinical and Translational Medicine 11(3): E341

Yang, C.; Pang, J.; Xu, J.; Pan, H.; Li, Y.; Zhang, H.; Liu, H.; Xiao, S.-Y. 2021: LRRK2 is a candidate prognostic biomarker for clear cell renal cell carcinoma. Cancer Cell International 21(1): 343

Nabar, N.R.; Heijjer, C.N.; Shi, C-Shan.; Hwang, I-Young.; Ganesan, S.; Karlsson, M.C.I.; Kehrl, J.H. 2021: LRRK2 is required for CD38-mediated NAADP-Ca 2+ signaling and the downstream activation of TFEB (transcription factor EB) in immune cells. Autophagy 2021: 1-19

Ysselstein, D.; Nguyen, M.; Young, T.J.; Severino, A.; Schwake, M.; Merchant, K.; Krainc, D. 2019: LRRK2 kinase activity regulates lysosomal glucocerebrosidase in neurons derived from Parkinson's disease patients. Nature Communications 10(1): 5570

Zhao, Y.; Keshiya, S.; Perera, G.; Schramko, L.; Halliday, G.M.; Dzamko, N. 2020: LRRK2 kinase inhibitors reduce alpha-synuclein in human neuronal cell lines with the G2019S mutation. Neurobiology of Disease 144: 105049

Bae, E-Jin.; Kim, D-Kyu.; Kim, C.; Mante, M.; Adame, A.; Rockenstein, E.; Ulusoy, A.; Klinkenberg, M.; Jeong, G.Ram.; Bae, J.Ryul.; Lee, C.; Lee, H-Jin.; Lee, B-Dae.; Di Monte, D.A.; Masliah, E.; Lee, S-Jae. 2018: LRRK2 kinase regulates α-synuclein propagation via RAB35 phosphorylation. Nature Communications 9(1): 3465

Cook, D.A.; Kannarkat, G.T.; Cintron, A.F.; Butkovich, L.M.; Fraser, K.B.; Chang, J.; Grigoryan, N.; Factor, S.A.; West, A.B.; Boss, J.M.; Tansey, M.G. 2017: LRRK2 levels in immune cells are increased in Parkinson's disease. Npj Parkinson's Disease 3: 11

Skorvanek, M.; Rizig, M.; Athanasiou-Fragkouli, A.; Necpal, J.; Straka, I.; Tamas, G.; Kurca, E.; Mosejova, A.; Han, V.; Lorincova, T.; Ostrozovicova, M.; Liesenerova, S.; Levicka, P.; Fajcikova, L.; Minar, M.; Valkovic, P.; Mákos, O.; Kelemen, A.; Grofik, M.; Cibulka, M.; Jama, F.; Houlden, H.; Sendekova, D.; Cobejova, J.; Cobej, M.; Sukovska, V.; Pálvölgyi, K.ár.é; Kovacs, N.; Pintér, D.; Ruzicka, E.; Holly, P.; Dusek, P.; Starkova, I.; Brdkova, J.; Smilowska, K.; Falup-Pecurariu, C.; Diaconu, S.; Klivenyi, P.; Balaz, M. 2021: LRRK2 mutations in Parkinson's disease patients from Central Europe: a case control study. Parkinsonism and Related Disorders 83: 110-112

Yun, H.Jin.; Park, J.; Ho, D.Hwan.; Kim, H.; Kim, C-Hyun.; Oh, H.; Ga, I.; Seo, H.; Chang, S.; Son, I.; Seol, W. 2013: LRRK2 phosphorylates Snapin and inhibits interaction of Snapin with SNAP-25. Experimental and Molecular Medicine 45: E36

Toyofuku, T.; Okamoto, Y.; Ishikawa, T.; Sasawatari, S.; Kumanogoh, A. 2020: LRRK2 regulates endoplasmic reticulum-mitochondrial tethering through the PERK-mediated ubiquitination pathway. EMBO Journal 39(18): E105826

Penney, J.; Tsurudome, K.; Liao, E.H.; Kauwe, G.; Gray, L.; Yanagiya, A.; R Calderon, M.; Sonenberg, N.; Haghighi, A.Pejmun. 2016: LRRK2 regulates retrograde synaptic compensation at the Drosophila neuromuscular junction. Nature Communications 7: 12188

Parisiadou, L.; Yu, J.; Sgobio, C.; Xie, C.; Liu, G.; Sun, L.; Gu, X-Long.; Lin, X.; Crowley, N.A.; Lovinger, D.M.; Cai, H. 2014: LRRK2 regulates synaptogenesis and dopamine receptor activation through modulation of PKA activity. Nature Neuroscience 17(3): 367-376

Radulovic, M.; Stenmark, H. 2020: LRRK2 to the rescue of damaged endomembranes. EMBO Journal 39(18): E106162

Rivero-Ríos, P.; Romo-Lozano, M.ía.; Fasiczka, R.; Naaldijk, Y.; Hilfiker, S. 2020: LRRK2-Related Parkinson's Disease Due to Altered Endolysosomal Biology with Variable Lewy Body Pathology: a Hypothesis. Frontiers in Neuroscience 14: 556

Follett, J.; Farrer, M.J. 2021: LRRK2; a dynamic regulator of cellular trafficking. Brain Research 1761: 147394

Francks, C.; Maegawa, S.; Laurén, J.; Abrahams, B.S.; Velayos-Baeza, A.; Medland, S.E.; Colella, S.; Groszer, M.; McAuley, E.Z.; Caffrey, T.M.; Timmusk, T.; Pruunsild, P.; Koppel, I.; Lind, P.A.; Matsumoto-Itaba, N.; Nicod, J.; Xiong, L.; Joober, R.; Enard, W.; Krinsky, B.; Nanba, E.; Richardson, A.J.; Riley, B.P.; Martin, N.G.; Strittmatter, S.M.; Möller, H-J.; Rujescu, D.; St Clair, D.; Muglia, P.; Roos, J.L.; Fisher, S.E.; Wade-Martins, R.; Rouleau, G.A.; Stein, J.F.; Karayiorgou, M.; Geschwind, D.H.; Ragoussis, J.; Kendler, K.S.; Airaksinen, M.S.; Oshimura, M.; DeLisi, L.E.; Monaco, A.P. 2007: LRRTM1 on chromosome 2p12 is a maternally suppressed gene that is associated paternally with handedness and schizophrenia. Molecular Psychiatry 12(12): 1129-39 1057

Kawamura, Y.; Suga, A.; Fujimaki, T.; Yoshitake, K.; Tsunoda, K.; Murakami, A.; Iwata, T. 2018: LRRTM4-C538Y novel gene mutation is associated with hereditary macular degeneration with novel dysfunction of ON-type bipolar cells. Journal of Human Genetics 63(8): 893-900

Roppongi, R.T.; Dhume, S.H.; Padmanabhan, N.; Silwal, P.; Zahra, N.; Karimi, B.; Bomkamp, C.; Patil, C.S.; Champagne-Jorgensen, K.; Twilley, R.E.; Zhang, P.; Jackson, M.F.; Siddiqui, T.J. 2020: LRRTMs Organize Synapses through Differential Engagement of Neurexin and PTPσ. Neuron 106(4): 701

Liu, F.; Yuan, Y.; Bai, L.; Yuan, L.; Li, L.; Liu, J.; Chen, Y.; Lu, Y.; Cheng, J.; Zhang, J. 2021: LRRc17 controls BMSC senescence via mitophagy and inhibits the therapeutic effect of BMSCs on ovariectomy-induced bone loss. Redox Biology 43: 101963

Shapiro, R.; Riordan, J.F.; Vallee, B.L. 1995: LRRning the RIte of springs. Nature Structural Biology 2(5): 350-354

Mishra, R.; Joshi, V.; Upadhyay, A.; Amanullah, A.; Dubey, A.R.; Singh, S.; Dubey, V.K.; Poluri, K.M.; Jana, N.R.; Mishra, A. 2021: LRSAM1 E3 ubiquitin ligase promotes proteasomal clearance of E6-AP protein. Cellular Signalling 77: 109836

Palaima, P.; Berciano, J.é; Peeters, K.; Jordanova, A. 2021: LRSAM1 and the RING domain: Charcot-Marie-Tooth disease and beyond. Orphanet Journal of Rare Diseases 16(1): 74

Peretti, A.; Perie, M.; Vincent, D.; Bouhour, Fçoise.; Dieterich, K.; Mallaret, M.; Duval, F.; Goizet, C.; Juntas-Morales, R.; Magy, L.; Solé, G.; Nollet, S.; Not, A.; Léonard-Louis, S.; Francou, B.; Leguern, E.; Lia, A-Sophie.; Magdelaine, C.; Latour, P.; Stojkovic, T. 2019: LRSAM1 variants and founder effect in French families with ataxic form of Charcot-Marie-Tooth type 2. European Journal of Human Genetics: Ejhg 27(9): 1406-1418

Shi, X.; Jin, Y.; Dou, Q.; Heng, P.-A. 2020: LRTD: long-range temporal dependency based active learning for surgical workflow recognition. International Journal of Computer Assisted Radiology and Surgery 15(9): 1573-1584

Huang, Z-Mei.; Liu, S-Rong.; Peng, H-Yan.; Li, X.; Huang, W-Qi. 2021: LRTM effect and electronic crystal imaging on silicon surface. Scientific Reports 11(1): 8388

Li, H.-K.; Zhou, Y.; Ding, J.; Xiong, L.; Shi, Y.-X.; He, Y.-J.; Yang, D.; Deng, Z.-L.; Nie, M.; Fei Gao, Y. 2020: LRTM1 promotes the differentiation of myoblast cells by negatively regulating the FGFR1 signaling pathway. Experimental Cell Research 396(1): 112237

Hung, J.-H.; Cheng, H.-Y.; Tsai, Y.-C.; Pan, H.-A.; Omar, H.A.; Chiu, C.-C.; Su, Y.-M.; Lin, Y.-M.; Teng, Y.-N. 2021: LRWD1 expression is regulated through DNA methylation in human testicular embryonal carcinoma cells. Basic and Clinical Andrology 31(1): 12

Yoon, J.; Cho, E.H.; Yun, J.W.; Kim, H.-Y.; Jang, J.H.; Kim, H.-J.; Kim, S.-H. 2021: LSAMP Rearrangement in Acute Myeloid Leukemia with a Jumping Translocation Involving 3q13.31. Annals of Laboratory Medicine 41(3): 342-345

Warnes, H. 1966: LSD 25 and related substances. Canadian Nurse 62(10): 46-48

Dolder, P.C.; Schmid, Y.; Müller, F.; Borgwardt, S.; Liechti, M.E. 2016: LSD Acutely Impairs Fear Recognition and Enhances Emotional Empathy and Sociality. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 41(11): 2638-2646

Luppi, A.I.; Carhart-Harris, R.L.; Roseman, L.; Pappas, I.; Menon, D.K.; Stamatakis, E.A. 2021: LSD alters dynamic integration and segregation in the human brain. Neuroimage 227: 117653

Olbrich, S.; Preller, K.H.; Vollenweider, F.X. 2021: LSD and ketanserin and their impact on the human autonomic nervous system. Psychophysiology 58(6): E13822

Von Hungen, K.; Roberts, S.; Hill, D.F. 1974: LSD as an agonist and antagonist at central dopamine receptors. Nature 252(5484): 588-589

Pieri, L.; Pieri, M.; Haefely, W. 1974: LSD as an agonist of dopamine receptors in the striatum. Nature 252(5484): 586-588

Drummond, A.H.; Bucher, F.; Levitan, I.B. 1978: LSD labels a novel dopamine receptor in molluscan nervous system. Nature 272(5651): 368-370

Vuillaume, M.; Berkaloff, A. 1974: LSD treatment of Pieris brassicae and consequences on the progeny. Nature 251(5473): 314-315

Killion, B.; Hai, A.H.; Alsolami, A.; Vaughn, M.G.; Sehun Oh, P.; Salas-Wright, C.P. 2021: LSD use in the United States: Trends, correlates, and a typology of us. Drug and Alcohol Dependence 223: 108715

Wießner, I.; Falchi, M.; Palhano-Fontes, F.; Feilding, A.; Ribeiro, S.; Tófoli, L.ís.F. 2021: LSD, madness and healing: Mystical experiences as possible link between psychosis model and therapy model. Psychological Medicine 2021: 1-15

Smit, E.M.; Borst, P. 1971: LSD-25 does not intercalate in DNA. Nature 232(5307): 191-192

Duerler, P.; Schilbach, L.; Stämpfli, P.; Vollenweider, F.X.; Preller, K.H. 2020: LSD-induced increases in social adaptation to opinions similar to one's own are associated with stimulation of serotonin receptors. Scientific Reports 10(1): 12181

Rodriguiz, R.M.; Nadkarni, V.; Means, C.R.; Pogorelov, V.M.; Chiu, Y-Ting.; Roth, B.L.; Wetsel, W.C. 2021: LSD-stimulated behaviors in mice require β-arrestin 2 but not β-arrestin 1. Scientific Reports 11(1): 17690

Agboyibor, C.; Dong, J.; Effah, C.Y.; Drokow, E.K.; Pervaiz, W.; Liu, H.-M. 2021: LSD1 as a Biomarker and the Outcome of its Inhibitors in the Clinical Trial: the Therapy Opportunity in Tumor. Journal of Oncology 2021: 5512524

Wang, Y.; Wu, Q.; Yang, P.; Wang, C.; Liu, J.; Ding, W.; Liu, W.; Bai, Y.; Yang, Y.; Wang, H.; Gao, S.; Wang, X. 2016: LSD1 co-repressor Rcor2 orchestrates neurogenesis in the developing mouse brain. Nature Communications 7: 10481

Ketscher, A.; Jilg, C.A.; Willmann, D.; Hummel, B.; Imhof, A.; Rüsseler, V.; Hölz, S.; Metzger, E.; Müller, J.M.; Schüle, R. 2014: LSD1 controls metastasis of androgen-independent prostate cancer cells through PXN and LPAR6. Oncogenesis 3: E120

Kohrogi, K.; Hino, S.; Sakamoto, A.; Anan, K.; Takase, R.; Araki, H.; Hino, Y.; Araki, K.; Sato, T.; Nakamura, K.; Nakao, M. 2021: LSD1 defines erythroleukemia metabolism by controlling the lineage-specific transcription factors GATA1 and C/EBPα. Blood Advances 5(9): 2305-2318

Zhao, L.-J.; Fan, Q.-Q.; Li, Y.-Y.; Ren, H.-M.; Zhang, T.; Liu, S.; Maa, M.; Zheng, Y.-C.; Liu, H.-M. 2020: LSD1 deletion represses gastric cancer migration by upregulating a novel miR-142-5p target protein CD9. Pharmacological Research 159: 104991

Lee, J-Y.; Park, J-H.; Choi, H-J.; Won, H-Y.; Joo, H-S.; Shin, D-H.; Park, M.K.; Han, B.; Kim, K.P.; Lee, T.J.; Croce, C.M.; Kong, G. 2017: LSD1 demethylates HIF1α to inhibit hydroxylation and ubiquitin-mediated degradation in tumor angiogenesis. Oncogene 36(39): 5512-5521

Metzger, E.; Wissmann, M.; Yin, N.; Müller, J.M.; Schneider, R.; Peters, A.H.F.M.; Günther, T.; Buettner, R.; Schüle, R. 2005: LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription. Nature 437(7057): 436-439

Barth, J.; Abou-El-Ardat, K.; Dalic, D.; Kurrle, N.; Maier, A-Maria.; Mohr, S.; Schütte, J.; Vassen, L.; Greve, G.; Schulz-Fincke, J.; Schmitt, M.; Tosic, M.; Metzger, E.; Bug, G.; Khandanpour, C.; Wagner, S.A.; Lübbert, M.; Jung, M.; Serve, H.; Schüle, R.; Berg, T. 2019: LSD1 inhibition by tranylcypromine derivatives interferes with GFI1-mediated repression of PU.1 target genes and induces differentiation in AML. Leukemia 33(6): 1411-1426

Nicolaides, T.P.; Hashizume, R. 2020: LSD1 inhibition in pHGG: the key to unleashing immunotherapy?. Neuro-Oncology 22(9): 1237-1238

Leiendecker, L.; Jung, P.S.; Krecioch, I.; Neumann, T.; Schleiffer, A.; Mechtler, K.; Wiesner, T.; Obenauf, A.C. 2020: LSD1 inhibition induces differentiation and cell death in Merkel cell carcinoma. EMBO molecular medicine 12(11): e12525

Longaretti, A.; Forastieri, C.; Toffolo, E.; Caffino, L.; Locarno, A.; Misevičiūtė, I.; Marchesi, E.; Battistin, M.; Ponzoni, L.; Madaschi, L.; Cambria, C.; Bonasoni, M.P.; Sala, M.; Perrone, D.; Fumagalli, F.; Bassani, S.; Antonucci, F.; Tonini, R.; Francolini, M.; Battaglioli, E.; Rusconi, F. 2020: LSD1 is an environmental stress-sensitive negative modulator of the glutamatergic synapse. Neurobiology of Stress 13: 100280

Kim, J.; Singh, A.Kumar.; Takata, Y.; Lin, K.; Shen, J.; Lu, Y.; Kerenyi, M.A.; Orkin, S.H.; Chen, T. 2015: LSD1 is essential for oocyte meiotic progression by regulating CDC25B expression in mice. Nature Communications 6: 10116

Lim, S-Young.; Macheleidt, I.; Dalvi, P.; Schäfer, S.C.; Kerick, M.; Ozretić, L.; Ortiz-Cuaran, S.; George, J.; Merkelbach-Bruse, S.; Wolf, Jürgen.; Timmermann, B.; Thomas, R.K.; Schweiger, M.R.; Buettner, R.; Odenthal, M. 2017: LSD1 modulates the non-canonical integrin β3 signaling pathway in non-small cell lung carcinoma cells. Scientific Reports 7(1): 10292

He, Y.; Zhao, Y.; Wang, L.; Bohrer, L.R.; Pan, Y.; Wang, L.; Huang, H. 2018: LSD1 promotes S-phase entry and tumorigenesis via chromatin co-occupation with E2F1 and selective H3K9 demethylation. Oncogene 37(4): 534-543

Duteil, D.; Metzger, E.; Willmann, D.; Karagianni, P.; Friedrichs, N.; Greschik, H.; Günther, T.; Buettner, R.; Talianidis, I.; Metzger, D.; Schüle, R. 2014: LSD1 promotes oxidative metabolism of white adipose tissue. Nature Communications 5: 4093

Christopher, M.A.; Myrick, D.A.; Barwick, B.G.; Engstrom, A.K.; Porter-Stransky, K.A.; Boss, J.M.; Weinshenker, D.; Levey, A.I.; Katz, D.J. 2017: LSD1 protects against hippocampal and cortical neurodegeneration. Nature Communications 8(1): 805

Adamo, A.; Sesé, B.; Boue, S.; Castaño, J.; Paramonov, I.; Barrero, M.J.; Izpisua Belmonte, J.Carlos. 2011: LSD1 regulates the balance between self-renewal and differentiation in human embryonic stem cells. Nature Cell Biology 13(6): 652-659

Hu, X.; Xiang, D.; Xie, Y.; Tao, L.; Zhang, Y.; Jin, Y.; Pinello, L.; Wan, Y.; Yuan, G-Cheng.; Li, Z. 2019: LSD1 suppresses invasion, migration and metastasis of luminal breast cancer cells via activation of GATA3 and repression of TRIM37 expression. Oncogene 38(44): 7017-7034

Sagarkar, S.; Choudhary, A.G.; Balasubramanian, N.; Awathale, S.N.; Somalwar, A.R.; Pawar, N.; Kokare, D.M.; Subhedar, N.K.; Sakharkar, A.J. 2021: LSD1-BDNF activity in lateral hypothalamus-medial forebrain bundle area is essential for reward seeking behavior. Progress in Neurobiology 202: 102048

Zhang, L.; Carnesecchi, J.; Cerutti, C.; Tribollet, V.; Périan, Séverine.; Forcet, C.; Wong, J.; Vanacker, J-Marc. 2018: LSD1-ERRα complex requires NRF1 to positively regulate transcription and cell invasion. Scientific Reports 8(1): 10041

Hirakawa, T.; Kuwata, K.; Gallego, M.E.; White, C.I.; Nomoto, M.; Tada, Y.; Matsunaga, S. 2019: LSD1-LIKE1-Mediated H3K4me2 Demethylation Is Required for Homologous Recombination Repair1. Plant Physiology 181(2): 499-509

Dan, S.; Song, Y.; Duan, X.; Pan, X.; Chen, C.; She, S.; Su, T.; Li, J.; Chen, X.; Zhou, Y.; Chen, W.; Zhang, X.; Pan, X.; Wang, Y-Jie.; Kang, B. 2021: LSD1-mediated demethylation of OCT4 safeguards pluripotent stem cells by maintaining the transcription of PORE-motif-containing genes. Scientific Reports 11(1): 10285

Amente, S.; Bertoni, A.; Morano, A.; Lania, L.; Avvedimento, E.V.; Majello, B. 2010: LSD1-mediated demethylation of histone H3 lysine 4 triggers Myc-induced transcription. Oncogene 29(25): 3691-3702

Vinckier, N.K.; Patel, N.A.; Geusz, R.J.; Wang, A.; Wang, J.; Matta, I.; Harrington, A.R.; Wortham, M.; Wetton, N.; Wang, J.; Jhala, U.S.; Rosenfeld, M.G.; Benner, C.W.; Shih, H-Ping.; Sander, M. 2020: LSD1-mediated enhancer silencing attenuates retinoic acid signalling during pancreatic endocrine cell development. Nature Communications 11(1): 2082

Tatsumi, G.; Kawahara, M.; Yamamoto, R.; Hishizawa, M.; Kito, K.; Suzuki, T.; Takaori-Kondo, A.; Andoh, A. 2020: LSD1-mediated repression of GFI1 super-enhancer plays an essential role in erythroleukemia. Leukemia 34(3): 746-758

Wang, J.; Telese, F.; Tan, Y.; Li, W.; Jin, C.; He, X.; Basnet, H.; Ma, Q.; Merkurjev, D.; Zhu, X.; Liu, Z.; Zhang, J.; Ohgi, K.; Taylor, H.; White, R.R.; Tazearslan, C.; Suh, Y.; Macfarlan, T.S.; Pfaff, S.L.; Rosenfeld, M.G. 2015: LSD1n is an H4K20 demethylase regulating memory formation via transcriptional elongation control. Nature Neuroscience 18(9): 1256-1264

Eller, J.L. 1971: LSD: what index of suspicion?. New England Journal of Medicine 284(3): 161

Grosse, L.; Bulavin, D.V. 2020: LSEC model of aging. Aging 12(11): 11152-11160

Thomas, H. 2019: LSEC stretch promotes fibrosis during hepatic vascular congestion. Nature Reviews. Gastroenterology and Hepatology 16(5): 262-263

Liu, D.; Lu, Q.; Wang, X.; Wang, J.; Lu, N.; Jiang, Z.; Hao, X.; Li, J.; Liu, J.; Cao, P.; Peng, G.; Tao, Y.; Zhao, D.; He, F.; Tang, L. 2019: LSECtin on tumor-associated macrophages enhances breast cancer stemness via interaction with its receptor BTN3A3. Cell Research 29(5): 365-378

Enaida, H.; Okamoto, K.; Fujii, H.; Ishibashi, T. 2010: LSFG findings of proliferative diabetic retinopathy after intravitreal injection of bevacizumab. Ophthalmic Surgery Lasers and Imaging: the Official Journal of the International Society for Imaging in the Eye 41 Online: E1-E3

Ni, K.; Ren, J.; Xu, X.; He, Y.; Finney, R.; Braun, S.M.G.; Hathaway, N.A.; Crabtree, G.R.; Muegge, K. 2020: LSH mediates gene repression through macroH2A deposition. Nature Communications 11(1): 5647

Flachsenberg, F.; Rarey, M. 2021: LSLOpt: An open-source implementation of the step-length controlled LSL-BFGS algorithm. Journal of Computational Chemistry 42(15): 1095-1100

Tanghetti, E. 2020: LSM Dermatology Edition: Introduction 2020. Lasers in surgery and medicine 52(1): 5-6

Gao, S.; Guo, N.; Mao, D. 2021: LSM-SEC: Tongue Segmentation by the Level Set Model with Symmetry and Edge Constraints. Computational Intelligence and Neuroscience 2021: 6370526

Lee, J.; Park, J.; Kim, J.-H.; Lee, G.; Park, T.-E.; Yoon, K.-J.; Kim, Y.K.; Lim, C. 2020: LSM12-EPAC1 defines a neuroprotective pathway that sustains the nucleocytoplasmic RAN gradient. Plos Biology 18(12): E3001002

Schäringer, K.; Maxeiner, S.; Schalla, C.; Rütten, S.; Zenke, M.; Sechi, A. 2021: LSP1-myosin1e bimolecular complex regulates focal adhesion dynamics and cell migration. FASEB journal: official publication of the Federation of American Societies for Experimental Biology 35(2): e21268

De Sa Nogueira, D.; Bourdy, R.; Filliol, D.; Quessada, C.; McCort-Tranchepain, I.; Acher, F.; Zwiller, J.; Romieu, P.; Befort, K. 2021: LSP2-9166, an orthosteric mGlu4 and mGlu7 receptor agonist, reduces cocaine self-administration under a progressive ratio schedule in rats. Neuroscience Letters 764: 135603

Zhang, M.; Ma, C. 2021: LSR Promotes Cell Proliferation and Invasion in Lung Cancer. Computational and Mathematical Methods in Medicine 2021: 6651907

Takahashi, Y.; Serada, S.; Ohkawara, T.; Fujimoto, M.; Hiramatsu, K.; Ueda, Y.; Kimura, T.; Takemori, H.; Naka, T. 2021: LSR promotes epithelial ovarian cancer cell survival under energy stress through the LKB1-AMPK pathway. Biochemical and Biophysical Research Communications 537: 93-99

Nodera, H.; Matsui, M. 2021: LSTM Neural Network for Inferring Conduction Velocity Distribution in Demyelinating Neuropathies. Frontiers in Neurology 12: 699339

Santosh, T.; Ramesh, D.; Reddy, D. 2020: LSTM based prediction of malaria abundances using big data. Computers in Biology and Medicine 124: 103859

Xiang, S.; Qin, Y.; Zhu, C.; Wang, Y.; Chen, H. 2020: LSTM networks based on attention ordered neurons for gear remaining life prediction. Isa Transactions 106: 343-354

Afebu, K.O.; Liu, Y.; Papatheou, E.; Guo, B. 2021: LSTM-based approach for predicting periodic motions of an impacting system via transient dynamics. Neural Networks: the Official Journal of the International Neural Network Society 140: 49-64

Ko, C.-R.; Chang, H.-T. 2021: LSTM-based sentiment analysis for stock price forecast. PEERJ. Computer Science 7: E408

Huang, G.; Shen, Q.; Zhang, G.; Wang, P.; Yu, Z.-G. 2021: LSTMCNNsucc: a Bidirectional LSTM and CNN-Based Deep Learning Method for Predicting Lysine Succinylation Sites. Biomed Research International 2021: 9923112

Hew, B.; Tan, Q.W.; Goh, W.; Ng, J.W.X.; Mutwil, M. 2020: LSTrAP-Crowd: prediction of novel components of bacterial ribosomes with crowd-sourced analysis of RNA sequencing data. Bmc Biology 18(1): 114

Fleming Walsh, S.; Balster, C.; Chandler, A.; Brown, J.; Boehler, M.; O'Rear, S. 2020: LSVT BIG® and long-term retention of functional gains in individuals with Parkinson's disease. PhysioTherapy Theory and Practice 2020: 1-8

Peterka, M.; Odorfer, T.; Schwab, M.; Volkmann, J.; Zeller, D. 2020: LSVT-BIG therapy in Parkinson's disease: physiological evidence for proprioceptive recalibration. Bmc Neurology 20(1): 276

Yu, Z.; Du, J.; Hui, H.; Kan, S.; Huo, T.; Zhao, K.; Wu, T.; Guo, Q.; Lu, N. 2021: LT-171-861, a novel FLT3 inhibitor, shows excellent preclinical efficacy for the treatment of FLT3 mutant acute myeloid leukemia. Theranostics 11(1): 93-106

Aradottir Pind, A.A.; Molina Estupiñan, J.L.; Magnusdottir, G.J.; Del Giudice, G.; Jonsdottir, I.; Bjarnarson, S.P. 2020: LT-K63 Enhances B Cell Activation and Survival Factors in Neonatal Mice that Translates into Long-Lived Humoral Immunity. Frontiers in Immunology 11: 527310

Azizi, F.; Amouzegar, A.; Mehran, L.; Abdi, H. 2020: LT4 and Slow Release T3 Combination: Optimum Therapy for Hypothyroidism?. International Journal of Endocrinology and Metabolism 18(2): E100870

Al-Khatib, S.M.; Abdo, N.; Al-Eitan, L.N.; Al-Mistarehi, A.-H.W.; Zahran, D.J.; Kewan, T.Z. 2020: LTA, LEP, and TNF-a Gene Polymorphisms are Associated with Susceptibility and Overall Survival of Diffuse Large B-Cell lymphoma in an Arab Population: a Case-Control Study. Asian Pacific Journal of Cancer Prevention: Apjcp 21(9): 2783-2791

Valli, E.; Harriett, A.J.; Nowakowska, M.K.; Baudier, R.L.; Provosty, W.B.; McSween, Z.; Lawson, L.B.; Nakanishi, Y.; Norton, E.B. 2019: LTA1 is a safe, intranasal enterotoxin-based adjuvant that improves vaccine protection against influenza in young, old and B-cell-depleted (μMT) mice. Scientific Reports 9(1): 15128

Surmiak, M.; Gielicz, A.; Stojkov, D.; Szatanek, Rł.; Wawrzycka-Adamczyk, K.; Yousefi, S.; Simon, H-Uwe.; Sanak, M. 2020: LTB 4 and 5-oxo-ETE from extracellular vesicles stimulate neutrophils in granulomatosis with polyangiitis. Journal of Lipid Research 61(1): 1-9

Fauler, J.; Wiemeyer, A.; Marx, K.H.; Kühn, K.; Koch, K.M.; Frölich, J.C. 1989: LTB4 in nephrotoxic serum nephritis in rats. Kidney International 36(1): 46-50

Li, P.; Oh, D.Young.; Bandyopadhyay, G.; Lagakos, W.S.; Talukdar, S.; Osborn, O.; Johnson, A.; Chung, H.; Maris, M.; Ofrecio, J.M.; Taguchi, S.; Lu, M.; Olefsky, J.M. 2015: LTB4 promotes insulin resistance in obese mice by acting on macrophages, hepatocytes and myocytes. Nature Medicine 21(3): 239-247

Fu, X.; Zhang, P.; Song, H.; Wu, C.; Li, S.; Li, S.; Yan, C. 2020: LTBP1 plays a potential bridge between depressive disorder and glioblastoma. Journal of Translational Medicine 18(1): 391

Azmanov, D.N.; Dimitrova, S.; Florez, L.; Cherninkova, S.; Draganov, D.; Morar, B.; Saat, R.; Juan, M.; Arostegui, J.I.; Ganguly, S.; Soodyall, H.; Chakrabarti, S.; Padh, H.; López-Nevot, M.A.; Chernodrinska, V.; Anguelov, B.; Majumder, P.; Angelova, L.; Kaneva, R.; Mackey, D.A.; Tournev, I.; Kalaydjieva, L. 2011: LTBP2 and CYP1B1 mutations and associated ocular phenotypes in the Roma/Gypsy founder population. European Journal of Human Genetics: Ejhg 19(3): 326-333

Désir, J.; Sznajer, Y.; Depasse, F.; Roulez, Fçoise.; Schrooyen, M.; Meire, Fçoise.; Abramowicz, M. 2010: LTBP2 null mutations in an autosomal recessive ocular syndrome with megalocornea, spherophakia, and secondary glaucoma. European Journal of Human Genetics: Ejhg 18(7): 761-767

Su, C-Ting.; Jao, T-Ming.; Urban, Z.; Huang, Y-Jhu.; See, D.H.W.; Tsai, Y-Chou.; Lin, W-Chou.; Huang, J-Wen. 2021: LTBP4 affects renal fibrosis by influencing angiogenesis and altering mitochondrial structure. Cell Death and Disease 12(10): 943

Ouyang, M.; Li, X.; Ma, J.; Chi, W.; Xiao, J.; Zou, M.; Chen, F.; Lu, C.; Zhang, L. 2011: LTD is a protein required for sorting light-harvesting chlorophyll-binding proteins to the chloroplast SRP pathway. Nature Communications 2: 277

Ashby, D.M.; Floresco, S.B.; Phillips, A.G.; McGirr, A.; Seamans, J.K.; Wang, Y.Tian. 2021: LTD is involved in the formation and maintenance of rat hippocampal CA1 place-cell fields. Nature Communications 12(1): 100

Piochon, C.; Kano, M.; Hansel, C. 2016: LTD-like molecular pathways in developmental synaptic pruning. Nature Neuroscience 19(10): 1299-1310

Centonze, F.G.; Reiterer, V.; Nalbach, K.; Saito, K.; Pawlowski, K.; Behrends, C.; Farhan, H. 2019: LTK is an ER-resident receptor tyrosine kinase that regulates secretion. Journal of Cell Biology 218(8): 2470-2480

Aruanno, A.; Urbani, S.; Frati, F.; Nucera, E. 2020: LTP allergy/sensitization in a pediatric population. Allergologia et Immunopathologia 48(6): 763-770

Frick, A.; Magee, J.; Johnston, D. 2004: LTP is accompanied by an enhanced local excitability of pyramidal neuron dendrites. Nature Neuroscience 7(2): 126-135

Grosshans, D.R.; Clayton, D.A.; Coultrap, S.J.; Browning, M.D. 2002: LTP leads to rapid surface expression of NMDA but not AMPA receptors in adult rat CA1. Nature Neuroscience 5(1): 27-33

Vickers, E.; Osypenko, D.; Clark, C.; Okur, Z.; Scheiffele, P.; Schneggenburger, R. 2020: LTP of inhibition at PV interneuron output synapses requires developmental BMP signaling. Scientific Reports 10(1): 10047

Toni, N.; Buchs, P.A.; Nikonenko, I.; Bron, C.R.; Muller, D. 1999: LTP promotes formation of multiple spine synapses between a single axon terminal and a dendrite. Nature 402(6760): 421-425

Granger, A.J.; Shi, Y.; Lu, W.; Cerpas, M.; Nicoll, R.A. 2013: LTP requires a reserve pool of glutamate receptors independent of subunit type. Nature 493(7433): 495-500

Huang, H-Li.; Chao, M-Wu.; Chen, C-Chun.; Cheng, C-Chun.; Chen, M-Chuan.; Lin, C-Feng.; Liou, J-Ping.; Teng, C-Ming.; Pan, S-Lin. 2016: LTP-1, a novel antimitotic agent and Stat3 inhibitor, inhibits human pancreatic carcinomas in vitro and in vivo. Scientific Reports 6: 27794

Di Lorenzo, F.; Motta, C.; Casula, E.P.; Bonnì, S.; Assogna, M.; Caltagirone, C.; Martorana, A.; Koch, G. 2020: LTP-like cortical plasticity predicts conversion to dementia in patients with memory impairment. Brain Stimulation 13(5): 1175-1182

Buss, S.S.; Press, D.Z.; McDonald, K.; Kitchener, E.; O'Connor, M.; Donohoe, K.; Shafi, M.M.; Pascual-Leone, A.; Fried, P.J. 2020: LTP-like plasticity is impaired in amyloid-positive amnestic MCi but independent of PET-amyloid burden. Neurobiology of Aging 96: 109-116

Kauer, J.A.; Malenka, R.C. 2006: LTP: AMPA receptors trading places. Nature Neuroscience 9(5): 593-594

Lisman, J.; Lichtman, J.W.; Sanes, J.R. 2003: LTP: perils and progress. Nature Reviews. Neuroscience 4(11): 926-929

Brind'Amour, J.; Kobayashi, H.; Richard Albert, J.; Shirane, K.; Sakashita, A.; Kamio, A.; Bogutz, A.; Koike, T.; Karimi, M.M.; Lefebvre, L.; Kono, T.; Lorincz, M.C. 2018: LTR retrotransposons transcribed in oocytes drive species-specific and heritable changes in DNA methylation. Nature Communications 9(1): 3331

Vangelisti, A.; Simoni, S.; Usai, G.; Ventimiglia, M.; Natali, L.; Cavallini, A.; Mascagni, F.; Giordani, T. 2021: LTR-retrotransposon dynamics in common fig (Ficus carica L.) genome. Bmc Plant Biology 21(1): 221

Nadler, M.J.; Hermosura, M.C.; Inabe, K.; Perraud, A.L.; Zhu, Q.; Stokes, A.J.; Kurosaki, T.; Kinet, J.P.; Penner, R.; Scharenberg, A.M.; Fleig, A. 2001: LTRPC7 is a Mg.ATP-regulated divalent cation channel required for cell viability. Nature 411(6837): 590-595

Yamaguchi, A.; Maya, S.; Maruchi, K.; Ueno, K. 2020: LTSpAUC: Learning Time-Series Shapelets for Partial AUC Maximization. Big Data 8(5): 391-411

Yamazaki, T.; Wennerberg, E.; Hensler, M.; Buqué, A.; Kraynak, J.; Fucikova, J.; Zhou, X.Kathy.; Sveinbjørnsson, B.; Rekdal, Øystein.; Demaria, S.; Galluzzi, L. 2021: LTX-315-enabled, radiotherapy-boosted immunotherapeutic control of breast cancer by NK cells. Oncoimmunology 10(1): 1962592

Shi, Y.; Wu, W.; Chai, Q.; Li, Q.; Hou, Y.; Xia, H.; Ren, B.; Xu, H.; Guo, X.; Jin, C.; Lv, M.; Wang, Z.; Fu, Y-Xin.; Zhu, M. 2016: LTβR controls thymic portal endothelial cells for haematopoietic progenitor cell homing and T-cell regeneration. Nature Communications 7: 12369

Potschka, H.; Löscher, W.; Wlaź, P.; Behl, B.; Hofmann, H.P.; Treiber, H.J.; Szabo, L. 1998: LU 73068, a new non-NMDA and glycine/NMDA receptor antagonist: pharmacological characterization and comparison with NBQX and L-701,324 in the kindling model of epilepsy. British Journal of Pharmacology 125(6): 1258-1266

Leclerc, S.; Smistad, E.; Ostvik, A.; Cervenansky, F.; Espinosa, F.; Espeland, T.; Rye Berg, E.A.; Belhamissi, M.; Israilov, S.; Grenier, T.; Lartizien, C.; Jodoin, P.-M.; Lovstakken, L.; Bernard, O. 2020: LU-Net: a Multistage Attention Network to Improve the Robustness of Segmentation of Left Ventricular Structures in 2-D Echocardiography. IEEE Transactions on Ultrasonics Ferroelectrics and Frequency Control 67(12): 2519-2530

Chu, Y.; Kang, Y.; Yan, C.; Yang, C.; Zhang, T.; Huo, H.; Liu, Y. 2020: LUBAC and OTULIN regulate autophagy initiation and maturation by mediating the linear ubiquitination and the stabilization of ATG13. Autophagy 2020: 1-16

Wu, M.; Chang, Y.; Hu, H.; Mu, R.; Zhang, Y.; Qin, X.; Duan, X.; Li, W.; Tu, H.; Zhang, W.; Wang, G.; Han, Q.; Li, A.; Zhou, T.; Iwai, K.; Zhang, X.; Li, H. 2019: LUBAC controls chromosome alignment by targeting CENP-E to attached kinetochores. Nature Communications 10(1): 273

Niu, J.; Shi, Y.; Iwai, K.; Wu, Z-Hui. 2011: LUBAC regulates NF-κB activation upon genotoxic stress by promoting linear ubiquitination of NEMO. EMBO Journal 30(18): 3741-3753

Stieglitz, B.; Morris-Davies, A.C.; Koliopoulos, M.G.; Christodoulou, E.; Rittinger, K. 2012: LUBAC synthesizes linear ubiquitin chains via a thioester intermediate. Embo Reports 13(9): 840-846

Iwai, K. 2021: LUBAC-mediated linear ubiquitination: a crucial regulator of immune signaling. Proceedings of the Japan Academy. Series B Physical and Biological Sciences 97(3): 120-133

Noad, J.; von der Malsburg, A.; Pathe, C.; Michel, M.A.; Komander, D.; Randow, F. 2017: LUBAC-synthesized linear ubiquitin chains restrict cytosol-invading bacteria by activating autophagy and NF-κB. Nature Microbiology 2: 17063

Li, Y.; Ito, M.; Sun, S.; Chida, T.; Nakashima, K.; Suzuki, T. 2016: LUC7L3/CROP inhibits replication of hepatitis B virus via suppressing enhancer II/basal core promoter activity. Scientific Reports 6: 36741

Mikhailovsky, G.E.; Gordon, R. 2021: LUCA to LECA, the Lucacene: a model for the gigayear delay from the first prokaryote to eukaryogenesis. Bio Systems 205: 104415

Sutherland, L.C.; Lerman, M.; Williams, G.T.; Miller, B.A. 2001: LUCA-15 suppresses CD95-mediated apoptosis in Jurkat T cells. Oncogene 20(21): 2713-2719

Sutherland, L.C.; Edwards, S.E.; Cable, H.C.; Poirier, G.G.; Miller, B.A.; Cooper, C.S.; Williams, G.T. 2000: LUCA-15-encoded sequence variants regulate CD95-mediated apoptosis. Oncogene 19(33): 3774-3781

Byun, H.J.; Yoon, J.H.; Lee, S.K. 2020: LUCAT1 Epigenetically Downregulates the Tumor Suppressor Genes CXXC4 and SFRP2 in Gastric Cancer. Yonsei Medical Journal 61(11): 923-934

Bentancor, M.; Fernández, S.án.; Viera, F.; Etcheverry, S.; Poradosú, C.; D'Angelo, P.; Montemuiño, H.án.; Mirazo, S.; Irigoyen, Ál.; Sanabria, A.ía.; Failache, H. 2021: LUCIA: An open source device for disinfection of N95 masks using UV-C radiation. Hardwarex 9: E00181

Derick, S.; Gironde, C.; Perio, P.; Reybier, K.; Nepveu, Fçoise.; Jauneau, A.; Furger, C. 2017: LUCS (Light-Up Cell System), a universal high throughput assay for homeostasis evaluation in live cells. Scientific Reports 7(1): 18069

Chen, X.; Li, X.; Hu, X.; Jiang, F.; Shen, Y.; Xu, R.; Wu, L.; Wei, P.; Shen, X. 2020: LUM Expression and its Prognostic Significance in Gastric Cancer. Frontiers in Oncology 10: 605

Nishi, S. 1964: Lumbago and Orthopedic Surgery. Obstetrical and Gynecological Therapy 9: 437-445

Silva, C.I.F.; Ecco, R.; Pimentel, S.P.; Pereira, R.D.O.; Carvalho, P.H.; Marliere, M.P.; Torres, R.C.S.; Nepomuceno, A.C. 2021: Lumbar Myelopathy Caused by Multiple Cartilaginous Exostoses in a Dog. Topics in Companion Animal Medicine 2021: 100529

Dittrich, R.J. 1964: Lumbodorsal Fascia and Related Structures as Factors in Disability. Applied Therapeutics 6: 923-927

López Morales, P.; Ruiz Marín, M.; Albarracín Marín-Blázquez, A. 2021: Lumen-apposing metal stent deployment failure. Revista Espanola de Enfermedades Digestivas: Organo Oficial de la Sociedad Espanola de Patologia Digestiva 113(3): 224-225

Belasso, C.J.; Behboodi, B.; Benali, H.; Boily, M.; Rivaz, H.; Fortin, M. 2020: LUMINOUS database: lumbar multifidus muscle segmentation from ultrasound images. Bmc Musculoskeletal Disorders 21(1): 703

Sun, J.; Movahed, N.; Zheng, H. 2020: Lunapark is an E3 Ligase that Mediates Degradation of Root Hair Defective3 to Maintain a Tubular Er Network in Arabidopsis. Plant Cell 32(9): 2964-2978

Sun, J.; Movahed, N.; Zheng, H. 2020: Lunapark is an E3 Ligase that Mediates Degradation of Root Hair Defective3 to Maintain a Tubular Er Network in Arabidopsis. Plant Cell 32(9): 2964-2978

Canup, R.M.; Visscher, C.; Salmon, J.; Fegley, B. 2015: Lunar Volatile Depletion Due to Incomplete Accretion Within An Impact-Generated Disk. Nature Geoscience 8: 918-921

Bailey, A.J. 1965: Lung Cancer and Smoking. Canadian Nurse 61: 285-286

Tomasek, L. 2020: Lung Cancer Lifetime Risks in Cohort Studies of Uranium Miners. Radiation Protection Dosimetry 191(2): 171-175

Shvaiko, L.I.; Bazyka, K.D.; Sushko, V.O.; Ilienko, I.M.; Bazyka, D.A. 2019: Lung Function and Telomere Relative Length in Clean-Up Workers of Chornobyl Npp Accident in a Remote Post-Accident Period. Problemy Radiatsiinoi Medytsyny Ta Radiobiolohii 24: 503-515

Bełz, A.; Rosiek, V.; Głogowska-Szeląg, J.; Stęplewska, K.; Kos-Kudła, B. 2020: Lung Nodule 25 Years after Lobectomy - Recurrence of Bronchial Carcinoid. Wiadomosci Lekarskie 73(10): 2309-2312

Pronyuk, K.O.; Kondratiuk, L.O.; Vysotskyi, A.D.; Golubovska, O.A.; Nikitina, I.M. 2021: Lung Ultrasound during Covid-19 Pandemics: Why, how and When?. Wiadomosci Lekarskie 74(8): 1783-1788

Beickert, A. 1965: Lupoid Nephritis. Description of Autoimmune Form of Primary Chronic Glomerulonephritis. Deutsche Medizinische Wochenschrift 90: 1381-1389

Siguier, F.; Godeau, P.; Levy, R.; Binet, J.L.; Rueff, B. 1964: Lupus Erythematosus and Pregnancy. Bulletins et Memoires de la Societe Medicale des Hopitaux de Paris 115: 119-126

Napiorkowska, W. 1964: Lupus Erythematosus and Pregnancy. Polski Tygodnik Lekarski 19: 390-392

Soldati, G.; Smargiassi, A.; Perrone, T.; Torri, E.; Mento, F.; Demi, L.; Inchingolo, R. 2022: LUS for COVID-19 Pneumonia: Flexible or Reproducible Approach?. Journal of Ultrasound in Medicine: Official Journal of the American Institute of Ultrasound in Medicine 41(2): 525-526

Patel, M.S.; Raza, I.M.; Hassan, S.Z. 2021: LUSPATERCEPT - a better strategy for thalassemia?. JPMA. Journal of the Pakistan Medical Association 71(8): 2107

Burakovskii, V.I.; Muravev, M.V.; Romashov, F.N. 1964: Lutembacher's Syndrome. Vestnik Khirurgii Imeni I. I. Grekova 93: 37-40

Zhang, C.; Gao, M.; Seitz, N.C.; Angel, W.; Hallworth, A.; Wiratan, L.; Darwish, O.; Alkharouf, N.; Dawit, T.; Lin, D.; Egoshi, R.; Wang, X.; McClung, C.Robertson.; Lu, H. 2019: LUX ARRHYTHMO mediates crosstalk between the circadian clock and defense in Arabidopsis. Nature Communications 10(1): 2543

Desai, M.Y.; Mentias, A.; Alashi, A.; Flamm, S.D.; Thamilarasan, M.; Lever, H.M.; Popovic, Z.B. 2020: LV Global Function Index Provides Incremental Prognostic Value over LGE and LV GLS in HCM. JACC. Cardiovascular Imaging 13(9): 2052-2054

Choudhary, P.; Strugnell, W.; Puranik, R.; Hamilton-Craig, C.; Kutty, S.; Celermajer, D.S. 2021: LV non-compaction in patients with coarctation of the aorta: prevalence and effects on cardiac function. Cardiology in the Young 31(9): 1445-1450

Kella, D.K.; Kantipudi, C.; Stambler, B.S. 2020: LV only pacing-mediated electrical storm with cardiac resynchronization therapy managed by simultaneous biventricular pacing. Journal of Cardiovascular Electrophysiology 31(9): 2539-2543

Lu, T.; Chen, T.; Gao, F.; Sun, B.; Ntziachristos, V.; Li, J. 2021: LV-GAN: a deep learning approach for limited-view optoacoustic imaging based on hybrid datasets. Journal of Biophotonics 14(2): E202000325

Castaldi, B.; Di Salvo, G. 2021: LV-GLS in congenital heart disease, time to go beyond ejection fraction. Echocardiography 38(3): 384-385

Loyaga-Rendon, R.Y.; Acharya, D.; Kirklin, J.K. 2020: LVAD Implantation or Heart Transplantation for ECMO-Supported Patients. Journal of the American College of Cardiology 76(21): 2575-2576

Garcia, R.Angel.; Gaznabi, S.; Musoke, L.; Osnard, M.; Balakumaran, K.; Armitage, K.B.; Al-Kindi, S.G.; Ginwalla, M.; Abu-Omar, Y.; Elamm, C.A. 2021: LVAD Vasculitis Case Series: Suggestion of a New Fatal LVAD-Related Phenomenon. JACC. Case Reports 3(7): 1013-1017

Iglesias-Álvarez, D.; Pathania, V. 2021: LVAD as a bridge to decision complicated with pump thrombosis and infection. Indian Journal of Thoracic and Cardiovascular Surgery 37(3): 341-344

Huynh, K. 2020: LVAD versus balloon pump in patients with AMI. Nature Reviews. Cardiology 17(5): 266

Hannon, M.V.; Schwartz, R.G. 2021: LVEF reserve: State of the heart is a matter of time, jeopardy and ischemic memory. Journal of Nuclear Cardiology: Official Publication of the American Society of Nuclear Cardiology 2021

Kang, J.; Tian, X.; Wu, Q.; Chen, E.; Feng, W.; Huang, Y.; Yang, F.; Tong, J.; Liu, Z. 2020: LVIS stent-assisted coil embolization in the acute stage of ruptured intracranial aneurysms. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue 32(7): 828-834

Choi, H.H.; Cho, Y.D.; Yoo, D.H.; Kang, H.-S.; Han, M.H. 2022: LVIS-within-enterprise double-stent procedure without coiling beneficial as treatment of unruptured vertebral artery dissecting aneurysms. Interventional Neuroradiology: Journal of Peritherapeutic Neuroradiology Surgical Procedures and Related Neurosciences 28(2): 136-141

Leslie, N.W. 1996: LVIs and BSE control measures. Veterinary Record 138(20): 503

Stevenson, R.M. 1996: LVIs and BSE control measures. Veterinary Record 138(20): 503

Choudhari, N.S.; Chandran, P.; Rao, H.L.; Jonnadula, G.B.; Addepalli, U.K.; Senthil, S.; Garudadri, C.Sekhar. 2020: LVPEI Glaucoma Epidemiology and Molecular Genetic Study: teleophthalmology screening for angle-closure disease in an underserved region. Eye 34(8): 1399-1405

Hung, H.-Y.; Chow, L.-H.; Kotlinska, J.H.; Drabik, A.; Silberring, J.; Chen, Y.-H.; Huang, E.Y.-K. 2021: LVV-hemorphin-7 (LVV-H7) plays a role in antinociception in a rat model of alcohol-induced pain disorders. Peptides 136: 170455

Liu, X.; Hu, P.; Li, H.; Yu, X-Xuan.; Wang, X-Yuan.; Qing, Y-Jie.; Wang, Z-Yu.; Wang, H-Zheng.; Zhu, M-Yuan.; Guo, Q-Long.; Hui, H. 2020: LW-213, a newly synthesized flavonoid, induces G2/M phase arrest and apoptosis in chronic myeloid leukemia. Acta Pharmacologica Sinica 41(2): 249-259

Wu, J-Fen.; Tsai, H-Lung.; Joanito, I.; Wu, Y-Chen.; Chang, C-Wen.; Li, Y-Hang.; Wang, Y.; Hong, J.Chan.; Chu, J-Wei.; Hsu, C-Ping.; Wu, S-Hsing. 2016: LWD-TCP complex activates the morning gene CCA1 in Arabidopsis. Nature Communications 7: 13181

Guo, X-Dan.; Sun, G-Long.; Zhou, T-Ting.; Wang, Y-Yang.; Xu, X.; Shi, X-Fan.; Zhu, Z-Yuan.; Rukachaisirikul, V.; Hu, L-Hong.; Shen, X. 2017: LX2343 alleviates cognitive impairments in AD model rats by inhibiting oxidative stress-induced neuronal apoptosis and tauopathy. Acta Pharmacologica Sinica 38(8): 1104-1119

Zambrowicz, B.; Freiman, J.; Brown, P.M.; Frazier, K.S.; Turnage, A.; Bronner, J.; Ruff, D.; Shadoan, M.; Banks, P.; Mseeh, F.; Rawlins, D.B.; Goodwin, N.C.; Mabon, R.; Harrison, B.A.; Wilson, A.; Sands, A.; Powell, D.R. 2012: LX4211, a dual SGLT1/SGLT2 inhibitor, improved glycemic control in patients with type 2 diabetes in a randomized, placebo-controlled trial. Clinical Pharmacology and Therapeutics 92(2): 158-169

Kim, H.; Park, S-Hyo.; Han, S.Yee.; Lee, Y-Sil.; Cho, J.; Kim, J-Mo. 2020: LXA 4 -FPR2 signaling regulates radiation-induced pulmonary fibrosis via crosstalk with TGF-β/Smad signaling. Cell Death and Disease 11(8): 653

Xie, T.; Cai, J.; Yao, Y.; Sun, C.; Yang, Q.; Wu, M.; Xu, Z.; Sun, X.; Wang, X. 2021: LXA4 protects against blue-light induced retinal degeneration in human A2E-laden RPE cells and Balb-c mice. Annals of Translational Medicine 9(15): 1249

Zhu, J.-J.; Yu, B.-Y.; Fu, C.-C.; He, M.-Z.; Zhu, J.-H.; Chen, B.-W.; Zheng, Y.-H.; Chen, S.-Q.; Fu, X.-Q.; Li, P.-J.; Lin, Z.-L. 2020: LXA4 protects against hypoxic-ischemic damage in neonatal rats by reducing the inflammatory response via the IκB/NF-κB pathway. International Immunopharmacology 89(Part B): 107095

Monaco, K.-A.; Delach, S.; Yuan, J.; Mishina, Y.; Fordjour, P.; Labrot, E.; McKay, D.; Guo, R.; Higgins, S.; Wang, H.Q.; Liang, J.; Bui, K.; Green, J.; Aspesi, P.; Ambrose, J.; Mapa, F.; Griner, L.; Jaskelioff, M.; Fuller, J.; Crawford, K.; Pardee, G.; Widger, S.; Hammerman, P.S.; Engelman, J.A.; Stuart, D.D.; Cooke, V.G.; Caponigro, G. 2021: LXH254, a Potent and Selective ARAF-Sparing Inhibitor of BRAF and CRAF for the Treatment of MAPK-Driven Tumors. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 27(7): 2061-2073

The Authors 2020: LXIi Congreso Nacional de la SEHH, XXXVi Congreso Nacional de la SETH Virtual, 26-30 de octubre, 2020. Haematologica 105(S3): 1-426

Lin, Z.; Xia, S.; Liang, Y.; Ji, L.; Pan, Y.; Jiang, S.; Wan, Z.; Tao, L.; Chen, J.; Lin, C.; Liang, X.; Xu, J.; Cai, X. 2020: LXR activation potentiates sorafenib sensitivity in HCC by activating microRNA-378a transcription. Theranostics 10(19): 8834-8850

Liang, H.; Shen, X. 2020: LXR activation radiosensitizes non-small cell lung cancer by restricting myeloid-derived suppressor cells. Biochemical and Biophysical Research Communications 528(2): 330-335

Brower, V. 1999: LXR needs an elixir to survive. Nature Biotechnology 17(6): 524-525

Ikonomopoulou, M.P.; Lopez-Mancheño, Y.; Novelle, M.G.; Martinez-Uña, M.; Gangoda, L.; Pal, M.; Costa-Machado, L.F.; Fernandez-Marcos, P.J.; Ramm, G.A.; Fernandez-Rojo, M.A. 2021: LXR stimulates a metabolic switch and reveals cholesterol homeostasis as a statin target in Tasmanian devil facial tumor disease. Cell Reports 34(11): 108851

Carpenter, K.J.; Valfort, A-Cecile.; Steinauer, N.; Chatterjee, A.; Abuirqeba, S.; Majidi, S.; Sengupta, M.; Di Paolo, R.J.; Shornick, L.P.; Zhang, J.; Flaveny, C.A. 2019: LXR-inverse agonism stimulates immune-mediated tumor destruction by enhancing CD8 T-cell activity in triple negative breast cancer. Scientific Reports 9(1): 19530

Hong, I.; Lee, M-Ho.; Na, T-Young.; Zouboulis, C.C.; Lee, M-Ock. 2008: LXRalpha enhances lipid synthesis in SZ95 sebocytes. Journal of Investigative Dermatology 128(5): 1266-1272

Zhang, T.; Duan, J.; Zhang, L.; Li, Z.; Steer, C.J.; Yan, G.; Song, G. 2019: LXRα Promotes Hepatosteatosis in Part Through Activation of MicroRNA-378 Transcription and Inhibition of Ppargc1β Expression. Hepatology 69(4): 1488-1503

Morén, A.; Bellomo, C.; Tsubakihara, Y.; Kardassis, D.; Mikulits, W.; Heldin, C-Henrik.; Moustakas, A. 2019: LXRα limits TGFβ-dependent hepatocellular carcinoma associated fibroblast differentiation. Oncogenesis 8(6): 36

Wang, K.; Xu, T.; Ruan, H.; Xiao, H.; Liu, J.; Song, Z.; Cao, Q.; Bao, L.; Liu, D.; Wang, C.; Cheng, G.; Liang, H.; Chen, Z.; Yang, H.; Chen, K.; Zhang, X. 2019: LXRα promotes cell metastasis by regulating the NLRP3 inflammasome in renal cell carcinoma. Cell Death and Disease 10(3): 159

Hu, C.; Liu, D.; Zhang, Y.; Lou, G.; Huang, G.; Chen, B.; Shen, X.; Gao, M.; Gong, W.; Zhou, P.; Dai, S.; Zeng, Y.; He, F. 2014: LXRα-mediated downregulation of FOXM1 suppresses the proliferation of hepatocellular carcinoma cells. Oncogene 33(22): 2888-2897

Patel, D.; Ahmad, F.; Kambach, D.M.; Sun, Q.; Halim, A.S.; Kramp, T.; Camphausen, K.A.; Stommel, J.M. 2019: LXRβ controls glioblastoma cell growth, lipid balance, and immune modulation independently of ABCA1. Scientific Reports 9(1): 15458

Wan, Y.-W.; Liu, W.; Feng, M.-T.; Pu, J.; Zhuang, S.-W.; He, B.; Liu, X. 2021: LXRβ is involved in the control of platelet production from megakaryocytes. Blood Cells Molecules and Diseases 89: 102568

Westendorf, K.; Žentelis, S.; Wang, L.; Foster, D.; Vaillancourt, P.; Wiggin, M.; Lovett, E.; van der Lee, R.; Hendle, J.ör.; Pustilnik, A.; Sauder, J.M.; Kraft, L.; Hwang, Y.; Siegel, R.W.; Chen, J.; Heinz, B.A.; Higgs, R.E.; Kallewaard, N.L.; Jepson, K.; Goya, R.; Smith, M.A.; Collins, D.W.; Pellacani, D.; Xiang, P.; de Puyraimond, V.; Ricicova, M.; Devorkin, L.; Pritchard, C.; O'Neill, A.; Dalal, K.; Panwar, P.; Dhupar, H.; Garces, F.A.; Cohen, C.A.; Dye, J.M.; Huie, K.E.; Badger, C.V.; Kobasa, D.; Audet, J.; Freitas, J.J.; Hassanali, S.; Hughes, I.; Munoz, L.; Palma, H.C.; Ramamurthy, B.; Cross, R.W.; Geisbert, T.W.; Menacherry, V.; Lokugamage, K.; Borisevich, V.; Lanz, I.; Anderson, L.; Sipahimalani, P.; Corbett, K.S.; Yang, E.S 2022: LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants. Biorxiv: the Preprint Server for Biology 2022

Jones, B.E.; Brown-Augsburger, P.L.; Corbett, K.S.; Westendorf, K.; Davies, J.; Cujec, T.P.; Wiethoff, C.M.; Blackbourne, J.L.; Heinz, B.A.; Foster, D.; Higgs, R.E.; Balasubramaniam, D.; Wang, L.; Bidshahri, R.; Kraft, L.; Hwang, Y.; Žentelis, S.; Jepson, K.R.; Goya, R.; Smith, M.A.; Collins, D.W.; Hinshaw, S.J.; Tycho, S.A.; Pellacani, D.; Xiang, P.; Muthuraman, K.; Sobhanifar, S.; Piper, M.H.; Triana, F.J.; Hendle, J.; Pustilnik, A.; Adams, A.C.; Berens, S.J.; Baric, R.S.; Martinez, D.R.; Cross, R.W.; Geisbert, T.W.; Borisevich, V.; Abiona, O.; Belli, H.M.; de Vries, M.; Mohamed, A.; Dittmann, M.; Samanovic, M.; Mulligan, M.J.; Goldsmith, J.A.; Hsieh, C.-L.; Johnson, N.V.; Wrapp, D.; McLellan, J.S.; Barnhart, B.C.; Graham, B.S.; Mascola, 2020: LY-CoV555, a rapidly isolated potent neutralizing antibody, provides protection in a non-human primate model of SARS-CoV-2 infection. Biorxiv: the Preprint Server for Biology 2020

Deba, F.; Ali, H.I.; Tairu, A.; Ramos, K.; Ali, J.; Hamouda, A.K. 2018: LY2087101 and dFBr share transmembrane binding sites in the (α4)3(β2)2 Nicotinic Acetylcholine Receptor. Scientific Reports 8(1): 1249

Wong, D.T.; Bymaster, F.P.; Mayle, D.A.; Reid, L.R.; Krushinski, J.H.; Robertson, D.W. 1993: LY248686, a new inhibitor of serotonin and norepinephrine uptake. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 8(1): 23-33

Breslin, E.M.; White, P.C.; Shore, A.M.; Clement, M.; Brennan, P. 2005: LY294002 and rapamycin co-operate to inhibit T-cell proliferation. British Journal of Pharmacology 144(6): 791-800

Yang, S-Min.; Park, Y-Kyoung.; Kim, J.In.; Lee, Y-Han.; Lee, T-Yun.; Jang, B-Churl. 2018: LY3009120, a pan-Raf kinase inhibitor, inhibits adipogenesis of 3T3-L1 cells by controlling the expression and phosphorylation of C/EBP-α, PPAR-γ, STAT‑3, FAS, ACC, perilipin A, and AMPK. International Journal of Molecular Medicine 42(6): 3477-3484

Chen, X.; Chen, W.; Aung, Z.M.; Han, W.; Zhang, Y.; Chai, G. 2021: LY3023414 inhibits both osteogenesis and osteoclastogenesis through the PI3K/Akt/GSK3 signalling pathway. Bone and Joint Research 10(4): 237-249

Poh, T.W.; Huang, S.; Hirpara, J.L.; Pervaiz, S. 2007: LY303511 amplifies TRAIL-induced apoptosis in tumor cells by enhancing DR5 oligomerization, DISC assembly, and mitochondrial permeabilization. Cell Death and Differentiation 14(10): 1813-1825

Ma, Y.; Xu, R.; Liu, X.; Zhang, Y.; Song, L.; Cai, S.; Zhou, S.; Xie, Y.; Li, A.; Cao, W.; Tang, X. 2021: LY3214996 relieves acquired resistance to sorafenib in hepatocellular carcinoma cells. International Journal of Medical Sciences 18(6): 1456-1464

Wang, Z-Bin.; Zhang, S.; Li, Y.; Wang, R-Mei.; Tong, L-Chang.; Wang, Y.; Liu, W-Ye.; Su, D-Feng.; Tu, Y.; Zhang, L-Chao.; Li, L. 2017: LY333531, a PKCβ inhibitor, attenuates glomerular endothelial cell apoptosis in the early stage of mouse diabetic nephropathy via down-regulating swiprosin-1. Acta Pharmacologica Sinica 38(7): 1009-1023

Gravekamp, C. 2021: LY6 gene family presents a novel class of potential biomarkers associated with overall survival outcome of pancreatic ductal adenocarcinoma. Oncotarget 12(12): 1122-1123

Nagano, T.; Iwasaki, T.; Onishi, K.; Awai, Y.; Terachi, A.; Kuwaba, S.; Asano, S.; Katasho, R.; Nagai, K.; Nakashima, A.; Kikkawa, U.; Kamada, S. 2020: LY6D-induced macropinocytosis as a survival mechanism of senescent cells. Journal of Biological Chemistry 296: 100049

Pfaender, S.; Mar, K.B.; Michailidis, E.; Kratzel, A.; Hirt, D.; V'kovski, P.; Fan, W.; Ebert, N.; Stalder, H.; Kleine-Weber, H.; Hoffmann, M.; Hoffmann, H.H.; Saeed, M.; Dijkman, R.; Steinmann, E.; Wight-Carter, M.; Hanners, N.W.; Pöhlmann, S.; Gallagher, T.; Todt, D.; Zimmer, G.; Rice, C.M.; Schoggins, J.W.; Thiel, V. 2020: LY6E impairs coronavirus fusion and confers immune control of viral disease. Biorxiv: the Preprint Server for Biology 2020

Pfaender, S.; Mar, K.B.; Michailidis, E.; Kratzel, A.; Boys, I.N.; V'kovski, P.; Fan, W.; Kelly, J.N.; Hirt, D.; Ebert, N.; Stalder, H.; Kleine-Weber, H.; Hoffmann, M.; Hoffmann, H-Heinrich.; Saeed, M.; Dijkman, R.; Steinmann, E.; Wight-Carter, M.; McDougal, M.B.; Hanners, N.W.; Pöhlmann, S.; Gallagher, T.; Todt, D.; Zimmer, G.; Rice, C.M.; Schoggins, J.W.; Thiel, V. 2020: LY6E impairs coronavirus fusion and confers immune control of viral disease. Nature Microbiology 5(11): 1330-1339

Mar, K.B.; Rinkenberger, N.R.; Boys, I.N.; Eitson, J.L.; McDougal, M.B.; Richardson, R.Blake.; Schoggins, J.W. 2018: LY6E mediates an evolutionarily conserved enhancement of virus infection by targeting a late entry step. Nature Communications 9(1): 3603

Matsuda, R.; Enokida, H.; Chiyomaru, T.; Kikkawa, N.; Sugimoto, T.; Kawakami, K.; Tatarano, S.; Yoshino, H.; Toki, K.; Uchida, Y.; Kawahara, K.; Nishiyama, K.; Seki, N.; Nakagawa, M. 2011: LY6K is a novel molecular target in bladder cancer on basis of integrate genome-wide profiling. British Journal of Cancer 104(2): 376-386

Laugier, P.; Gisselbrecht, H.; Risold, J.P.; Pageault, G. 1964: Lyell's Syndrome. Bulletin de la Societe Francaise de Dermatologie et de Syphiligraphie 71: 38-39

Jung, E.G.; Storck, H. 1964: Lyell's Syndrome. Schweizerische Medizinische Wochenschrift 94: 1790-1794

Liu, H.; Yu, Z.; Tang, B.; Miao, S.; Qin, C.; Li, Y.; Liang, Z.; Shi, Y.; Zhang, Y.; Wang, Q.; Yan, M.; Song, Z.; Ren, H.; Dong, Y. 2021: LYG1 Deficiency Attenuates the Severity of Acute Graft-Versus-Host Disease via Skewing Allogeneic T Cells Polarization Towards Treg Cells. Frontiers in Immunology 12: 647894

Nykytyuk, S.; Klymnyuk, S.; Podobivsky, S.; Levenets, S.; Stelmakh, O. 2020: Lyme Borreliosis - Endemic Disease in Children of Ternopil Region. Georgian Medical News 307: 95-104

Mallick, B.; Praharaj, D.L.; Nath, P.; Panigrahi, S.C.; Anand, A.C. 2021: Lymphadeno-Duodenal Fistula in Tuberculosis. Arquivos Brasileiros de Cirurgia Digestiva: Abcd 34(1): E1570

Kinoshita, J.H. 1964: Lymphadenosis. Archives of Ophthalmology 72: 578

Alcorn, F.S.; Hussey, F.L. 1964: Lymphangiography. Presbyterian-St. Luke's Hospital Medical Bulletin 3: 2-15

Rosenbaum, R.R.; Shtasel, P.; Halin, L. 1964: Lymphangiography. Journal of the American Osteopathic Association 63: 931-940

Wolfel, D.A. 1964: Lymphangiography. Maryland State Medical Journal 13: 75

White, W.F. 1964: Lymphangiography. British Journal of Clinical Practice 18: 359-368

Ouyang, C.; Chi, A.S.; Yang, P.C.; Shih, H. 1964: Lymphangiography. Chinese Medical Journal 83: 470-474

Schlachter, L.; Heiser, W. 1965: Lymphangiography. Illinois Medical Journal 127: 364-369

Seitzman, D.M. 1965: Lymphangiography. Gp 32: 117

Ruettimann, A. 1964: Lymphedema. Schweizerische Medizinische Wochenschrift 94: 846-848

Burattini, R.; Pricolo, V. 1964: Lymphedema of the Lower Extremities. Minerva Medica 55: 2471-2473

Thompson, H.B. 1927: Lymphoblastoma. California and Western Medicine 27(3): 343-345

Cudkowicz, G.; Upton, A.C.; Shearer, G.M.; Hughes, W.L. 1964: Lymphocyte Content and Proliferative Capacity of Serially Transplanted Mouse Bone Marrow. Nature 201: 165-167

De Roo, T. 1964: Lymphography. Nederlands Tijdschrift Voor Geneeskunde 108: 627-628

Desprez-Curely, J.P.; Bismuth, V. 1964: Lymphography. Coeur et Medecine Interne 19: 369-388

Asechi, S. 1964: Lymphography. Hinyokika Kiyo. Acta Urologica Japonica 10: 657-658

Eiken, M. 1965: Lymphography. Nordisk Medicin 73: 264-265

Ruettimann, A. 1964: Lymphography. Tijdschrift Voor Gastro-Enterologie 7: 127-141

Wiljasalo, M. 1965: Lymphography. Duodecim; Laaketieteellinen Aikakauskirja 81: 525-529

Caralpsriera, A. 1964: Lymphography in the Investigation of Inapparent Superficial Adenopathies. Revista Clinica Espanola 94: 372-375

Bwzes, H.; Armengaud, M. 1964: Lymphography in Tropical Elephantiasis of the Lower Extremities. Atlas de Radiologie Clinique de la Presse Medicale 1: 1-4

Smith, T.A. 1924: Lymphoid Hyperplasia of the Appendix in Children; its Relation to Recurrent Appendicitis. Annals of Surgery 79(6): 871-878

Clariaolmedo, R.A. 1964: Lymphosarcoma. Revista de la Sanidad Militar Argentina 63: 58-59

Navrkalova, V.; Plevova, K.; Hynst, J.; Pal, K.; Mareckova, A.; Reigl, T.; Jelinkova, H.; Vrzalova, Z.; Stranska, K.; Pavlova, S.; Panovska, A.; Janikova, A.; Doubek, M.; Kotaskova, J.; Pospisilova, S. 2021: LYmphoid NeXt-Generation Sequencing (LYNX) Panel: a Comprehensive Capture-Based Sequencing Tool for the Analysis of Prognostic and Predictive Markers in Lymphoid Malignancies. Journal of Molecular Diagnostics: Jmd 23(8): 959-974

Moser, H.; Toenz, O. 1964: Lyon's Hypothesis. Annales Paediatrici. International Review of Pediatrics 203: 385-389

Vang, T.; Liu, W.H.; Delacroix, L.; Wu, S.; Vasile, S.; Dahl, R.; Yang, L.; Musumeci, L.; Francis, D.; Landskron, J.; Tasken, K.; Tremblay, M.L.; Lie, B.A.; Page, R.; Mustelin, T.; Rahmouni, S.; Rickert, R.C.; Tautz, L. 2012: LYP inhibits T-cell activation when dissociated from CSK. Nature Chemical Biology 8(5): 437-446

He, H-Qiong.; Wu, Y-Xian.; Nie, Y-Juan.; Wang, J.; Ge, M.; Qian, F. 2017: LYRM03, an ubenimex derivative, attenuates LPS-induced acute lung injury in mice by suppressing the TLR4 signaling pathway. Acta Pharmacologica Sinica 38(3): 342-350

He, X.; Howard, B.A.; Liu, Y.; Neumann, A.K.; Li, L.; Menon, N.; Roach, T.; Kale, S.D.; Samuels, D.C.; Li, H.; Kite, T.; Kita, H.; Hu, T.Y.; Luo, M.; Jones, C.N.; Okaa, U.J.; Squillace, D.L.; Klein, B.S.; Lawrence, C.B. 2021: LYSMD3: a mammalian pattern recognition receptor for chitin. Cell Reports 36(3): 109392

Rinaldi, E.; Baggi, F. 2018: LYVE-1 is 'on stage' now: an emerging player in dendritic cell docking to lymphatic endothelial cells. Cellular and Molecular Immunology 15(7): 663-665

Guo, Y.; Zhao, Y.; Zhou, Y.; Tang, X.; Li, Z.; Wang, X. 2019: LZ-101, a novel derivative of danofloxacin, induces mitochondrial apoptosis by stabilizing FOXO3a via blocking autophagy flux in NSCLC cells. Cell Death and Disease 10(7): 484

Zou, X.; Meng, F.; Fu, C.; Zhou, J.; Zhang, Y.; Wang, R.; Zhang, C.; Li, Z.; Guo, Q.; Yang, L. 2020: LZ-106, a potent lysosomotropic agent, causing TFEB-dependent cytoplasmic vacuolization. Gene 760: 145017

Wu, J.-X.; He, K.-Y.; Zhang, Z.-Z.; Qu, Y.-L.; Su, X.-B.; Shi, Y.; Wang, N.; Wang, L.; Han, Z.-G. 2021: LZP is required for hepatic triacylglycerol transportation through maintaining apolipoprotein B stability. Plos Genetics 17(2): E1009357

Wei, Q.; Chen, Z-H.; Wang, L.; Zhang, T.; Duan, L.; Behrens, C.; Wistuba, I.I.; Minna, J.D.; Gao, B.; Luo, J-H.; Liu, Z.P. 2016: LZTFL1 suppresses lung tumorigenesis by maintaining differentiation of lung epithelial cells. Oncogene 35(20): 2655-2663

Abe, T.; Umeki, I.; Kanno, S-Ichiro.; Inoue, S-Ichi.; Niihori, T.; Aoki, Y. 2020: LZTR1 facilitates polyubiquitination and degradation of RAS-GTPases. Cell Death and Differentiation 27(3): 1023-1035

Muthusamy, K.; Mrugala, M.M.; Bendok, B.R.; Dhamija, R. 2021: LZTR1-related spinal schwannomatosis and 7q11.23 duplication syndrome: a complex phenotype with dual diagnosis. Molecular Genetics and Genomic Medicine 9(1): E1560

Zhang, H.; Cao, X.; Wang, J.; Li, Q.; Zhao, Y.; Jin, X. 2021: LZTR1: a promising adaptor of the CUL3 family. Oncology Letters 22(1): 564

Christoffer, C.; Bharadwaj, V.; Luu, R.; Kihara, D. 2021: LZerD Protein-Protein Docking Webserver Enhanced with de novo Structure Prediction. Frontiers in Molecular Biosciences 8: 724947

Talebzadeh, Z.; Masjedi-Arani, M.; Amiri, O.; Salavati-Niasari, M. 2021: La2Sn2O7/g-C3N4 nanocomposites: Rapid and green sonochemical fabrication and photo-degradation performance for removal of dye contaminations. Ultrasonics Sonochemistry 77: 105678

Boudry, A. 1949: La Bourboule, thermal arsenical gynecological therapy station; new indications and techniques. Concours Medical 71(22): 1279

Rylett, R.J.; Alary, F.; Goldberg, J.; Rogers, S.; Versteegh, P. 2020: La COVID-19 et les priorités de recherche sur le vieillissement. Canadian Journal on Aging 39(4): 506-512

Cappelle, F. 1948: La Cerdague and Font-Romeu altitude climatotherapy. Gazette Medicale de France 55(12): 475-478

Masson, G.ér. 2020: La Chimie Organique en France: Une Longue Tradition qui Persiste!. Journal of Organic Chemistry 85(18): 11589-11591

Castellari, E.; Tiboldo, G.; Moro, D.; Bimbo, F. 2021: La Dolce Vita in times of harshness: Prevalence of health-related behaviors during the great recession in Italy. Economics and Human Biology 43: 101062

Lees, A.J. 2020: La Folie des Grandeurs. Brain: a Journal of Neurology 143(7): 2325-2328

Lees, A.J. 2020: La Folie des Grandeurs. Brain: a Journal of Neurology 143(7): 2325-2328

Pereira Duarte, M.; Lencina, O.; Camino Willhuber, G.; Kido, G.; Julio, B.; Petracchi, M.; Solá, C.; Gruenberg, M. 2021: La Frailty as a predictor index in spine surgery. Revista de la Facultad de Ciencias Medicas 78(1): 9-16

Yang, D.; Greenfield, J.L.; Ronson, T.K.; von Krbek, L.K.S.; Yu, L.; Nitschke, J.R. 2020: LaIIi and ZnIi Cooperatively Template a Metal-Organic Capsule. Journal of the American Chemical Society 142(47): 19856-19861

Aubé, T.; Pisanu, S.; Merry, L. 2019: La Maison Bleue: Strengthening resilience among migrant mothers living in Montreal, Canada. Plos one 14(7): E0220107

Feng, M.; McPhaden, M.J.; Xie, S-Ping.; Hafner, J. 2013: La Niña forces unprecedented Leeuwin Current warming in 2011. Scientific Reports 3: 1277

Ambikapathi, R.; Kosek, M.N.; Lee, G.O.; Olortegui, M.P.; Zaitchik, B.; Peñataro Yori, P.; Bauck, A.; Caulfield, L.E. 2021: La Niña weather impacts dietary patterns and dietary diversity among children in the Peruvian Amazon. Public Health Nutrition 24(11): 3477-3487

Di Paolo, F.; Ledo, J.; Ślęzak, K.; Martínez van Dorth, D.; Cabrera-Pérez, Ián.; Pérez, N.M. 2020: La Palma island (Spain) geothermal system revealed by 3D magnetotelluric data inversion. Scientific Reports 10(1): 18181

Packard, F.R. 1919: La Société Française D' Historie de la Médecine. Annals of Medical History 2(2): 209-210

Le Briand, N.; Casalegno, J.-S.éb.; Escuret, V.; Gaymard, A.; Lina, B.; Ottmann, M.èl.; Frobert, E. 2016: La balance HA-NA des virus influenza A(H1N1). Virologie 20(1): 47-60

Huang, Z.; Zhao, S.; Li, Z.; Chen, W.; Zhao, L.; Deng, L.; Song, B. 2020: La batalla contra la enfermedad del Coronavirus 2019 (COVID-19): Manejo de Emergencia y Control de Infecciones en un Departamento de Radiología. Journal of the American College of Radiology: Jacr 17(7): E29-E36

Amerio, A.; Odone, A.; Aguglia, A.; Gianfredi, V.; Bellini, L.; Bucci, D.; Gaetti, G.; Capraro, M.; Salvati, S.; Serafini, G.; Signorelli, C.; Amore, M.; Ghaemi, S.N. 2020: La casa de papel: a pandemic in a pandemic. Journal of Affective Disorders 277: 53-54

Bridarolli, A.; Spiers, J.; Pituskin, E. 2020: La cloche de l'espoir : étude descriptive interprétative de l'expérience des patients atteints de cancer et des proches aidants à la fin du traitement. Canadian Oncology Nursing Journal 30(1): 43-47

Organista, K.C.; Arreola, S.G.; Neilands, T.B. 2016: La desesperación in Latino migrant day laborers and its role in alcohol and substance-related sexual risk. Ssm - Population Health 2: 32-42

Nisker, J. 2021: La distanciation physique favorise la proximité sociale dans un département d'obstétrique et gynécologie. Journal of Obstetrics and Gynaecology Canada: Jogc 43(6): 687-689

Koninckx, P.R.; Ussia, A.; Mashiach, R.; Vilos, G.; Martin, D.C. 2021: La douleur irradiée liée à l'endométriose. Journal of Obstetrics and Gynaecology Canada: Jogc 43(9): 1037-1038

Razvi, H. 2020: La feuille d'automne, emportée par le vent…. Canadian Urological Association Journal 14(10): E474

Tobaly-Tapiero, J.ël.; Zamborlini, A.; Saïb, A. 2012: La fixation des cellules, un écueil expérimental à éviter. Virologie 16(5): 332-333

Myster, F.ço.; Sorel, O.éa.; Palmeira, L.; Vanderplasschen, A.; Dewals, B.G. 2012: La forme africaine du coryza gangreneux est une maladie lymphoproliférative létale causée par l'herpèsvirus alcélaphin 1. Virologie 16(5): 299-314

Kenan, D.J.; Keene, J.D. 2004: La gets its wings. Nature Structural and Molecular Biology 11(4): 303-305

Train, A.; Moe, S.; Allan, G.M. 2021: La glucosamine et la chondroïtine sont-elles des remèdes naturels pour l'arthrose?. Canadian Family Physician Medecin de Famille Canadien 67(2): E59-E60

Jamain, B.; Bonhomme, J. 1955: La gyné cologie in 1954. La Revue du Praticien 5(21): 2145-2148

Sánchez-Pérez, O.A.; Rodríguez-Orozco, A.R. 2021: La higiene en la ciudad de Morelia, México, durante el régimen del porfiriato. Cirugia y Cirujanos 89(4): 565-569

Pages, W.H. 1982: La importancia de la areas libres de fiebre aftos para los paises importadores de productos y subproductos pecuarios. Revue Scientifique et Technique 1(3): 741-772

Chai, J.-S.; Yang, G.; Xu, J.; Wang, W.-W.; Xu, L.-F.; Wang, J.-T. 2021: La induced Si3 trimer bilayer on the Si(111) surface. Physical Chemistry Chemical Physics: Pccp 23(19): 11466-11471

Gaumont, R. 1983: La leptospirose chez le bétail en Europe. Revue Scientifique et Technique 2(1): 57-77

Ziegler, C. 2021: La litterature médicale mondiale. Journal of Obstetrics and Gynaecology Canada: Jogc 43(5): 551-554

Ziegler, D.C. 2021: La litterature médicale mondiale. Journal of Obstetrics and Gynaecology Canada: Jogc 43(7): 807-811

Ziegler, C. 2020: La littérature médicale mondiale. Journal of Obstetrics and Gynaecology Canada: Jogc 42(5): 546-549

Ziegler, C. 2020: La littérature médicale mondiale. Journal of Obstetrics and Gynaecology Canada: Jogc 42(9): 1076-1079

Ziegler, C. 2020: La littérature médicale mondiale. Journal of Obstetrics and Gynaecology Canada: Jogc 42(11): 1314-1317

Ziegler, C. 2021: La littérature médicale mondiale. Journal of Obstetrics and Gynaecology Canada: Jogc 43(3): 294-297

El-Messidi, A. 2020: La littérature médicale mondiale : obstétrique. Journal of Obstetrics and Gynaecology Canada: Jogc 42(8): 943-947

Maxwell, D.C. 2020: La littérature médicale mondiale : obstétrique. Journal of Obstetrics and Gynaecology Canada: Jogc 42(12): 1466-1468

Maxwell, D.C. 2021: La littérature médicale mondiale : obstétrique. Journal of Obstetrics and Gynaecology Canada: Jogc 43(4): 432-434

Scully, C. 1993: La maladie du petit papier. British Dental Journal 175(8): 289-292

Meisner, B.A.; Boscart, V.; Gaudreau, P.; Stolee, P.; Ebert, P.; Heyer, M.; Kadowaki, L.; Kelly, C.; Levasseur, M.él.; Massie, A.S.; Menec, V.; Middleton, L.; Taucar, L.S.; Thornton, W.L.; Tong, C.; van den Hoonaard, D.K.; Wilson, K. 2020: La nécessité des approches interdisciplinaires et collaboratives pour évaluer l'impact de la COVID-19 sur les personnes âgées et le vieillissement: déclaration conjointe de l'ACG / CAG et de la RCV / CJA. Canadian Journal on Aging 39(4): 487-499

Sperandio, A.Maria.Girotti.; Bloes, R.Brandini.; Cifoni, G.Gastaldo.; de Andrade, Mônica. 2021: La pandemia de la COVID-19 y las estrategias de promoción de la salud en las ciudades brasileñas. Global Health Promotion 2021: 17579759211009196

Steben, M.; Norris, T.; Rosberger, Z. 2020: La pandémie de COVID-19 ne sera pas la dernière (ni la pire) : Il est temps d'intégrer la résilience à nos objectifs d'élimination du cancer du col de l'utérus. Journal of Obstetrics and Gynaecology Canada: Jogc 42(10): 1197-1199

Pavio, N.; Rose, N.; Barnaud, E.; Doceul, V. 2015: La pluralité de l'hépatite E : des formes cliniques aux souches animales. Virologie 19(3): 149-160

Muraille, E. 2021: La promoción de la salud en un mundo globalizado necesita adoptar la perspectiva 'Una Salud'. Global Health Promotion 2021: 17579759211035071

Muraille, E. 2021: La promotion de la santé dans un monde globalisé nécessite l'adoption d'une perspective One health. Global Health Promotion 2021: 17579759211035072

Laverack, G. 2018: La promotion de la santé est-elle culturellement compétente pour travailler avec les migrants ?. Global Health Promotion 25(2): 96-98

Caporale, V.P.; Nannini, D. 1984: La prophylaxie de la brucellose bovine en Italie. Revue Scientifique et Technique 3(4): 909-920

Chadi, N.; Vyver, E.; Bélanger, R.E. 2021: La protection des enfants et des adolescents contre les risques du vapotage. Paediatrics and Child Health 26(6): 358-374

Morin, B.; Whelan, S.P.J. 2012: La protéine L des Mononegavirales. Virologie 16(4): 258-268

Quetier, I.; Kremsdorf, D. 2014: La protéine X du virus de l'hépatite B et son rôle dans le développement du carcinome hépatocellulaire. Virologie 18(4): 229-238

Delaugerre, C.; Gatey, C.; Chaix, M.-L.; Molina, J.-M. 2016: La prévention pré-exposition au VIH-1 par les antirétroviraux, la PrEP. Virologie 20(3): 147-157

Andral, L.; Blancou, J. 1982: La rage. Nouveaux développements en matière de vaccination. Revue Scientifique et Technique 1(4): 895-990

Ball, C.G.; Harvey, E.J. 2020: La recherche médicale en temps de pandémie. Canadian Journal of Surgery. Journal Canadien de Chirurgie 63(3): E314

Hutten-Czapski, P. 2021: La résilience rurale. Canadian Journal of Rural Medicine: the Official Journal of the Society of Rural Physicians of Canada 26(3): 100

Gaitán-Duarte, H.; Estrada-Orozco, K. 2021: Safety in healthcare services, a worldwide priority in women care. Revista Colombiana de Obstetricia y Ginecologia 72(2): 141-148

Teixeira, M.Teresa.; Gilson, E. 2007: La sets the tone for telomerase assembly. Nature Structural and Molecular Biology 14(4): 261-262

Tarbouriech, N.; Flusin, O.; Sele, C.él.; Iseni, F.éd.ér. 2012: La synthèse du génome des poxvirus. Virologie 16(4): 210-224

Aschman, N.; Weissenhorn, W.; Renesto, P. 2012: La tétherine, dernière amarre du VIH. Virologie 16(1): 32-42

Guerra-Librero, P. 2020: La voz de una enfermera desde la zona roja. Medicc Review 22(4): 74-79

Gamov, G.A.; Zavalishin, M.N.; Pimenov, O.A.; Klochkov, V.V.; Khodov, I.A. 2020: La(III), Ce(III), Gd(III), and Eu(III) Complexation with Tris(hydroxymethyl)aminomethane in Aqueous Solution. Inorganic Chemistry 59(23): 17783-17793

Liao, T.; Huang, P.; Song, H.; Guo, J.; Fu, X.; Yu, X.; Peng, L.; Han, B.; Zhu, Y.; Zhang, Y. 2020: La(OH)3-modified magnetic sodium carboxymethyl cellulose for sequential removal of pollutants: adsorption of phosphate and subsequent photocatalytical reduction of Cr(VI). Environmental Science and Pollution Research International 27(32): 40346-40354

He, J.; Yang, Y.; Xu, Y.; Wang, Z.; Xu, B.; Huang, Y.; Yang, L. 2020: La(OH)3 nano-rods/polyacrylonitrile nanofibers: fabrication, characterization and application for phosphate removal. Water Science and Technology: a Journal of the International Association on Water Pollution Research 82(10): 2098-2113

Malissen, B.; Marguet, D. 2011: La(s)t but not least. Nature Immunology 12(7): 592-593

Liu, B.; Nan, J.; Zu, X.; Zhang, X.; Huang, W.; Wang, W. 2020: La-based-adsorbents for efficient biological phosphorus treatment of wastewater: Synergistically strengthen of chemical and biological removal. Chemosphere 255: 127010

Yuan, C.; Chen, R.; Wang, J.; Wu, H.; Sheng, J.; Dong, F.; Sun, Y. 2020: La-doping induced localized excess electrons on (BiO)2CO3 for efficient photocatalytic NO removal and toxic intermediates suppression. Journal of Hazardous Materials 400: 123174

Warusawithana, M.P.; Richter, C.; Mundy, J.A.; Roy, P.; Ludwig, J.; Paetel, S.; Heeg, T.; Pawlicki, A.A.; Kourkoutis, L.F.; Zheng, M.; Lee, M.; Mulcahy, B.; Zander, W.; Zhu, Y.; Schubert, J.; Eckstein, J.N.; Muller, D.A.; Hellberg, C.Stephen.; Mannhart, J.; Schlom, D.G. 2013: LaAlO3 stoichiometry is key to electron liquid formation at LaAlO3/SrTiO3 interfaces. Nature Communications 4: 2351

Qiu, P.; Yang, X.; Zou, L.; Zhu, T.; Yuan, Z.; Jia, L.; Li, J.; Chen, F. 2020: LaCrO3-Coated La0.6Sr0.4Co0.2Fe0.8O3-δ Core-Shell Structured Cathode with Enhanced Cr Tolerance for Intermediate-Temperature Solid Oxide Fuel Cells. Acs Applied Materials and Interfaces 12(26): 29133-29142

Liu, J.; Xia, Y.; Jiang, W.; Shen, G.; Pang, Y. 2021: LaPT2 Gene Encodes a Flavonoid Prenyltransferase in White Lupin. Frontiers in Plant Science 12: 673337

Xu, Z.; Palgrave, R.G.; Hayward, M.A. 2020: LaSrCo0.5Rh0.5O3.25 and LaSrNi0.5Rh0.5O3.25:Topochemically Reduced, Mixed Valence Rh(I)/Rh(III) Oxides. Inorganic Chemistry 59(18): 13767-13773

Poddig, H.; Finzel, K.; Doert, T. 2020: LaTe1.82(1): modulated crystal structure and chemical bonding of a chalcogen-deficient rare earth metal polytelluride. Acta Crystallographica. Section C Structural Chemistry 76(Part 6): 530-540

Graham, D.M. 2016: Lab Animal is turning 45. Lab Animal 45(1): 3

Khanfar, H.S.; Sitepu, H. 2021: Lab Case Study of Microbiologically Influenced Corrosion and Rietveld Quantitative Phase Analysis of X-ray Powder Diffraction Data of Deposits from a Refinery. Acs Omega 6(18): 11822-11831

Landhuis, E. 2016: Lab Mice Are Too Clean. Scientific American 315(1): 12-13

Hackett, J. 2016: Lab Tech Opening: 249 Miles above Earth. Scientific American 314(6): 17

Bateson, P.; Ragan, C.Ian. 2014: Lab animals: Can GM marmoset use be justified?. Nature 514(7524): 567

Penglase, S.; Moren, M.; Hamre, K. 2012: Lab animals: Standardize the diet for zebrafish model. Nature 491(7424): 333

Bonetta, L. 2003: Lab architecture: do you want to work here?. Nature 424(6950): 718-720

Georghiou, L. 2012: Lab assets: Database for sharing costly equipment. Nature 490(7420): 342

Samuel Reich, E. 2012: Lab astrophysics aims for the stars. Nature 491(7425): 509

Blow, N. 2008: Lab automation: tales along the road to automation. Nature Methods 5(1): 109-112

Wadman, M. 2011: Lab bred chimps despite ban. Nature 479(7374): 453-454

Osumi-Sutherland, D. 2004: Lab chiefs fear European rules will cost postdoc jobs. Nature 431(7004): 6

Pearson, H. 2004: Lab closure sparks fears that US prion research is waning. Nature 430(7000): 596

Lindley, D. 1992: Lab death blamed on gas build-up. Nature 357(6380): 620